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The present study examined the influence of hormones on obsessive-compulsive disorder (OCD) 
symptoms and related phenomena across the menstrual cycle. After exclusions, 223 participants 
(51 free-cycling women, 100 hormonal contraceptive users, and 72 men), completed 
questionnaires on disgust sensitivity, OCD symptoms, responsibility beliefs, risk-taking, and 
anxiety two weeks apart using a within-subjects design (follicular and luteal phases for free-
cycling women). Laboratory participants (n = 178) also completed an emotion discrimination 
task, had 2D:4D measured, and a subset of women provided saliva samples (n = 56). Contrary to 
the compensatory prophylaxis hypothesis, subclinical OCD contamination symptoms, disgust 
sensitivity, and related phenomena did not increase with progesterone levels. However, changes 
in salivary progesterone levels across the cycle were positively correlated with changes in 
anxiety and negatively correlated with risk-taking. Sexual activity and level of contamination 
fears were significant moderators of behavior change across the cycle. Non-sexually active 
(versus sexually active) women and women with high (versus low) contamination fears showed 
an increase in OCD symptoms from the follicular to the luteal phases. Women with PMS (versus 
those without) showed increased OCD symptoms, disgust-sensitivity and responsibility beliefs at 
both phases of the menstrual cycle. Finally, women were more sensitive to detecting facial 
expressions of disgust than men. Greater disgust sensitivity detection was also associated with 
higher 2D:4D, and use of oral contraceptives with either high progesterone dosage or low 
androgenicity. The current findings suggest that perhaps not all women experience an increase in 
precautionary behaviour across the menstrual cycle, but that there may be subgroups of women 
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Anxiety Symptoms and Precautionary Behaviour across the Menstrual Cycle: The Role of 
Hormones 
There are particular “windows of vulnerability” across a woman’s lifetime where the risk 
of mood disturbance increases, such as puberty, the premenstrual phase, pregnancy, the 
postpartum period, and menopause (Soares, 2010b). Reproductive events such as the 
premenstrual phase, pregnancy, and the postpartum period have also been shown to affect 
obsessive compulsive symptoms in women (Labad et al., 2005). These major reproductive events 
correspond to periods of fluctuating reproductive hormone levels in women (e.g., estrogen and 
progesterone). Emerging research suggests that the hormone progesterone may affect obsessive-
compulsive symptoms related to fears of contamination. Examining the association between 
hormones and sub-clinical obsessive compulsive symptoms (and related phenomena) may help 
to explain sex differences in anxiety symptoms. 
Mood across reproductive events 
Rates of depression are equivalent between boys and girls in childhood but radically shift 
as women experience menarche, or the commencement of menstruation. Following puberty 
women are two times more likely to develop depression compared to men, a difference that 
persists throughout the reproductive years and declines again following menopause (Steiner, 
2009). These marked sex differences in mood have implicated gonadal steroid hormones (e.g., 
estrogen, progesterone) in the development of depression. Women experience a series of 
reproductive events across the lifespan that are accompanied by specific hormonal changes. 
These include menarche, across different menstrual cycle phases, pregnancy, the postpartum 





Menarche. Puberty refers to a series of changes that take place in adolescence to develop 
the capacity for reproduction. Pubertal changes include the development of primary and 
secondary sexual characteristics (e.g., development of the sex organs and pubic hair growth), 
physical maturation (e.g., growth spurt), and the occurrence of specific events such as menarche 
(first menstruation) for women and oigarche (first ejaculation) for men (Reardon, Leen-Feldner, 
& Hayward, 2009). Although puberty occurs on average between the ages of 12 and 13, pubertal 
changes can span over the course of up to four years (Reardon et al., 2009). Compared to other 
aged-matched peers, onset of puberty can be early, on-time, or late (Reardon et al., 2009). In a 
longitudinal study of over 2,000 girls, Joinson, Heron, Lewis, Croudace, and Araya (2011) found 
earlier age at menarche was associated with higher levels of depressive symptoms compared to 
girls with a normal and later age at menarche. 
The menstrual cycle. In order for women to be able to reproduce, a complex process is 
maintained on a monthly basis by the secretion of hormones from several endocrine glands. The 
hypothalamus secretes gonadotropin-releasing hormone (GnRH) through the hypophyseal portal 
system to the anterior pituitary (Hawkins & Matzuk, 2008). Follicle-stimulating hormone (FSH) 
and luteinizing hormone (LH) are then secreted from the anterior pituitary and travel through the 
bloodstream to reach the ovaries (Becker, Breedlove, Crews, & McCarthy, 2001). Follicle-
stimulating hormone, as the name suggests, stimulates the growth of follicles in the ovary. Each 
follicle contains an egg, or an oocyte (Greenberg, Bruess, & Conklin, 2011). 
The menstrual cycle can be divided into three general phases: the follicular phase (days 
1-13), ovulation (days 13-14), and the luteal phase (days 15-28; Sigmon & Schartel, 2008). 
Although the average cycle length is 28 days, there is significant variation in cycle length with 





cycle also has a number of sub-phases within the overarching phases. Although there are subtle 
differences across definitions, days 1-5 generally correspond to the early follicular or menstrual 
phase, days 6-10 to the mid-follicular or postmenstrual phase, days 11-14 to the late follicular or 
periovulatory phase, days 15-18 to the early luteal phase, days 19- 23 to the mid-luteal phase, 
and days 24-28 to the late luteal phase (Bäckström, Boyle, & Baird, 1981; Sanders, Warner, 
Bäckström, & Bancroft, 1983). 
During the follicular phase the ovaries secrete estrogen, which causes the endometrium 
(lining of the uterus) to proliferate (Hawkins & Matzuk, 2008; Luria, Friedman, & Rose, 1987). 
As estrogen levels increase throughout the late follicular phase, a negative feedback signal is sent 
back to the anterior pituitary causing a surge in LH that triggers ovulation (Hawkins & Matzuk, 
2008). The release of an egg leaves a ruptured follicle that becomes the corpus luteum. During 
the luteal phase the corpus luteum secretes progesterone and estrogen and the endometrium 
thickens in order for a fertilized embryo to attach (Greenberg et al., 2011; Hawkins & Matzuk, 
2008; Luria et al., 1987). High levels of estrogen and progesterone cause negative feedback 
which keeps FSH and LH levels low. If the egg is not fertilized and fails to attach, the corpus 
luteum degenerates and progesterone and estrogen levels consequently drop (Luria et al., 1987). 
Decreased levels of estrogen and progesterone signal the endometrium to shed, or menstruation 
to begin. During the menstrual or early follicular phase FSH levels start to rise and the cycle 
starts anew. 
Both estrogen and progesterone levels fluctuate across the menstrual cycle, but show 
considerably different patterns. Progesterone levels remain low throughout the early and mid-
follicular phases, and start to rise during the late follicular phase just prior to ovulation. 





phase, and then begin to fall during the late luteal phase (Sanders et al., 1983). In contrast, 
estrogen levels are initially low during the early follicular phase, rise in the mid-follicular phase, 
and peak in the late follicular phase just prior to the LH peak. Estrogen levels fall after the late 
follicular phase peak, then begin to rise again during the early luteal phase, peak during the mid-
luteal phase, and then fall during the late luteal phase (Sanders et al., 1983). 
For many women natural changes in estrogen and progesterone levels across the 
menstrual cycle have noticeable effects on mood. Premenstrual syndrome (PMS) is likely the 
most well-known mood disturbance related to the menstrual cycle. Premenstrual symptoms can 
include sadness, tension/anxiety, mood lability, irritability or anger, lack of interest in normal 
activities, fatigue, appetite changes, insomnia, feeling overwhelmed, and physical symptoms 
such as headaches, muscle pain, bloating, or breast tenderness (American Psychiatric 
Association, 2000). A recent large-scale study of nearly 4,000 women (Tschudin, Bertea, & 
Zemp, 2010) found that 91% of women sampled experienced at least one PMS symptom, but 
only 10.3% met criteria for PMS according to the Premenstrual Symptoms Screening Tool 
(PSST; Steiner, Macdougall, & Brown, 2003). To meet criteria for PMS according to the PSST 
women must experience at least five symptoms that occur exclusively in the pre-menstrual 
period, which moderately to severely interfere with at least one of five psychosocial domains of 
functioning (Steiner et al., 2003). There appears to be a genetic component to PMS, as 
concordance rates for identical twins are 90% compared to 44% for fraternal twins (Clayton, 
2008). Furthermore, PMS is more likely in women whose mothers have a history of PMS, 
although this could also be due to environmental causes such as attitudes and expectancies 





Premenstrual Dysphoric Disorder (PMDD) is a more severe form of premenstrual mood 
disturbance that significantly interferes with work, school, or social functioning, or causes 
significant distress. It is far less common than PMS, occurring in only 3 to 8% of women 
(Steiner, Dunn, & Born, 2003). Although PMDD was previously listed under “Criteria Sets and 
Axes Provided for Further Study” (i.e., Appendix B) of the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR; American Psychiatric Association, 2000, 
p. 759), it has been added to the DSM-5 as a new depressive disorder (American Psychiatric 
Association, 2013). In order to meet criteria for PMDD, five of the following nine symptoms 
must be present: marked affective lability, marked irritability, marked depressed mood, marked 
anxiety, decreased interest in usual activities, difficulty concentrating, lack of energy/fatigue, 
hypersomnia/insomnia, feeling out of control/overwhelmed, and physical symptoms such as 
breast tenderness and bloating. Out of the four core affective symptoms (i.e., depressed mood, 
anxiety, irritability/anger, and affective lability), at least one must be present (Sigmon & 
Schartel, 2008). Most importantly, these symptoms must be present during the week before 
menstruation, improve shortly after the onset of menses, and be minimal or absent in the week 
after menses (American Psychiatric Association, 2013; Tschudin et al., 2010).  
Given the lack of reliability with retrospective self-reports, prospective daily measures 
are needed across two cycles in order to more accurately diagnose PMDD (American Psychiatric 
Association, 2011; Sigmon & Schartel, 2008). However, this gold-standard approach is not 
always feasible in research or in practice. It is also expected that to receive the diagnosis, 
symptoms must be present in the majority of menstrual cycles in the past year. A diagnosis of 
PMDD should not be given if there is premenstrual exacerbation of another disorder (e.g., major 





between PMDD and premenstrual exacerbation of anxiety or mood disorders can be extremely 
challenging. There is significant comorbidity between diagnoses of PMDD and major 
depression, as 30 to 70% of women with PMDD have a history of a depressive episode (Burt & 
Stein, 2002). Furthermore, selective serotonin reuptake inhibitors (SSRIs) have been found to be 
effective for treating both depression and PMDD (Braverman, 2007; Soares & Zitek, 2008). 
Although this suggests a common cause, SSRI treatment for PMDD improves symptoms 
immediately (1-2 days) rather than requiring 4 to 6 weeks, and is only needed during the luteal 
phase of the menstrual cycle rather than continuously (Braverman, 2007). 
Hormonal contraceptives. Contraceptive use is very common in women of childbearing 
age, with one national study finding that 62% of women aged 15-44 in the United States were 
using some form of contraception between 2006 and 2010 (Jones, Mosher, & Daniels, 2012). 
There are a number of different methods of contraception, including pills or oral contraceptives 
(OCs), contraceptive patch (e.g., Ortho-Evra), injectable birth control (e.g., Depo-Provera), 
vaginal rings (e.g., NuvaRing), implant (e.g., Implanon), intrauterine device (IUD), and barrier 
methods (e.g., diaphragm, cervical cap; Jones et al., 2012). Whereas the methods listed above are 
reversible, there are also permanent methods of birth control such as female sterilization. Of all 
the types of contraception, the pill was found to be the most common contraceptive method for 
younger women and female sterilization was the most common method for older women (Jones 
et al., 2012). 
Oral contraceptive pills come in many different formulations with different types of 
synthetic hormones. Ethinyl estradiol (EE) is the form of estrogen typically used in OCs whereas 
several different types of progestins are used across different brands of OCs (e.g., norgestimate, 





according to their specific formulations. Monophasic OCs supply consistent amounts of estrogen 
and progesterone across the first three weeks of the cycle whereas triphasic OCs provide 
increasing amounts of progesterone each week (Kiley & Hammond, 2007). The final week is 
either a pill-free interval or consists of placebo pills, which are hormonally equivalent (Kiley & 
Hammond, 2007). Triphasic pills were created with the aim of more naturally mimicking the 
menstrual cycle as well as decreasing side effects (Van Vliet, Grimes, Lopez, Schulz, & 
Helmerhorst, 2006). In a meta-analysis of 21 trials, Van Vliet and colleagues (2006) found that 
mono and triphasic formulations were equally effective for contraception and there were no 
differences in the rates of discontinuation. Extended use OCs are also available (e.g., Seasonale), 
where a woman can reduce the number of menstrual periods down to four a year by taking 84 
straight days of active pills (Kiley & Hammond, 2007). Thus, Seasonale contains the same 
formulation of hormones as other monophasic OCs, but removes the monthly seven day pill-free 
interval. Extended use OCs have demonstrated long-term safety (Anderson, Gibbons, & 
Portman, 2006) and are similar to standard 28-day cycle OCs in terms of contraceptive efficacy, 
compliance, and satisfaction rates (Edelman, Micks, Gallo, Jensen, & Grimes, 2014). There is 
also evidence suggesting that extended use OCs may reduce premenstrual symptoms (Coffee, 
Kuehl, Willis, & Sulak, 2006; Edelman et al., 2014), although more research is needed in this 
area. 
Oral contraceptives contain a combination of estrogen and progesterone that inhibit LH, 
FSH, and GnRH levels and thereby typically prevent ovulation from occurring (Rapkin, Biggio, 
& Concas, 2006). Women taking OCs do not experience the characteristic rise of estrogen and 
progesterone across the cycle and therefore they act as a naturally occurring control group for 





show clear hormonal differences compared to naturally cycling women, including lower serum 
levels of estradiol and progesterone (Fleischman et al., 2010; Kjeld, Puah, & Joplin, 1976), and 
more recently evidence has emerged suggesting lower androgen levels. A recent meta-analysis of 
over 40 studies concluded that OC use significantly decreased circulating levels of total and free 
testosterone (Zimmerman, Eijkemans, Coelingh Bennink, Blankenstein, & Fauser, 2014). 
Oral contraceptives differ in their level of androgenicity or androgen receptor binding, 
which may have an effect on mood symptoms. Some formulations of OCs contain progestins 
with high levels of androgenic activity (e.g., norgestrel, levonorgestrel), while other formulations 
contain progestins with anti-androgenic properties (e.g., drospirenone, norgestimate; Chiang, 
2005; Dickey, 2010). Research suggests that low androgenicity OCs may have a more favourable 
effect on mood compared to high androgenicity OCs (Poromaa & Segebladh, 2012). 
Research suggests that hormonal contraceptives may have a protective effect on mood. In 
a review of the effects of OCs on mood, Oinonen and Mazmanian (2002) found that generally 
speaking, OC users experience less variability in affect across the menstrual cycle and less 
negative affect during menstruation compared to non-users. Monophasic OCs were found to 
provide more mood stability compared to triphasic OCs (Oinonen & Mazmanian, 2002). 
Furthermore, a recent study of a large sample of sexually active women in the United States 
found that current hormonal contraceptive users (aged 25-34) had lower levels of depressive 
symptoms compared to women using non-hormonal contraception or no form of contraception, 
even when controlling for past depressive symptoms (Keyes et al., 2013). Oral contraceptives 
can be helpful for women with severe premenstrual symptoms, as they have been shown to 





Despite the seemingly protective effect of OCs on mood, there is a subset of women who 
experience adverse mood and somatic symptoms when taking OCs (Oinonen & Mazmanian, 
2002). Prospective studies suggest that between 4 and 10% of women experience deterioration in 
mood or emotional well-being as a result of OC use, with these symptoms being most 
pronounced during the pill-free interval of the cycle (Poromaa & Segebladh, 2012). A prior 
history of depression or premenstrual mood symptoms, pregnancy-related mood symptoms, 
family history of OC-related mood symptoms, and being in the postpartum period were several 
factors that Oinonen and Mazmanian (2002) identified as increasing the risk for women 
experiencing negative mood symptoms as a result of OC use. Use of OCs can also affect 
symptom severity for existing psychological conditions. For instance, in a small retrospective 
study of 16 patients diagnosed with OCD, Labad and colleagues (2006) found that 19% of 
patients reported that OC use was associated with a change in OCD symptoms. Two patients 
reported an improvement in symptoms and one patient reported a worsening of symptoms. 
Therefore, OC use may represent an additional period of vulnerability to fluctuating hormone 
levels in some women. 
The postpartum period. Although depressive symptoms can occur during pregnancy, 
the postpartum period is still recognized as a time of particular vulnerability for a range of mood 
disturbances. There appears to be something unique about the postpartum period which triggers 
index episodes of depression (Stowe & Nemeroff, 1995). Depressive symptoms can range 
considerably in severity from the “baby blues” to postpartum depression. 
The “blues” is the most common postpartum mood disturbance, occurring in 39 to 85% 
of mothers (Spinelli, 1998). Symptoms include tearfulness, fatigue, dysphoria, mood lability, 





Symptoms typically emerge in the first week postpartum, peaking around day 5, and subside by 
the second week postpartum (Steiner et al., 2003). Due to the common occurrence of the blues 
and the fact that symptoms typically resolve themselves, treatment is not generally sought for 
this condition (Heron et al., 2005). However, women who experience the blues are thought to be 
at a greater risk of developing postpartum depression (Spinelli, 1998; Steiner et al., 2003). 
Therefore, in some cases the blues can endure and lead to more serious depressive symptoms. 
 Postpartum depression is a more severe form of the blues and occurs in between 10 to 
15% of women following delivery (Steiner et al., 2003). For 50% of women who experience 
postpartum depression, it is their first mood episode (Stowe & Nemeroff, 1995). Although the 
diagnostic criteria for postpartum depression is the same as depression at any other stage of life, 
the DSM-IV-TR includes additional symptoms which may be more specific to the postpartum 
period such as mood lability, anxiety, preoccupation with the well-being of the infant, over-
intrusiveness, and disinterest or fear of being alone with the infant (American Psychiatric 
Association, 2000). Similarly, Sharma (2005) refers to additional symptoms which may occur in 
the postpartum including features of anxiety such as obsessionality, feeling inadequate as a 
mother, and having a fear of harming the baby.  
Menopause. By the age of 51, most women experience menopause, or the absence of 
menstruation for 12 consecutive months (Burt & Stein, 2002). Perimenopause marks the 5 to 15 
year period of gradual estrogen depletion until the cessation of menstruation, or amenorrhea 
(Burt & Stein, 2002; Deecher, Andree, Sloan, & Schechter, 2008; Rapkin, Mikacich, Moatakef-
Imani, & Rasgon, 2002). Perimenopause is a time of particular variability in estrogen levels as 
menstrual cycles become more irregular closer to menopause (Douma, Husband, O’Donnell, 





be a time of heightened risk for developing depression. Women with a history of depression 
during other reproductive events are especially at risk for relapse during perimenopause (Parry, 
2008). A perimenopausal period of longer duration has also been found to increase the risk of 
depression (Rapkin et al., 2002). 
In terms of new onset of depression, Cohen, Soares, Vitonis, Otto, and Harlow (2006) 
examined 460 pre-menopausal women between the ages of 36 and 45 with no prior history of 
major depression. After controlling for age upon entering the study and negative life events, 
women entering perimenopause were twice as likely to develop symptoms of depression 
compared to women who did not begin the transition to menopause. A similar study of 231 pre-
menopausal women without a history of depression was conducted by Freeman, Sammel, Lin, 
and Nelson (2006). After an eight year follow-up period, 43% of participants had begun 
transitioning to menopause. Women who had begun the menopause transition were four times 
more likely to have high depression scores compared to premenopausal women. Interestingly, 
variability in mean estradiol levels was associated with high depressive scores, highlighting the 
possible role of fluctuating estrogen levels in the development of depression. 
Hormones and mood 
The mood-altering effects of estrogen have been well documented. Estrogen receptors  
have been found throughout the brain in areas such as the amygdala, the hippocampus, and the 
hypothalamus, to name a few (Soares & Zitek, 2008; Wise, Felker, & Stahl, 2008). Estrogen has 
been found to modulate a number of neurotransmitters such as serotonin, dopamine, 
norepinephrine, glutamate, and GABA (Douma et al., 2005; Wise et al., 2008). Estrogen has 
been found to act in accordance with the first class of antidepressants, the monoamine-oxidase 





for metabolizing monoamine neurotransmitters (e.g., norepinephrine, dopamine, serotonin) 
lingering in the pre-synaptic terminal, thus increasing their availability (Meyer & Quenzer, 
2005). Estrogen also breaks down MAO, thus causing antidepressant-like effects (Studd & 
Panay, 2009). In addition, estrogen exerts influence on the expression of the serotonin reuptake 
transporter (SERT) and activates other enzymes involved in increasing the availability of 
serotonin (e.g., tryptophan hydroxylase; Deecher et al., 2008). 
The importance of estrogen in the development of depression is also evidenced by the 
effectiveness of estrogen therapy for treating depression across numerous reproductive events, 
such as the postpartum (Ahokas, Kaukoranta, Wahlbeck, & Aito, 2001) and perimenopausal 
period (de Novaes Soares, Almeida, Joffe, & Cohen, 2001; Gordon & Girdler, 2014). Cohen and 
colleagues (2006) found that hormonal therapy acted as a preventive measure, as severe 
depressive symptoms were less common among women who initiated hormonal therapy to 
regulate their cycles or to manage perimenopausal symptoms. Hormone therapy has been 
particularly publicized for use surrounding menopause due to its effects not just on mood, but 
also on cognitive and vasomotor symptoms (Parry, 2010; Soares, 2010a). For women who have 
experienced depression across several reproductive events, hormonal therapy may be a more 
effective choice than antidepressants (Studd & Panay, 2009). Future studies should include head 
to head trials of antidepressants and hormone therapy in women with depression, with and 
without a history of depression across several reproductive events. 
Hormonal theories of reproductive mood change. There is a strong link between mood 
and reproductive events. Earlier age at menarche, irregular menstrual cycles, PMS, and PMDD 
are all associated with an increased risk for developing depression (Bloch, Rotenberg, Koren, & 





research was heavily focused on examining differences in absolute levels of various hormones 
such as estrogen and progesterone to explain the occurrence of depression across reproductive 
events. However, differences have generally not been found between absolute hormone levels 
and depressive symptoms across reproductive events. For instance, Klier et al. (2007) did not 
find a relationship between total levels of estrogen and progesterone or the magnitude of change 
in these hormones and depressive symptoms in the early postpartum period. In addition, PMS is 
not thought to be related to abnormal levels of estrogen or progesterone, but occurs in women 
who may be sensitive to normal hormonal fluctuations (Braverman, 2007; Studd & Panay, 2009). 
Thus, examining the magnitude of hormonal changes may be an overly simplistic approach, as 
hormonal profiles differ considerably across reproductive events. Progesterone levels increase 
from late adolescence into the mid-twenties, but become more variable after age 35 and begin to 
decrease as ovarian function gradually starts to decline (Ellison, 1993). During pregnancy, 
progesterone and estrogen rise 10-and 50-fold over maximum menstrual cycle levels in the third 
trimester and then drop dramatically within the first week following delivery (Bloch, Daly, & 
Rubinow, 2003). In contrast to sudden hormone withdrawal, fluctuating estrogen levels are 
associated with puberty, PMS, and the perimenopausal period (Douma et al., 2005). 
The theory of hormonal sensitivity posits that mood disturbance across major 
reproductive events can be caused by vulnerability to fluctuating hormone levels. According to 
this model, reproductive events such as menarche, the premenstrual period, postpartum, and 
perimenopause are seen as “windows of vulnerability” for mood disorders (Soares, 2010b). A 
subgroup of women is thought to show a heightened sensitivity to intense hormonal fluctuations 
across major reproductive events (Deecher et al., 2008; Soares, 2010b; Soares & Zitek, 2008). 





proposed as a reproductive subtype of depression (Payne, Palmer, & Joffe, 2009). More 
specifically, this vulnerability to depression is thought to be biological, possibly resulting from 
the interaction between estrogen and specific brain areas or neurotransmitter systems (e.g., 
serotonin; Payne et al., 2009). 
The hormonal sensitivity theory has been likened to the kindling hypothesis (Post, 1992), 
as women who experience depression at one reproductive event are thought to have an increased 
risk for developing depression across additional reproductive events (Soares & Zitek, 2008). For 
instance, a history of postpartum blues and severe PMS have both been found to be predictors of 
depressed mood during the menopausal transition (Freeman et al., 2004; Woods et al., 2008). 
Gregory, Masand, and Yohai (2000) examined mood across four major reproductive events (i.e., 
premenstrual phase, while taking hormonal contraceptives, postpartum period, and 
perimenopausal period) in 72 women with a major depressive episode. The authors found 
moderate correlations between premenstrual and perimenopausal mood ratings as well as 
postpartum and perimenopausal mood ratings. Furthermore, severe depression across at least two 
reproductive events was associated with earlier age at first treatment, bipolar disorder diagnosis, 
and family psychiatric history. These results support the hypothesis that certain women may be 
susceptible to mood difficulties across major reproductive events. 
 Hormonal sensitivity was examined in a rare double-blind experimental study by Bloch 
and colleagues (2000), who mimicked the hormonal milieu of the postpartum period with 
hormonal injections. Sixteen women participated, eight with a history of postpartum depression 
and eight without such a history. After a baseline period, high levels of estradiol and 
progesterone were administered to simulate pregnancy. The high levels of hormones were then 





follow-up without medication. The results of this study found that 62.5% of women with a 
history of postpartum depression developed significant mood symptoms compared to 0% of 
women without such a history. Since hormone levels were kept the same across conditions, these 
findings clearly show that women with a history of postpartum depression are sensitive to 
changes in gonadal hormones. Although the hormonal sensitivity hypothesis has received 
empirical support, it is important to remember that there are also additional factors already 
known to contribute to the development of depression, such as genetics and vulnerability to 
stress (Steiner, 2009). These factors may be independent of, or interact with, hormonal 
sensitivity. 
Anxiety across reproductive events 
Given the significant degree of comorbidity between depression and anxiety, it is not 
surprising to find that women also experience exacerbation in anxiety symptoms across 
reproductive events. Comorbidity rates for anxiety and depression, when considering lifetime 
diagnoses, are as high as 76% (Moses & Barlow, 2006). Depression and anxiety are thought to 
share a common diathesis and are both subsumed under the higher order factor of negative 
affectivity (Moses & Barlow, 2006). 
Menarche. Consistent with research examining age at menarche and depression, studies 
have shown that earlier age at menarche is also associated with increased risk of developing 
symptoms of anxiety (Leen-Feldner, Reardon, Hayward, & Smith, 2008). After reviewing more 
than 45 articles and controlling for age, Reardon and colleagues (2009) concluded that early 
pubertal timing was consistently related to an increased risk of developing an anxiety disorder. 
Premenstrual exacerbation. Individuals suffering from anxiety disorders commonly 





menstrual cycle. For instance, in a study by Hsiao, Hsiao, and Liu (2004), 52% of individuals 
with pre-existing generalized anxiety disorder (GAD) and 36% of individuals with panic disorder 
experienced a premenstrual exacerbation of their symptoms. Premenstrual exacerbation of 
symptoms extends not only to mood and anxiety disorders but also to psychotic disorders 
(Kornstein & Sloan, 2006). In a recent article examining sex differences and the DSM-5, 
Kornstein (2010) recommends that “with premenstrual exacerbation” be added as a new specifier 
akin to “with postpartum onset”. 
 Pregnancy and the postpartum. The term postpartum depression is frequently used as 
an overarching term to describe any type of emotional distress following childbirth (Abramowitz 
et al., 2010; Miller, Pallan, & Negri, 2006). However, the exclusive focus on postpartum 
depression may be misleading, as there is a high prevalence of anxiety in pregnancy and the 
postpartum period that can be overlooked and not properly treated. Recent research suggests that 
anxiety may be even more prevalent than depression during pregnancy and the postpartum 
(Wenzel, Haugen, Jackson, & Brendle, 2005). For instance, Lee and colleagues (2007) found 
that anxiety was more prevalent than depression in antenatal assessments (54% versus 37% 
respectively). Using DSM-IV criteria, Reck et al. (2008) examined over 1,000 postpartum women 
across a three-month period and found that anxiety disorders were more common than depressive 
disorders (11.1% versus 6.1%, respectively). It is also important to recognize that depressive 
symptoms do not often occur in isolation. For example, Heron, O’Connor, Evans, Golding, and 
Glover (2004) found that 43.7% of women experiencing postpartum depression also had 
significant symptoms of anxiety at some point during pregnancy (i.e., early, middle, or late). 
Similarly, Ross, Gilbert Evans, Sellers, and Romach (2003) found that up to 50% of women with 





Although maternal anxiety is very common, it can cause significant impairment in 
functioning across multiple domains and therefore warrants attention. Many women do not meet 
criteria for GAD because their worries are specific to maternal concerns and not focused on a 
range of topics, thereby excluding the diagnosis. Currently, these women tend to be classified 
with either sub-threshold symptoms of GAD or with an anxiety disorder not otherwise specified 
(ADNOS). For instance, Wenzel, Haugen, Jackson, and Robinson (2003) found that 4.4% of 
women met criteria for GAD and 27.9% of women had sub-threshold generalized anxiety. 
Wenzel et al. (2005) also found high rates of sub-syndromal GAD (19.7%). More recently, 
Phillips, Sharpe, Matthey, and Charles (2009) found that 10.8% of women in the postpartum 
period met criteria for GAD, with an additional 10.8% meeting criteria for ADNOS.  
The high prevalence of anxiety and worry during pregnancy the postpartum period is 
perhaps not very surprising, especially for first-time parents, given the heightened sense of 
responsibility that occurs with having a highly dependent and vulnerable child and the impetus to 
protect the child from harm (Fairbrother & Abramowitz, 2007). From an evolutionary 
perspective there is a clear adaptive value to increased anxiety during pregnancy and the 
postpartum period, as increased vigilance and attention to possible threats toward the infant 
could directly impact the child’s chances of survival (Eşel, 2010; Ross & McLean, 2006). 
Therefore, it is important for clinicians to distinguish between “normal” anxiety and maternal 
anxiety that is significantly interfering with a woman’s functioning and requires treatment. 
Menopause. Li, Yu, Ma, Sun, and Yang (2008) reported a prevalence of 10.2% for 
anxiety symptoms during perimenopause. Consistent with the hormonal sensitivity hypothesis, 
having a history of PMDD was found to be a risk factor for experiencing anxiety symptoms 





methodological limitations of research examining anxiety during menopause, conclusions cannot 
be made at this time. The few studies that have been done to date rely on retrospective reports or 
cross-sectional designs and have used non-validated anxiety measures (Bryant, Judd, & Hickey, 
2012). Furthermore, there is significant overlap between anxiety symptoms and the vasomotor 
symptoms of menopause (e.g., hot flashes) that have not been adequately disentangled (Hickey, 
Bryant, & Judd, 2012). Therefore, longitudinal research in this area with validated measures and 
proper controls is needed before any strong conclusions can be drawn. 
Obsessive-compulsive disorder and reproductive events 
Obsessive-compulsive disorder (OCD) is defined by the presence of obsessions and 
compulsions that are excessive or unreasonable, time consuming, and cause marked impairment 
in daily functioning (American Psychiatric Association, 2000). Obsessions are defined as 
intrusive thoughts, images, or impulses which occur and are experienced as distressing 
(American Psychiatric Association, 2000). In order to decrease the anxiety associated with 
obsessional thoughts or to try and suppress them, an individual feels driven to perform repetitive 
behaviours or mental acts (i.e., compulsions).  
Individuals suffering from OCD are often classified according to the following symptom 
domains: harm obsessions and checking rituals, obsessions without overt compulsions, 
contamination and washing/cleaning, and hoarding (Sookman, Abramowitz, Calamari, Wilhelm, 
& McKay, 2005). Checking behaviour commonly occurs when there is excessive doubt over 
actions (e.g., “Did I turn the stove off?”) or fear of harm to self or others (e.g., excessive 
reassurance-seeking that a relative is safe; Sookman et al., 2005). Obsessions without 
behavioural or overt compulsions can be more elusive compared to other OCD subtypes, but do 





compelled to repeat a specific word in their head for a predetermined number of times in order to 
prevent something catastrophic from happening (e.g., a car accident). An individual with 
contamination obsessions may fear contracting an illness when using a public washroom. This 
fear may cause the individual to engage in compulsive cleaning behaviour after using a public 
bathroom, avoidance of public bathrooms altogether, or use of precautionary strategies such as 
using their elbow to open the bathroom door (Rachman, 2004).  Finally, hoarding involves 
excessive acquisition and accumulation of items which the individual feels emotionally 
connected to and has difficulty discarding. Although hoarding was long conceptualized as a 
subtype of OCD, the DSM-5 now considers hoarding to be its own disorder (American 
Psychiatric Association, 2013).  
 Sex differences exist in both the prevalence and presentation of OCD symptoms. Among 
children, OCD is up to three times more common in boys compared to girls, a difference that 
disappears once puberty hits (McLean & Anderson, 2009). In one study of over 200 outpatients 
with OCD, age of onset was significantly younger in men (M = 22) compared to women (M = 
26), and women were more likely to be married and have children compared to men (Castle, 
Deale, & Marks, 1995). Furthermore, women are twice as likely to have contamination 
obsessions and cleaning compulsions compared to men (Labad et al., 2010), and men are more 
likely to have sexual and religious obsessions and symmetry and exactness compulsions 
(Altemus, Sarvaiya, & Epperson, 2014). 
Several lines of evidence point to the influence of hormones and reproductive events on 
OCD symptoms. The timing of OCD onset has been found to cluster around major reproductive 
events such menarche, pregnancy, and the postpartum. Furthermore, as noted below, in cases of 





during menopause. However, it should be noted that many of the studies described below (e.g., 
Labad et al., 2005, 2010; Vulink, Denys, Bus, & Westenberg, 2006; Williams & Koran, 1997) 
involve retrospective reporting of the onset or exacerbation of OCD symptoms across major 
reproductive events as opposed to the use of prospective daily measures, and thus should be 
interpreted cautiously. 
Menarche. Labad and colleagues (2005, 2010) found that the onset of OCD occurred at 
the time of menarche for 22% of outpatients surveyed. Compared to other symptom dimensions 
of OCD, hoarding was four times more likely to occur in the year surrounding menarche (Labad 
et al., 2010).  
The menstrual cycle. The menstrual cycle itself has been found to impact OCD 
symptom severity. Premenstrual worsening of OCD symptoms has been frequently observed and 
ranges from 20% (Labad et al., 2005) to 49% of women sampled (Vulink et al., 2006).  
Hormonal sensitivity in individuals with OCD is also evidenced by the high rates of PMS 
and PMDD. For instance, Williams and Koran (1997) found that 21% of outpatients with OCD 
who were sampled experienced dysphoric symptoms pre-menstrually.  Kim and colleagues 
(2004) found a rate of 11% for OCD in women who presented for treatment at a PMS clinic. In a 
sample of 101 women with OCD (Vulink et al., 2006), 11% experienced comorbid PMDD, and a 
striking 82% of these women experienced premenstrual exacerbation of OCD symptoms.  
Pregnancy and the postpartum. A recent meta-analysis found that pregnant and 
postpartum women were approximately 1.5 to 2 times more likely to experience OCD compared 
to women in the general population (Russell, Fawcett, & Mazmanian, 2013). Research suggests 
that the postpartum period may be a time of particular vulnerability for obsessive-compulsive 





compared to pregnancy (Misri & Kendrick, 2007; Ross & McLean, 2006), with estimates 
ranging from 7 to as high as 47% (Labad et al., 2005; Leight, Fitelson, Weston, & Wisner, 2010; 
Miguel et al., 2005). Maina, Albert, Bogetto, Vaschetto, and Ravizza, (1999) found that in eight 
cases of OCD surrounding childbirth, onset occurred in the postpartum as opposed to pregnancy 
in all women examined, although premorbid symptoms had been present before pregnancy.  
In the postpartum period obsessional thoughts revolve primarily around accidental harm 
to the baby, fear of being separated from the infant, fear of contamination related to the infant, 
and fear of criticism of one’s competency as a mother (Misri & Kendrick, 2007). However, many 
women have thoughts or images of deliberately harming their child that are clearly extremely 
distressing (McGuinness, Blissett, & Jones, 2011). Common compulsions include excessive 
checking and cleaning behaviours (Misri & Kendrick, 2007). 
The postpartum period has also been found to exacerbate pre-existing OCD to a greater 
extent than pregnancy. For instance, Labad et al. (2005) reported symptom exacerbation in 8% of 
women with OCD during pregnancy compared to 50% during the postpartum period. In a study 
by Vulink and colleagues (2006), OCD symptoms were more likely to worsen during the 
postpartum period (48%) compared to pregnancy (33%) in women diagnosed with OCD.  
Given the heightened level of stress associated with having a baby, it is not surprising to 
find that men also experience the onset of OCD symptoms at this time. However, prevalence 
rates for men linger around 5%, which is considerably lower than the rates observed for their 
female counterparts and suggests that hormones may be influential for women (Labad et al., 
2005). 
Women with OCD appear to be at a greater risk for developing postpartum depression 





sample of 24 outpatients diagnosed with OCD who gave birth experienced postpartum 
depression, nearly double the expected rate. A literature review by Vulink and colleagues (2006) 
estimated 37 to 60% comorbidity between OCD and depression in the postpartum. In a study by 
Abramowitz and colleagues (2010), women who were classified as depressed according to the 
Edinburgh Postnatal Depression Scale (EPDS) had significantly higher compulsion scores on the 
Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Obsessive thoughts are more likely to 
accompany depressive episodes with postpartum onset as opposed to onset outside this window 
(57% vs. 36%; Wisner, Peindl, Gigliotti, & Hanusa, 1999).  
Similar risk factors have been observed for postpartum depression and OCD. Maina and 
colleagues (1999) found that postpartum OCD was significantly associated with obstetric 
complications such as ceasarean section, which has also been found to be a risk factor for 
postpartum depression (Josefsson et al., 2002). Labad et al. (2005) examined outpatients 
diagnosed with OCD and found that the greater the number of PMS symptoms women 
experienced, the more likely they were to experience the onset or worsening of OCD during the 
postpartum period. The fact that the premenstrual and postpartum period are both associated with 
fluctuating hormone levels and that both OCD and PMS symptoms respond to treatment with 
selective serotonin reuptake inhibitors (SSRIs) is consistent with the hormonal sensitivity 
hypothesis (Labad et al., 2005). 
Subclinical OCD symptoms during pregnancy and the postpartum. Maternal 
preoccupations have been found to resemble obsessive-compulsive symptoms (Leckman et al., 
1999). Sub-clinical obsessive and compulsive behaviour, among women without a history or 
diagnosis of OCD, appears to be extremely common in the postpartum period (Misri & 





women endorsed having at least one intrusive thought, with the two most common intrusive 
thoughts involving the infant dying of sudden infant death syndrome (SIDS; 57%) and thoughts 
of the infant suffocating (52%). Women reporting intrusive thoughts also used neutralizing or 
ritualistic strategies in response to these thoughts, with the most common being reassurance that 
everything is okay (72%) and checking on the baby more frequently (68%). Thirty-eight percent 
of women had clinically significant obsessive compulsive symptoms according to the Y-BOCS, 
whereas the majority of women experienced only mild obsessive-compulsive symptoms.  
The focus of maternal preoccupations was further explored by Brockington, Macdonald, 
and Wainscott (2006) in the course of interviewing 129 mothers. In the prepartum, the most 
frequent fear expressed was of foetal abnormality (43%), followed by fear of foetal death (40%), 
inadequacy as a mother (32%), and fear of inadequate support (21%). Despite these high rates of 
reported fears, they were only clinically significant in 2-9% of women. Fear of foetal death was 
more likely to be reported by women who experienced the death of an infant in utero, multiple 
miscarriages, stillbirths, and infertility problems. Where losing a child increased maternal 
preoccupations in subsequent pregnancies, in general the unfamiliarity with pregnancy in 
primiparous (or first-time) mothers leads to significantly higher anxiety and greater 
preoccupation with their baby compared to multiparous mothers (Eberhard-Gran, Tambs, 
Opjordsmoen, Skrondal, & Eskild, 2003; Leckman et al., 1999; Maina et al., 1999). Maternal 
preoccupations in the postpartum period were parallel to those in pregnancy, with morbid anxiety 
about the infant’s health and safety the most common (32%), followed by pathological fear of 
crib death (29%). These fears were associated with sleep deprivation and frequent checking of 





fear of criticism or removal of child (19%) and fear of lack of support (16%). Although 
frequently endorsed, these fears caused significant impairment in only 5 to 12% of women.  
Leckman and colleagues (1999) also found a high rate of maternal worry with over 80% 
of mothers worried that something bad would happen to their baby. With over 90% of women 
reporting checking on their babies (Leckman et al., 1999), this behaviour is clearly adaptive. 
Whereas most women reported checking on their babies in response to some type of signal from 
the infant, 75% of parents admitted to checking behaviour even when they subjectively knew 
that everything was okay. Thus, excessive anxiety and checking could possibly represent the 
over-activation of an adaptive behaviour meant to increase parental responsiveness and bonding. 
Given that the majority of women do experience some degree of obsessive-compulsive 
symptoms during pregnancy or the postpartum, maternal preoccupations should be viewed on a 
continuum or dimensionally rather than categorically. It remains unclear whether or not we are 
over-pathologizing the occurrence of anxiety at a time where it is advantageous.  
Menopause. Although research in this area is currently limited, menopause does appear 
to be associated with an exacerbation of OCD symptoms. For instance, Labad et al. (2005) 
reported worsening of OCD symptoms in 8% of women during menopause. In addition, Vulink 
et al. (2006) found that 47% of women with OCD going through menopause experienced 
symptom exacerbation. Clearly further research is needed to clarify the course of symptoms at 
this time. 
Evolutionary models of OCD 
The evolutionary value of increased anxiety and preoccupation with a newborn infant is  
clear, as increased vigilance increases the chance of infant survival (Eşel, 2010; Ross & McLean, 





on their mother for survival. Women are highly invested in their offspring given the fact that a 
woman has a limited number of potential opportunities to reproduce across her lifetime (Hahn-
Holbrook, Holbrook, & Haselton, 2011). Furthermore, only recently have infant mortality rates 
fallen due to increased quality of living and advanced medical care (Leckman et al., 1999). Not 
only would losing a child be devastating for a mother, but it would also dramatically reduce her 
reproductive success (Hahn-Holbrook et al., 2011). Therefore, obsessive thinking and ritualistic 
behaviour that led to harm avoidance would be adaptive in the sense that it increased infant 
survival and successful reproduction, thereby increasing the likelihood of natural selection of 
these traits (Eilam, Izhar, & Mort, 2011).  
This line of reasoning has led to evolutionary accounts of OCD, which suggest that 
individuals with OCD have an exaggerated or pathological form of an adaptive mechanism that 
helps to protect offspring from real or potential threats (Eilam et al., 2011; Hahn-Holbrook et al., 
2011; Woody & Szechtman, 2011). This potential mechanism has been described as a 
motivational system and has received several labels, including the “hazard-precaution system” 
and the “security motivation system” (Woody & Szechtman, 2011). 
When individuals are highly sensitive to potential threats their security motivation system 
becomes hyperactive, which initiates behaviour aimed at reducing the subjective feeling of 
danger or that things are “not right.” However, individuals with OCD do not stop after 
completing a ritualistic behaviour because they do not receive a proper stop-signal (Eilam et al., 
2011). Researchers have described this stop signal as a “sense of knowing”, or yedasentience 
(Szechtman & Woody, 2004). Often times there is no clear stop-signal from the environment and 
it must be generated within the individual (Woody & Boyer, 2011). For instance, the smell of 





throw out the food beside it as it may also be contaminated. In other words, an internal stop 
signal is not generated to conclude that the correct precautions have been made and it is now safe 
to stop. Therefore, excessive activation of the security motivation system and improper inhibition 
of the system is thought to be the underlying mechanism of OCD. 
The security motivation system differs from that of a fear based, flight-or-fight response 
to an easily identifiable threat or danger (e.g., encountering a bear in the woods). In contrast, it is 
more focused on anticipated or hidden threats (e.g., potential contamination) that are more 
difficult to predict and have a high cost (Woody & Szechtman, 2011). Whereas fear commonly 
encourages avoidance behaviour, the security motivation system is geared more towards the 
engagement of preventative behaviour (e.g., washing; Woody & Szechtman, 2011). Brain areas 
activated upon imagination of future scenarios are the same regions implicated in OCD (Brune, 
2006). This suggests that individuals with OCD are cognizant of future events and tend to engage 
in behaviour that would prevent anticipated danger (Brune, 2006). Therefore, it has been 
hypothesized that individuals with OCD should be less likely to engage in risky behaviour. 
Cognitive theory of OCD 
According to the cognitive model of OCD, it is not the intrusive thoughts alone that cause 
distress but the significance and meaning attributed to these thoughts (Salkovskis, 1999). The 
majority of individuals experience intrusive thoughts but individuals with OCD attribute greater 
meaning and significance to these thoughts. For instance, a new mother may have an intrusive 
thought of harming her infant and believe that this thought speaks to her “true” feelings about the 
infant or she may become afraid that she will harm the infant (Abramowitz, Schwartz, Moore, & 





OCD increase their efforts to control their thoughts using thought suppression or they engage in 
rituals to “neutralize” the negative thoughts (e.g., by repeating positive thoughts).  
The belief that having a thought increases the likelihood of it occurring is referred to as 
thought-action fusion (Smári & Hόlmsteinsson, 2001). There are two components to thought 
action fusion: a negative thought increases the likelihood of a negative event happening to the 
self or others, and that having a thought is the moral equivalent of committing the act in question 
(e.g., thinking about smothering your child is the equivalent of actually smothering your child; 
Smári & Hόlmsteinsson, 2001). Thought-action fusion has been found to be significantly more 
likely in individuals with obsessional thinking compared to non-obsessionals or “normal” control 
groups (Shafran, Thordarson, & Rachman, 1996). Additional beliefs surrounding the 
uncontrollability and danger of thoughts have also been found to predict obsessive-compulsive 
symptoms (Myers & Wells, 2005).  
Inflated responsibility, or the belief that an individual has the power to cause an event or 
prevent an event from happening, is another important cognitive component of OCD (Myers & 
Wells, 2005). For instance, believing you caused a fellow student to suffer an anaphylactic shock 
in the library because you did not clean up your peanut butter cookie crumbs earlier that day 
(Purdon & Clark, 2005). Similarly, if an individual with OCD has an intrusive thought about a 
loved one being involved in a car accident and the loved one is involved in an accident several 
days later, the individual is likely to believe that their thought caused the accident (Shafran et al., 
1996). Clearly these beliefs would cause significant distress for the individual. Responsibility 
beliefs were found to mediate the relationship between intrusive thoughts and obsessive-
compulsive symptoms (Smári & Hόlmsteinsson, 2001). An inflated sense of responsibility can 





Rachman, & Freeston, 1999). Infants are born totally dependent on their parents for care and 
safety, which can cause a heightened sense of responsibility and lead to maternal preoccupations 
and frequent checking to ensure the infant is not in harm’s way (Leckman et al., 2004). 
 Many constructs that are important for the development and maintenance of OCD (e.g., 
inflated responsibility beliefs) as well as symptoms of OCD (e.g., excessive washing) can be 
conceptualized as strategies for reducing harm (Brune, 2006). Alonso and colleagues (2008) 
found that outpatients diagnosed with OCD had significantly higher harm avoidance scores and 
lower novelty-seeking scores (according to the Temperament and Character Inventory) compared 
to matched controls. Similarly, Ettelt and colleagues (2008) found that individuals diagnosed 
with OCD had higher harm avoidance scores (assessed using Cloninger's Tridimensional 
Personality Questionnaire) compared to age and sex-matched controls. Furthermore, the first 
degree relatives of individuals diagnosed with OCD had higher levels of harm avoidance 
compared to first degree relatives of control subjects. Anxiety in general is associated with risk-
avoidance as decision-making is associated with the overestimation of the probability and 
severity of negative outcomes (Maner, 2009). 
 Disgust also plays a role in harm avoidance. Sensation seeking was found to negatively 
correlate with scores on the Disgust Scale (Rozin, Haidt, McCauley, Dunlop, & Ashmore, 1999). 
In a study by Fessler, Pillsworth, and Flamson (2004), a mood induction procedure was used to 
examine the influence of different emotions on risk-taking behaviour. Men in the anger condition 
displayed significantly more risk-taking behaviour in a gambling task than men in the control 
condition. In contrast, women were found to be less likely to engage in risk-taking behaviour 





Cross-cultural differences in personality have been found according to the prevalence of 
infectious disease. Consistent with their hypothesis, Schaller and Murray (2008) found that 
disease prevalence significantly negatively correlated with sociosexuality, extraversion, and 
openness to experience. In essence, the risk of disease transmission increases when people 
expose themselves to unfamiliar people and practices (Schaller & Murray, 2008). Therefore, 
people living in areas with increased disease prevalence tended to exhibit a more cautious 
disposition. Similarly, individuals who are prone to contamination fears should be less likely to 
engage in risky behaviour (e.g., unprotected sex). 
There also appear to be consistent sex differences in risk-taking. In a meta-analysis of 
150 studies, Byrnes, Miller, and Schafer (1999) concluded that men engage in greater risk-taking 
compared to women. The effect size was small but meaningful (d = 0.13), indicating an 
approximate 6% difference in the likelihood of engaging in risky behaviour (e.g., unsafe driving) 
between men and women. However, the authors warn that there is variability in estimates 
depending upon age and specific contexts. In other words, men are more likely overall to engage 
in risky behaviour compared to women, but there are specific situations where these sex 
differences disappear (e.g., smoking). These findings support examining both overall risk-taking 
as well as risk-taking within specific domains. 
Disgust sensitivity 
Disgust is one of six basic human emotions that are easily recognizable across cultures, 
along with happiness, sadness, fear, anger, and surprise (Brune, 2006). The characteristic 
expression of disgust consists of a wrinkled brow-line and raised upper lip (Jhung et al., 2010; 
Rozin, Haidt, & McCauley, 1999). Gaping of the mouth is also common in relation to food and 





associated with a feeling of nausea and can cause a gagging reflex or vomiting (Rachman, 2004). 
Brain structures such as the insula and putamen are critical for recognizing and expressing 
disgust. For instance, a patient (N.K.) with damage to the insula and putamen was significantly 
less able to recognize facial and vocal expressions of disgust compared to controls, although no 
differences were observed across the other primary emotions (Calder, Keane, Mane, Antoun, & 
Young, 2000). In addition, when the insula was electrically stimulated by the famous 
neurosurgeon Wilder Penfield, patients experienced unpleasant tastes and feelings of nausea 
(Calder, Lawrence, & Young, 2001). The basal ganglia are also activated when viewing or 
smelling disgust-provoking stimuli or recalling autobiographical memories of disgust (Curtis et 
al., 2011). Brain regions found to be involved with processing disgusting stimuli in an fMRI 
study included the insula, ventrolateral prefrontal cortex, temporal pole, putamen–globus 
pallidus, dorsal anterior cingulate gyrus, and the visual cortex (Mataix‐Cols et al., 2008). 
Disgust was initially defined narrowly as a reaction that facilitated the rejection of food 
(Haidt, McCauley, & Rozin, 1994), but is now viewed more broadly as being potentially induced 
across a variety of stimuli. Haidt and colleagues (1994) were the first to create a measure of 
disgust that captured individual differences in disgust sensitivity and identified the different 
domains of disgust. Following a rational-empirical approach to test construction, a list of 
disgusting objects and actions was created and continually refined based on item-analysis across 
four samples of respondents. The final Disgust Scale consisted of eight domains: food (e.g., 
spoiled milk), body products (e.g., vomit, mucous), animal (e.g., cockroach, maggot), sex (e.g., 
incest), personal hygiene (e.g., not letting your body touch a public toilet), envelope violations 
(e.g., seeing someone’s intestines exposed), death (e.g., touching a dead body), and magical 





theory of disgust, the first three domains pertain to core disgust whereas the next four pertain to 
animal-reminder disgust. The last domain, magical thinking, is thought to occur across many 
disgust situations and therefore is not considered its own distinct disgust elicitor. Whereas core 
disgust is viewed as an oral defense (or a first line defense against contaminated foods), animal-
reminder disgust corresponds to stimuli that remind us of our own mortality, or animal nature.  
Disgust has also been conceptualized more broadly to include sexual and moral disgust. 
Tybur, Lieberman, and Griskevicius (2009) propose a multidimensional model of disgust based 
on factor analysis that consists of pathogen, sexual, and moral disgust. Pathogen disgust aids in 
the avoidance of potential contaminants and is elicited by exposure to stimuli such as dead 
bodies or feces. In contrast, sexual disgust motivates avoidance of sexual behaviour such as 
inbreeding that result in decreased reproductive success. Finally, moral disgust motivates 
avoidance of individuals who engage in antisocial activities such as stealing that from an 
evolutionary perspective would have a high cost on one’s social group. This model is reflected in 
the Three Domain Disgust Scale created by the authors, with research showing discriminant 
validity across the three domains of disgust. 
Baumeister, Vohs, and Funder (2007) point out the possible discrepancy between self-
reports and actual behaviour. Therefore, it is important to consider the predictive validity of 
questionnaires. Studies have shown that questionnaire measures of disgust do indeed predict 
actual behaviour. In an fMRI study Mataix‐Cols et al. (2008) found that high trait disgust 
sensitivity predicted greater brain activation in response to viewing disgusting pictures from the 
International Affective Picture System. In a series of experiments examining the predictive 
validity of the 32-item Disgust Scale,  Rozin, Haidt, McCauley, Dunlop, et al. (1999) found that 





significantly correlated with Disgust Scale total scores from two months earlier (r = -.41) and at 
the time of testing (r = -.51). In addition, the authors found that questionnaire scores were not 
associated with factors such as embarrassment (e.g., touching an unused tampon or condom) and 
compliance (i.e., general willingness to engage in unpleasant tasks), that added variance to the 
prediction of behavioural tasks. Deacon and Olatunji (2007) found that Disgust Scale scores 
predicted increased anxiety and avoidance of behavioural tasks involving exposure to a used 
comb, a cookie on the floor, and a bedpan filled with toilet water. Finally, scores on the core, 
animal-reminder, and contamination subscales of the Disgust Scale-Revised were found to 
predict specific behavioural patterns. Core disgust, animal-reminder disgust, and contamination 
disgust uniquely predicted visual avoidance of a video depicting the consumption of coagulated 
cow blood, surgery, and potential contaminants, respectively (Olatunji, Haidt, McKay, & David, 
2008). 
The role of disgust in OCD symptomatology. Fear has been characterized as the 
prominent emotion associated with anxiety disorders, with little focus on disgust (Rachman, 
2004). Nevertheless, researchers are now increasingly becoming aware of the role of disgust in 
the development of anxiety disorders such as OCD. Disgust has been strongly linked to disease 
avoidance. For instance, Stevenson, Case, and Oaten (2009) found evidence for disgust 
sensitivity as an adaptive mechanism for preventing illness. In a sample of over 600 university 
students, higher disgust sensitivity and contamination scores (as measured by the Padua 
Inventory) significantly predicted fewer recent infections. Disgust may be particularly important 
in the development of contamination fears. Individuals with OCD often report feelings of disgust 
rather than fear in the presence of contaminated objects, which leads to excessive washing to 





individuals suffering from the contamination subtype of OCD were slower to habituate to 
disgust-provoking stimuli across exposure sessions compared to individuals with non-
contamination OCD symptoms. Furthermore, functional magnetic resonance imaging (fMRI) 
experiments have shown that metabolic activity in the insula correlates with Y-BOCS scores and 
Padua Inventory–Revised (PI-R) scores, particularly washing symptoms (Calder et al., 2001; 
Mataix-Cols et al., 2004). 
Over the course of history, humans have developed a physiological immune system that 
is quick to respond to pathogens and foreign material after it has invaded the body. However, it 
is also possible that humans have developed a “behavioural immune system” to avoid infection 
altogether (Neuberg, Kenrick, & Schaller, 2011; Van Vugt & Park, 2009). Disgust can help 
species avoid potential contaminants and infectious disease by either recognizing cues of 
potential contamination before direct exposure, or ridding the body of contaminants after 
exposure (e.g., vomiting; Lienard, 2011; Rozin, Haidt, & McCauley, 1999). For instance, the 
appearance of rotting food elicits a feeling of disgust that enables us to avoid eating a 
contaminated substance that could cause infection. On the other hand, experiencing disgust upon 
eating an unknown but dangerous food source may cause vomiting, ridding of the body of a 
potential toxin.  
Just as the physiological immune system can overreact to normal tissues in the body (as 
in the case of an autoimmune disease), so too can the behavioural immune system perceive 
potential threats of contamination or disease that are actually harmless (Neuberg et al., 2011). 
Sympathetic magic works according to this principle, as a secondary object can acquire the 
properties of a contaminated object through physical contact. For example, Olatunji, Lohr, 





toilet and then sanitized. Participants in the high OCD symptom group were significantly more 
likely to refuse to comply with the task than participants in the low OCD symptom group. 
Through the endorsement of a number of irrational beliefs individuals can come to believe that 
an object is contaminated even when there is no objective threat (Olatunji, Lohr, et al., 2007). 
For instance, people are reluctant to drink from a water fountain on top of a toilet despite no 
objective threat of contamination.  
Sympathetic magic dates back to writings from the early 1900’s that attempted to explain 
the universal principles underlying magic (Nemeroff & Rozin, 1994). In the disgust literature 
sympathetic magic refers to the beliefs about the transmission of contagion (Olatunji et al., 
2007). Researchers have identified two primary laws of sympathetic magic: the law of contagion 
and the law of similarity (Rozin, Millman, & Nemeroff, 1986). The “chain of contagion” 
procedure by Tolin, Worhunsky, and Maltby (2004) clearly demonstrates the law of contagion, 
or “once in contact, always in contact” (Oaten, Stevenson, & Case, 2009, p. 312). The chain of 
contagion procedure involved a pencil being touched to a contaminated object, and then a second 
pencil was touched to the first, and so on until 12 pencils had been used. Anxious and non-
anxious control participants reported that the threat of contamination quickly decreased with the 
addition of pencils and by the end of 12 pencils reported a 100% drop in contamination ratings. 
In contrast, individuals diagnosed with OCD only reported a 40% drop in contamination ratings 
following the last pencil. Despite 12 degrees of removal from the original source of 
contamination, participants with OCD still endorsed a high contamination rating. Thus, an 
essence of the original contaminant still existed and could not be eliminated. No differences were 





The law of similarity refers to the belief that objects that are similar share the “same 
essence” (Oaten et al., 2009). For example, in a study by Rozin and colleagues (1986), 
participants were given two pieces of the same chocolate fudge, one in the shape of a disc and 
another in the shape of dog feces, and were asked to rate their desire for each piece of fudge. The 
fudge in the shape of dog feces was given significantly lower ratings compared to the fudge in 
the shape of a disc. Although these beliefs are irrational, they are clearly adaptive as it is safer to 
avoid an object that has come into contact with a contaminant at some point in time or resembles 
a known pathogen (Oaten et al., 2009). 
Disgust has also been associated with OCD symptoms in non-clinical samples. In a study 
by Olatunji, Lohr, and colleagues (2007) introductory psychology students were separated into a 
high and low OCD symptom group based on contamination scores on the Padua Inventory. The 
high OCD symptom group was less likely to engage in a series of behavioural avoidance tasks 
(e.g., picking up a pair of stained underwear) and found them more disgust-provoking than the 
low OCD symptom group. Several other researchers have also found that disgust sensitivity 
predicted obsessive-compulsive symptoms in a non-clinical sample (Mancini, Gragnani, & 
D’Olimpio, 2001; Murisa et al., 2000; Tolin et al., 2006). Disgust sensitivity has been found to 
most strongly predict cleaning and washing symptoms (Mancini et al., 2001; Murisa et al., 2000; 
Tolin et al., 2006). Whereas disgust is most associated with cleaning and washing subscales, 
anxiety and depression were found to be better predictors of the impulses and rumination 
subscales of the Padua Inventory-Revised (Mancini et al., 2001). Furthermore, the relationship 
between disgust sensitivity and OCD contamination symptoms has been found to be independent 





Cisler, McKay, & Phillips, 2010; Olatunji, Sawchuk, Arrindell, & Lohr, 2005; Tolin et al., 
2006). 
Sex differences in disgust: The potential role of progesterone. Research has shown 
that women have greater disgust sensitivity compared to men (Druschel & Sherman, 1999; 
Murisa et al., 2000). For instance, Haidt et al. (1994) found that women scored a full standard 
deviation higher on the Disgust Scale than men. In a study by Rohrmann, Hopp, and Quirin 
(2008) women and men were shown pictures and film clips to elicit disgust (e.g., viewing an 
amputation). Across both pictures and films, women consistently showed greater disgust 
responses compared to men. In addition to self-reports women showed greater skin conductance 
to disgust-eliciting stimuli than men. Tybur and colleagues (2009) also found that women scored 
consistently higher than men in terms of disgust sensitivity, with a large effect size for the sexual 
domain and small effect sizes for the moral and pathogen domains. In a large sample of 
undergraduate students, Olatunji and colleagues (2005) found that disgust sensitivity predicted 
contamination fears, with a greater effect for women than men. The authors also found support 
for disgust sensitivity mediating the relationship between sex and contamination fears. A 
consensus regarding the cause of observed sex differences in disgust sensitivity is yet to be 
established. 
It has been argued that greater disgust sensitivity in women is a function of women 
scoring higher than men in neuroticism. Neuroticism, as generally assessed by the NEO 
Personality Inventory-Revised, measures the six personality facets of anxiety, depression, angry 
hostility, self-consciousness, impulsiveness, and vulnerability (Costa & McCrae, 1992). Women 
are 2 to 3 times more likely to experience depression in comparison to men (Curtis et al., 2011). 





to openness to experience (Druschel & Sherman, 1999; Olatunji et al., 2008). Thus, individuals 
who are high on neuroticism are more likely to experience negative affect, including disgust 
(Druschel & Sherman, 1999). However, studies also suggest that disgust sensitivity is distinct 
from anxiety and depression. For instance, Olatunjia, Lohr, et al. (2007) found that participants 
in the high OCD symptom group experienced greater disgust sensitivity even when negative 
affect scores were controlled. Similarly, Tolin and colleagues (2004) found that anxious and non-
anxious control participants performed similarly in their chain of contagion procedure and did 
not show the same degree of sympathetic magic beliefs as the OCD group. 
It is also possible that there is a hormonal mechanism underlying the sex differences in 
disgust sensitivity. Not only are women more likely than men to have obsessions and 
compulsions concerning contamination, but the onset and exacerbation of OCD symptoms is 
closely tied to reproductive events such as menarche and pregnancy (Lienard, 2011). These 
reproductive times correspond to times of increased progesterone levels. Progesterone levels rise 
after ovulation and are highest in the mid-luteal phase of the menstrual cycle. If conception does 
not occur progesterone levels decrease. If conception does occur, progesterone levels rise across 
pregnancy (Fessler, 2002). Whereas estrogen has a stimulating response on the immune system, 
progesterone suppresses the immune system (Druckmann, 2001). The suppression of the immune 
system by progesterone ensures that conception can in fact occur without the embryo being 
rejected (Lienard, 2011). In short, high progesterone levels stimulate the production of 
progesterone-induced blocking factor (PIBF), which stimulates T Helper cells and thereby 
decreases Natural Killer cells (Fessler, 2002). Therefore, foreign paternal material is less likely 
to be attacked by the body, but as a consequence women become more susceptible to infection 





Given the fact that the immune system is reduced when progesterone levels are increased, 
it would be adaptive to develop behavioural strategies to ensure avoidance of potential 
contaminants at these times.  The idea that disgust sensitivity increases to compensate for greater 
vulnerability to infection during times of immunosuppression has been termed the compensatory 
prophylaxis hypothesis (Fessler, Eng, & Navarrete, 2005). In other words, changes in the 
physiological immune system spark commensurate changes in the behavioural immune system to 
help avoid exposure to infectious agents (Curtis et al., 2011). Consistent with this hypothesis, 
healthy faces have been found to be more strongly preferred during times of immunosuppression 
(or high progesterone).  Jones, Perrett, and colleagues (2005) found that women preferred the 
faces of men that were pre-rated as healthy compared to unhealthy more when they were in the 
luteal phase of the menstrual cycle versus the follicular phase (in the context of a short-term 
relationship). Similarly, pregnant women had a stronger preference for healthy faces compared to 
non-pregnant women (Jones, Perrett, et al., 2005). Furthermore, women who perceive 
themselves as more vulnerable to disease also show stronger preferences for healthy faces, which 
would potentially decrease the likelihood of interacting with individuals who could transmit 
disease (Welling, Conway, Debruine, & Jones, 2007). Conway and colleagues (2007) found that 
women were more sensitive to cues of nearby threat and contagion when their progesterone 
levels were higher. More specifically, when progesterone levels were high participants rated 
disgusted and fearful facial expressions as more intense when the gaze was averted versus direct.  
However, there was no difference in intensity of happy facial expressions with direct versus 
averted gaze. The authors state that averted gaze signals the presence of a nearby physical threat 





recognizing facial cues signaling threat or contagion. This heightened sensitivity to potential 
threats with increased progesterone is thought to be adaptive for protecting the fetus from harm. 
Several researchers have conceptualized food aversions and morning sickness during 
pregnancy as adaptive mechanisms for reducing the risk of infection at times that are critical for 
reproductive success. Food aversions are closely linked with disgust sensitivity. Lesions to the 
insula (a region of the brain critical for experiencing disgust) in rats results in difficulty acquiring 
taste aversions (Calder et al., 2001). After reviewing 41 studies, Flaxman and Sherman (2000) 
reported that as many as 65% of pregnant women experienced food aversions. Food aversions 
were significantly more likely to occur in the first trimester of pregnancy than in the second or 
third trimester. The most common food aversions were to animal products (i.e., meat, fish, 
poultry, and eggs), with a rate twice as high as non-pregnant controls. In contrast, pregnancy 
cravings tended to be highest for foods that had the lowest likelihood of being reported as food 
aversions, such as fruit, grains and starches, dairy and ice cream, and sweets. Avoiding meat 
during the first trimester of pregnancy may be an important precautionary measure for avoiding 
food-borne illness. This mechanism would have been particularly important in early human 
history given the lack of refrigeration and sanitary conditions, as meat that is raw or left for long 
periods at room temperature is likely to develop bacteria or spoil (Flaxman & Sherman, 2000; 
Hahn-Holbrook et al., 2011). 
Morning sickness during the first trimester of pregnancy has been viewed as a 
mechanism for voiding the body of potential toxins at a time when the risk of fetal deformation 
is highest. The first trimester of pregnancy is a critical time for the development of the fetus, as 
the neural tube is developing and any exposure to viruses or toxins can result in serious 





and vomiting during pregnancy resulted in a decreased risk of miscarriage across nine studies 
examined. In addition, societies where morning sickness is less common are significantly less 
likely to consider meat a staple food.  
Disgust sensitivity has also been found to increase during the first trimester of pregnancy 
along with morning sickness and food aversions. In a study by Fessler and colleagues (2005), 
496 pregnant women answered an online survey assessing their disgust sensitivity using the 
Disgust Scale and their current level of nausea. Consistent with their hypothesis, disgust 
sensitivity was greatest during the first trimester of pregnancy. Although women in the first 
trimester of pregnancy experienced greater levels of nausea compared to women in the second 
and third trimester of pregnancy, even after controlling for nausea there was still a significant 
elevation in disgust in the first trimester of pregnancy in the food domain. The results of this 
study suggest that women develop increased sensitivity to disgust in the first semester of 
pregnancy- a time when the immune system is the most compromised and food-borne illness 
would incur the greatest risk to the fetus.  
Disgust sensitivity has also been examined across the menstrual cycle. Using an internet-
based questionnaire, Fessler and Navarrete (2003) examined the effect of conception risk and 
immunosuppression on disgust sensitivity across the menstrual cycle in free-cycling women. 
Based on the number of days since the onset of menstruation, the authors calculated the 
conception risk and presumed level of immunosuppression (according to daily reference values 
for progesterone) for 307 women. The authors found that sexual disgust was related to 
conception risk as hypothesized, but presumed conception risk did not predict global disgust 
scores or any of the individual disgust subscales. However, the subscales of the original Disgust 





Sub-clinical OCD symptoms have recently been found to be associated with progesterone 
levels in normally cycling female undergraduates (Gonda et al., 2008). Using a prospective 
design, the well-being of 63 free-cycling undergraduate women was examined across three 
phases the menstrual cycle (early follicular, late follicular, and late luteal). Obsessive-compulsive 
symptoms as measured by the Symptom Distress Checklist (SCL-51) were found to increase 
from the late follicular to the late luteal phase, in addition to increases in anxiety, depression, and 
somatization (Gonda et al., 2008).  
Avgoustinaki and colleagues (2012) examined the association between sex steroids and 
Minnesota Multiphasic Personality Inventory (MMPI) subscales in a sample of young health 
professionals (n = 59). All women were free-cycling (non-hormonal contraceptive users) with 
normal menstrual cycles and were tested on the 21st day of their menstrual cycle (i.e., mid-luteal 
phase). The authors found a significant correlation between progesterone levels and scale 7 
(Psychasthenia/Obsessive compulsive behaviour). However, within a regression model 
progesterone only explained 7% of the variance in scale 7, which was not significant. 
In a recent study by Fleischman and Fessler (2011), undergraduate participants provided 
a saliva sample for measurement of hormone levels, rated their level of disgust in response to 
disgust-eliciting photographs, completed the Revised Padua Obsessive-Compulsive Inventory, 
and completed a self-report questionnaire concerning behaviour in public bathrooms. Public 
bathrooms display clear clues of potential contamination and can lead to ritualistic behaviour in 
individuals with and without OCD (e.g., covering the toilet seat, excessive hand-washing). The 
authors found a significant positive correlation between progesterone levels and OCD symptoms 





ordering). Furthermore, disgust sensitivity and bathroom behaviour related to disease avoidance 
were also significantly correlated with progesterone levels. 
Upon examining the influence of progesterone levels across the menstrual cycle in 
relation to OCD symptoms, research to date has a number of methodological limitations. Only 
one study used a prospective, within-subjects design (Gonda et al., 2008), and none of the studies 
employed both a prospective, repeated-measures design combined with measuring salivary 
hormone levels. A within-subjects design would allow for the examination of individual 
variability in the magnitude of change across the menstrual cycle in OCD symptoms and provide 
stronger conclusions. Furthermore, women using hormonal contraceptives were excluded in 
previous studies. Thus, what is needed is a within-subjects design following women across the 
menstrual cycle where progesterone levels are measured and hormonal contraceptive users are 
included as a comparison group.   
The role of hormones in facial preference and emotion recognition 
Hormones have been shown to influence women’s facial preferences. Women’s 
preference for masculinized male faces has been shown to vary across the menstrual cycle, with 
a strong preference for masculine male faces during the menstrual phase compared to the luteal 
phase of the cycle (Penton-Voak & Perrett, 2000). Penton-Voak and colleagues (1999) found 
that women preferred less feminine male faces during periods of high versus low conception-risk 
in the context of short-term relationships. In a study by Macrae, Alnwick, Milne, and 
Schloerscheidt (2002), female participants were shown 100 faces and asked to categorize them as 
male or female. During the high conception risk phase of the menstrual cycle (i.e., ovulation) 
women were faster at categorizing male faces, but no differences were found in the 





showed that women were significantly more likely to choose a more masculinized face as 
conception risk increased before ovulation compared to after ovulation. Furthermore, a 
preference for masculinity in male faces is not shown in pre-pubescent and post-menopausal 
women, only in women of reproductively active ages, thus strengthening the hormonal account 
(Little et al., 2010). 
Masculinized and symmetrical male faces are thought to be indicators of higher levels of 
testosterone and disease-resistance (DeBruine, Jones, Tybur, Lieberman, & Griskevicius, 2010; 
Fink, Neave, Manning, & Grammer, 2006; Penton-Voak et al., 1999; Penton-Voak & Chen, 
2004). When women were given a forced-choice task they rated pictures of men who had higher 
salivary testosterone levels as more masculine than men with lower salivary testosterone levels 
(Penton-Voak & Chen, 2004). Symmetrical faces are rated as more attractive and healthier 
compared to faces low in symmetry (Fink et al., 2006). More masculinized faces have been 
classified as more healthy (Johnston et al., 2001), and facial masculinity has in fact been found to 
negatively correlate with frequency and duration of disease (Thornhill & Gangestad, 2006). High 
facial symmetry has been related to measures of increased fertility in men, thus acting as a gauge 
of greater genetic quality (Oinonen & Mazmanian, 2007). Oinonen and Mazmanian (2007) found 
that in general women prefer more symmetrical male faces, with greater symmetry detection 
performance during menses compared to the luteal phase. The fact that Penton-Voak et al. (1999) 
did not find differences in facial preferences across the cycle in women using hormonal 
contraceptives, suggests that these differences are influenced by hormones. These findings show 
a differential pattern of preferences for male faces depending on menstrual cycle phase or 
conception risk, suggesting that these differences reflect adaptive strategies for acquiring more 





High masculinity and related high testosterone is associated with low paternal 
investment, as research suggests that men with high-testosterone levels are more likely to have 
short-term relationships, less likely to get married, and are less responsive to infants (DeBruine 
et al., 2010). Therefore, researchers hypothesize that, for women, a trade-off occurs between the 
benefits and costs of increased masculinity in a partner (e.g., healthy offspring versus low 
paternal investment; DeBruine et al., 2010; Penton-Voak & Perrett, 2000). Jones, Little, and 
colleagues (2005) found that women were most attracted to masculinity during the late follicular 
phase when progesterone levels are low and most attracted to apparent health during the mid-
luteal phase when progesterone levels are highest. High progesterone levels were also associated 
with a preference for more feminine male faces. Women were also found to report greater 
commitment to their partner when progesterone levels were highest (Jones, Little, et al., 2005). 
These findings make sense from an evolutionary perspective, as periods of high progesterone 
mimic pregnancy and it would be advantageous for pregnant women to seek out high paternal 
investment within a stable relationship. 
Women’s preferences for masculinized faces also vary as a function of pathogen disgust. 
Pathogen disgust scores have been found to be positively correlated with a preference for 
masculinity in male faces (DeBruine et al., 2010). In addition, women preferred more masculine 
and symmetric male faces after viewing slides depicting images of high pathogen cues compared 
to images of low pathogen cues (Little, DeBruine, & Jones, 2011). In a study examining nearly 
5,000 women from 30 different countries, preference for masculinized male faces increased as an 
index of national health decreased (based on World Health Organization statistics such as impact 
of communicable diseases; DeBruine et al., 2010). These findings are consistent with the 





associated with increased attraction to apparent health in faces. Therefore, increased pathogen 
exposure or exposure to pathogen cues may prime the preference for masculinity in male 
partners in order to reduce the risk of infection during pregnancy (Jones, Little, et al., 2005). 
Emotional recognition has also been found to vary across the menstrual cycle. Compared 
to other facial expressions, disgust, fear, and anger may be the most crucial from an evolutionary 
perspective as they signal a threat (Collignon et al., 2010). In ancient history, displaying 
expressions of fear or disgust provided cues to another person to signal potential threats (e.g., a 
predator or a source of contamination). In many instances, we take cues from other people in 
terms of what we approach or avoid, which could have a direct impact on our survival (Martin et 
al., 2006). Using a cross-sectional design, Pearson and Lewis (2005) found that fear recognition 
was significantly higher in the pre-ovulatory stage when estrogen levels are highest and lowest 
during menses when estrogen levels are lowest. Although hormone levels were not directly 
measured in this study, the findings suggest that higher estrogen levels facilitate more accurate 
recognition of fear. In an fMRI study conducted by Derntl, Windischberger, and colleagues 
(2008), amygdala activation was significantly stronger in women in the follicular phase 
compared to women in the luteal phase, corresponding to greater emotion recognition in the 
follicular phase than in the luteal phase. Derntl, Kryspin-Exner, Fernbach, Moser, and Habel 
(2008) also found higher emotion recognition accuracy in the late follicular phase. In addition, 
emotion recognition accuracy was negatively correlated with progesterone levels. However, 
females were more likely to misperceive other negative emotions (e.g., sadness, fear) as angry or 
disgusted in the luteal phase compared to the follicular phase. 
Women have been found to be more accurate at identifying and portraying expressions of 





participants were shown emotional stimuli (visual, auditory, and bimodal) representing fear or 
disgust and then given a forced-choice discrimination test. Women were found to outperform 
men across all three modalities. Male and female participants were more accurate when the actor 
portraying the emotion was female. Guapo and colleagues (2009) also found that for every 
emotion except fear, female faces were identified more accurately than male faces. This female 
advantage may be a function of differences in caretaking between the sexes, as the importance of 
conveying and perceiving an emotion quickly is essential (Collignon et al., 2010).  
In contrast to previous findings (e.g., Derntl, Kryspin-Exner, et al., 2008), women might 
be expected to show enhanced recognition of disgust during times of immunosuppression or 
increased progesterone (i.e., the luteal phase) according to the compensatory prophylaxis 
hypothesis. As already discussed, women display enhanced preferences for healthy faces (Jones, 
Perrett, et al., 2005) and enhanced perceptions of intensity of disgusted faces with averted eyes 
(Conway et al., 2007) during the luteal phase of the menstrual cycle. If considering only 
immunosuppression, opiate users have a suppressed immune system and were found to be 47% 
more accurate in recognizing facial expressions of disgust compared to former users, and 31% 
more accurate than control participants (Martin et al., 2006). Given the increased levels of 
progesterone during pregnancy, enhanced recognition of disgust would be expected. In a 
prospective study by Pearson, Lightman, and Evans (2009), facial recognition accuracy was 
examined in 101 pregnant women at 11 weeks and again at 37 weeks of pregnancy. Participants 
were shown 60 faces displaying six basic human emotions (i.e., happiness, sadness, fear, anger, 
disgust, and surprise) and had to choose which of the six emotions was being displayed. The 
results revealed that women were more accurate at identifying emotions that signal a threat (i.e., 





The fact that women in the later stages of pregnancy were more vigilant towards threats 
makes sense from an evolutionary perspective as there is clear adaptive value for being able to 
identify threats in the environment, whether they signal potential danger or contamination. 
Oxytocin has been found to increase from the first to third trimester of pregnancy (Prevost et al., 
2014), and affect emotion recognition (Van IJzendoorn & Bakermans-Kranenburg, 2012). The 
hormone oxytocin serves several important functions in women including stimulation of uterine 
contractions, lactation, and promotion of maternal bonding behaviour (Weller, Zagoory-Sharon, 
& Levine, 2007). Oxytocin levels in pregnancy and the postpartum have been linked to enhanced 
maternal bonding behaviours (Feldman, Weller, Zagoory-Sharon, & Levine, 2007) and lower 
oxytocin scores in mid-pregnancy have been linked to higher postnatal depression scores in the 
early postpartum period (Skrundz, Bolten, Nast, Hellhammer, & Meinlschmidt, 2011). In a 
recent meta-analysis, Van IJzendoorn and Bakermans-Kranenburg (2012) showed that intranasal 
administration of oxytocin significantly enhanced facial emotion recognition (d = 0.21). 
Oxytocin administration also improves emotion recognition in individuals with schizophrenia 
(e.g., Averbeck, Bobin, Evans, & Shergill, 2012). Oxytocin has also been shown to improve 
accuracy of inferring the emotional states of others based only on viewing pictures of their eyes 
(Domes, Heinrichs, Michel, Berger, & Herpertz, 2007). However, there is conflicting evidence 
for the effect of oxytocin administration on amygdala response to fearful stimuli as measured by 
fMRI, as intranasal oxytocin has been found to reduce amygdala activation in some studies (e.g., 
Domes, Heinrichs, Glascher, et al., 2007; Kirsch et al., 2005) and increase amygdala activation 
in others compared to placebo (Domes et al., 2010). Thus, it is not clear whether oxytocin 






Not all studies examining emotion recognition across the menstrual cycle have shown 
enhanced recognition of disgust during periods of increased progesterone (i.e., the luteal phase). 
For instance, Guapo et al. (2009) examined the effect of sex hormones on the recognition of 
facial expressions. Women were booked to participate in the study during either the early 
follicular phase (n = 11), ovulatory phase (n = 9), or luteal phase (n = 10) of their menstrual 
cycle and compared to a sample of men (n = 10). All six basic emotions were presented across 
different intensity levels (e.g., 10%-100%) and identification accuracy scores were created for 
each emotion. When examining menstrual cycle phases, women in the early follicular phase 
more accurately perceived angry faces compared to women in the luteal phase and men. During 
the ovulatory phase women were more accurate at identifying expressions of fear compared to 
men, and women were more accurate at recognizing sadness in the early follicular phase 
compared to the luteal phase. However, women did not differ in their recognition accuracy of 
disgust across the menstrual cycle. Lastly, the only notable finding pertaining to hormone levels 
was a negative correlation between estrogen levels and identification of anger. One of the 
limitations of this study, however, was the small number of women per menstrual cycle phase. 
In the real world facial expressions are often perceived at a distance and in a wide variety 
of contexts, which differs greatly from the standardized presentations used in the laboratory. 
Thus, instead of using clearly identifiable facial expressions, ambiguous facial expressions and 
incorrect classifications have been used as measures of perceptual bias. For instance, individuals 
with PMDD have been shown to display a negative bias similar to that of individuals with 
depression during the luteal phase of the menstrual cycle, with neutral faces being misjudged as 
sad (Rubinow, Smith, Schenkel, Schmidt, & Dancer, 2007). These differences were not observed 





accuracy, Derntl, Kryspin-Exner, and colleagues (2008) found that women in the luteal phase 
were biased toward classifying negative emotions as disgusted or angry. Individuals with OCD 
also show perceptual biases in emotion detection. Jhung et al. (2010) found that individuals with 
OCD were more likely to perceive disgust and less likely to perceive anger in ambiguous facial 
expressions compared to control participants, although no differences were observed in non-
ambiguous facial expressions. As individuals with OCD have increased disgust sensitivity, they 
may be primed to perceive facial expressions of disgust in others. Furthermore, increased 
cleaning symptoms and contamination-based disgust scores increased the likelihood of 
perceiving disgust in ambiguous facial expressions. These findings suggest state dependent 
changes in emotional processing and highlight the role of schema-consistent processing or 
filtering of information. 
Moderators of behaviour change across the menstrual cycle  
Recent menstrual cycle research suggests that not all women show the same cyclical 
changes across the menstrual cycle and that different groups of women may experience different 
patterns across the cycle. For instance, one variable that has been found to moderate behavioral 
changes across the cycle is sociosexuality. Individuals with lower or more restricted 
sociosexuality tend to have fewer sexual partners, require commitment and closeness before 
having sex, and are unlikely to have casual sex, whereas individuals with higher or more 
unrestricted sociosexuality are more comfortable engaging in uncommitted sexual behavior and 
tend to have a greater number of sexual partners (Simpson & Gangestad, 1991).  
Oinonen, Klemencic, and Mazmanian (2008) found that women with high and low 
sociosexuality showed opposite shifts in mating strategies across the menstrual cycle, which they 
termed the Periovulatory Sociosexuality Tactic Shift (PSTS). Whereas restricted women showed 





phase (i.e., became more promiscuous), unrestricted women showed a decrease in their one-night 
stand interest during the periovulatory phase (i.e., became less promiscuous). 
Sociosexuality was also found to moderate the relationship between testosterone levels 
and relationship status (Edelstein, Chopik, & Kean, 2011). Partnered men with low sociosexual 
desire (i.e., more restricted) showed significantly lower testosterone levels compared to single 
men. However, partnered men with a higher sociosexual desire who reported a greater desire for 
uncommitted sexual activity showed testosterone levels that were comparable to single men. 
Furthermore, similar results were found for women. Partnered women with more restricted 
sociosexual behavior had lower levels of testosterone compared to single women, whereas 
women who reported more frequent uncommitted sexual behavior had testosterone levels 
comparable to single women (Edelstein et al., 2011). 
Digit ratio has also been found to moderate changes in facial preferences across the cycle 
(Scarbrough & Johnston, 2005). The ratio of the length of the second digit to the fourth digit 
(2D:4D) is thought to be a proxy measure of prenatal androgen and estradiol exposure (Manning, 
Scutt, Wilson, & Lewis-Jones, 1998; Manning, Bundred, Newton, & Flanagan, 2003). Whereas 
women tend to show equal digit lengths or a ratio of approximately 1, men tend to have a longer 
fourth digit making the ratio below one (Manning et al., 1998). Lutchmaya, Baron-Cohen, 
Raggatt, Knickmeyer, and Manning (2004) found that high levels of fetal testosterone as 
measured through amniocentesis were significantly related to low 2D:4D ratios measured at two 
years of age. Experimental studies with mice have shown that sex differences in 2D:4D emerge 
at a specific time in embryonic development and correspond to differential patterns of androgen 





differences persisted throughout the lifespan, providing evidence that 2D:4D is a stable and 
reliable indicator of prenatal hormone exposure (but see Hampson & Sankar, 2012). 
Digit ratio is also related to sociosexuality, as lower (or more masculinized) 2D:4D is 
associated with unrestricted sociosexuality (Clark, 2004). Scarbrough and Johnston (2005) found 
that when women had to select the most attractive male face at two points across the menstrual 
cycle, women with low 2D:4D shifted towards a more masculine face during the high conception 
probability phase, whereas women with high 2D:4D shifted toward a less masculinized face in 
the high conception probability phase. 
 These findings suggests that not all women show the same pattern of behavioral change 
across the menstrual cycle and it may be important to examine potential moderators of change 
across the cycle. For instance, sexual activity may be a potential proxy measure of 
sociosexuality, and research suggests that hormone profiles may differ according to relationship 
status. 
The present study 
Evolutionary psychologists posit that precautionary behaviours are evident in 
childbearing women because they represent adaptive strategies for protecting their offspring 
from threat. These threats have been present in ancient times and remain important to this day. 
Hahn-Holbrook et al. (2011) categorize these potential risks to offspring according to the threat 
of disease, attack, and accidents. In this conceptualization, disgust proneness, contamination 
fears, and heightened risk aversion have direct benefits such as reducing pathogen exposure that 
could cause birth defects or by preventing accidental harm to the infant (e.g., falling). In other 
words, precautionary behaviours provide important functions that increase the likelihood of 





of equal reproductive importance. For instance, in free-cycling women, every menstrual cycle 
represents the possibility of conception and includes periods of low and high progesterone levels. 
There is evidence suggesting that disgust sensitivity and contamination-related OCD symptoms 
increase during times of increased progesterone, although the findings are not consistent. 
Reproductive hormones may provide important insights into the sex differences in disgust 
sensitivity and contamination-related OCD symptoms. Furthermore, constructs closely 
associated with OCD symptoms including harm avoidance and responsibility beliefs have yet to 
be examined in this context. In the present study harm avoidance will be characterized by lower 
risk-taking scores. 
The purpose of the present study was to examine differences between free-cycling 
women and women taking hormonal contraceptives in terms of: disgust sensitivity, OCD 
contamination symptoms, responsibility beliefs, risk-taking across the cycle, and to compare 
emotion discrimination between men and women over the cycle or corresponding length of time 
for men. The present study overcame several limitations of past research in this area, while also 
attempting to find novel associations. Prior studies in many of the areas discussed previously 
have included the use of hormonal contraceptives as exclusionary criteria in their designs. The 
menstrual cycle research previously discussed consists of largely cross-sectional designs with 
low sample sizes per menstrual cycle phase and without the direct measurement of hormone 
levels. Thus, the present study was designed to address these limitations and make stronger 
conclusions regarding within-subject differences in precautionary behaviour across the menstrual 








1. Free-cycling women will show an increase in contamination-based OCD symptoms, 
disgust sensitivity, and responsibility beliefs and a decrease in risk-taking during the 
luteal phase of the menstrual cycle compared to the follicular phase, whereas women 
taking hormonal contraceptives will show significantly attenuated effects compared to 
free-cycling women in terms of these dependent variables. 
Potential moderating variables will also be explored to see if subgroups of women  
display different patterns of behavior change cross the cycle. 
2. Increasing salivary progesterone levels across the menstrual cycle will be associated 
with increased OCD symptomatology, disgust sensitivity, responsibility beliefs, and 
decreased risk-taking across the cycle. 
Since the luteal phase of the menstrual cycle is characterized by high levels of 
progesterone (which suppress the immune system), the compensatory prophylaxis 
hypothesis (Fessler et al., 2005) predicts that obsessive compulsive behaviour and disgust 
sensitivity will increase to compensate for greater vulnerability to infection. Harm 
avoidance and responsibility beliefs are also hypothesized to increase at this time as they 
are closely related to OCD (Salkovskis et al., 2000), and changes in behaviour and 
cognition generally do not occur independently. 
Women taking hormonal contraceptives generally have decreased endogenous 
progesterone levels compared to free-cycling women (Fleischman et al., 2010). Therefore 
if progesterone is driving changes in precautionary behaviour across the cycle there 





Previous research suggests that not all women show the same pattern of behavior 
change across the cycle (e.g., Edelstein et al., 2011; Oinonen et al., 2008; Scarbrough & 
Johnston, 2005). Thus, there may be variables that moderate the pattern of change in the 
main dependent variables across the cycle. By exploring potential moderating variables it 
may be possible to identify different subgroups of women who show different patterns of 
behavior change across the menstrual cycle. 
3.  a) Women will show increased sensitivity for identifying facial expressions of disgust 
compared to men. 
 Women are hypothesized to show greater sensitivity in identifying facial 
expressions of disgust due to findings of increased disgust sensitivity in women and more 
accurate identification and portrayal of expressions of disgust compared to men (e.g., 
Collignon et al., 2010). 
b) Free-cycling women with a more liberal bias in terms of perceiving facial expressions 
of disgust will have increased levels of progesterone and pathogen disgust compared to 
women with a more conservative bias. 
It is predicted, based on the compensatory prophylaxis hypothesis, that during 
times of immunosuppression (or increased progesterone) it would be beneficial to have a 
more liberal bias in terms of recognizing potential signals of contamination or threat. 
Furthermore, individuals with OCD have been found to be biased toward perceiving 
disgust in ambiguous facial expressions, with high contamination-based disgust scores 
increasing this effect. Therefore, heightened contamination disgust and increased 







1. Sex differences will be found in disgust sensitivity and risk-taking with women scoring 
higher than men in disgust sensitivity and lower in risk-taking. 
This hypothesis is in line with past research showing that women have greater 
disgust sensitivity than men (e.g., Druschel & Sherman, 1999; Murisa et al., 2000; 
Rohrmann et al., 2008; Tybur et al., 2009) and a meta-analysis showing that women 
engage in less risk-taking behaviour than men (Byrnes et al., 1999). 
2. Women who are more hormonally sensitive (i.e., meet criteria for PMS) will report 
greater average OCD symptoms across the menstrual cycle. 
 This prediction is based on findings showing a high degree of comorbidity 
between OCD and PMS/PMDD (Vulink et al., 2006; Williams and Koran, 1997). 
Furthermore, women meeting criteria for PMS or PMDD appear to be more likely to 
have comorbid psychopathology. For instance, psychiatric symptoms such as depression, 
anxiety, aggression, and interpersonal sensitivity were found to be significantly higher in 
a group of women with PMS compared to a “healthy” group of women (Firoozi, Kafi, 
Salehi, & Shirmohammadi, 2012). 
Exploratory Hypothesis 
To further study the impact of hormones on precautionary behaviour, the following 
research question will also be investigated: Is there a relationship between 2D:4D and symptoms 
of obsessive-compulsive disorder?  
High testosterone levels have been linked to obsessive-compulsive disorder, after case 
studies were published showing that anti-androgen treatment led to symptom improvement (e.g., 





triptorelin in patients diagnosed with OCD who had not shown a response to SSRI treatment. 
Triptorelin is a gonadotropin-releasing hormone agonist that reduces LH and testosterone levels. 
Five out of six patients experienced significant reductions in OCD symptoms. In addition, men 
are more likely to have aggressive and sexual obsessions and compulsions than women (Lochner 
et al., 2004; Saad, 2006). Although these studies suggest that high levels of testosterone may 
play a role in the development of obsessive-compulsive disorder, other studies suggest the 
opposite pattern. For instance, men with more feminized 2D:4D ratios have been found to have 
greater anxiety symptoms (Evardone & Alexander, 2009). In addition, harm avoidance has been 
linked to OCD and a recent study found that risk-taking was negatively correlated with 2D:4D 
ratios in men (Stenstrom, Saad, Nepomuceno, & Mendenhall, 2011). These findings suggest that 
obsessive-compulsive symptoms may be associated with a more feminized 2D:4D pattern. 
Method 
Participants 
A total of 509 people completed the online screening questionnaire for the study. 
Participants were recruited locally from Introductory Psychology classes, higher level 
psychology courses, and the general university community as well as online through social 
networking websites. Participants were primarily female (77.4%), and were between 17 and 59 
years of age (M = 22.00, SD = 6.52).  
Of the overall sample of 509 participants, 332 went on to complete the phase 
questionnaires. Those who only completed the screening questionnaire were slightly younger (M 
= 21.25, SD = 5.87, n = 177) compared to those who went on to complete the full study (M = 
22.39, SD = 6.81, n = 332), although this difference was only a trend, t(504) = -1.86, p = .06. 





(1) = 7.12, p = .008; phi = - 0.12, although this was a small effect size. No differences were 
found between people who completed only the screening questionnaire and those who went on to 
complete the study in terms of ethnicity, marital status, education, religion, or sexual orientation. 
Of the 332 people who completed the current study, 261 (78.6%) completed the study in 
the laboratory whereas 71 (21.4%) completed the fully online version of the study (see Table 1 
for demographic characteristics of the total sample). Participants who completed the fully online 
version of the study were significantly older (M = 26.34, SD = 8.40, n = 71) than participants 
who completed the laboratory version of the study (M = 21.41, SD = 6.10, n = 261), t(91.25) = -
5.54, p < .001. Men were significantly more likely to participate in the laboratory version of the 
study compared to women, χ2 (1) = 5.36, p = .02; phi = 0.13. Participants who completed the 
study in the laboratory were less likely to be married or common-law and more likely to be 
single, χ2 (3) = 15.69, p = .001; phi = 0.22. Participants who completed the fully online version 
of the study had significantly more years of education (M = 15.77, SD = 2.15, n = 71) compared 
to participants who completed the study in the laboratory (M = 13.61, SD = 2.58, n = 261), t(330) 
= - 6.48, p < .001. Participants who completed the study in the laboratory were more likely to be 
Introductory Psychology students whereas participants completing the fully online version of the 
study were likely to be students in upper year psychology classes. 
Of those who completed the laboratory version of the study, the majority received bonus 
points (82.8% for session 1, 86.3% for session 2) rather than Tim Horton gift certificates (17.2% 
for session 1, 13.7% for session 2). Of those who completed the fully online version of the study, 
the majority received bonus points (78.9% for session 1, 78.8% for session 2), and the rest were 
entered into a prize draw (21.1% at session 1, 21.2% at session 2).  







Demographic Characteristics of the Overall Sample (N = 332) 
             
                                      Total Sample       Men (n = 87)   Women (n = 245)         
Variable      n (%)      n (%)     n (%) 
               
Age (M (SD))      22.46 (6.94)    22.94 (7.24)    22.29 (6.84)     
 
Years of Education (M (SD))    14.07 (2.65)    14.48 (2.51)    13.93 (2.69) 
  
Marital status  Married/common law   28 (8.9%)    4 (4.8%)    24 (10.5%) 
   Single    276 (88.2%)    77 (91.7%)    199 (86.9%) 
       Divorced/separated  7 (2.2%)    3 (3.6%)    4 (1.7%) 
   Widowed   2 (0.6%)      0 (0%)    2 (0.9%)   
      
Dating/Relationship Yes    119 (45.9%)    25 (32.5%)    101 (53.4%) 
   No    140 (54.1%)    52 (67.5)    88 (46.6%) 
  
Ethnicity  European Descent  285 (86.1%)    74 (85.1%)    211 (86.5%) 
African Canadian/Black    5 (1.5%)    3 (3.4%)    2 (0.8%) 
Middle Eastern    2 (0.6%)    0 (0%)    2 (0.8%) 
Native-Canadian/Aboriginal 15 (4.5%)    2 (2.3%)    13 (5.3%) 
East Indian   3 (0.9%)    2 (2.3%)    1 (0.4%) 
Asian    11 (3.3%)    2 (2.3%)    9 (3.7%) 
Other       10 (3%)    4 (4.6%)    6 (2.5%) 
 
Religion  Christian   185 (56.6%)    42 (48.8%)    143 (59.3%) 
   Agnostic   26 (8.0%)    11 (12.8%)    15 (6.2%) 
   Buddhist   6 (1.8%)    1 (1.2%)    5 (2.1%) 
   Muslim    4 (1.2%)    1 (1.2%)    3 (1.2%) 
   Atheist    60 (18.3%)    20 (23.3%)    40 (16.6%) 
   Other    46 (14.1%)    11 (12.8%)    35 (14.5%) 
 
Sexual Orientation Asexual   2 (0.6%)    1 (1.1%)    1 (0.4%) 
   Exclusively heterosexual 266 (80.9%)    65 (74.7%)    201 (83.1%) 
Predominantly heterosexual 38 (11.5%)    10 (11.5%)    28 (11.6%) 
Equally hetero/homosexual  10 (3%)    1 (1.1%)    9 (3.7%) 
Predominantly homosexual 6 (1.8%)    4 (4.5%)    2 (0.8%) 
Exclusively homosexual 7 (2.1%)    6 (6.9%)    1 (0.4%) 
 
Education  High school diploma  88 (26.7%)    20 (23.0%)    68 (28%) 
Some college   3 (0.9%)    1 (1.1%)    2 (0.8%) 
 College diploma  25 (7.6%)    6 (6.9%)    19 (7.8%) 
 Some university  169 (51.2%)    45 (51.7%)    124 (51%)    
 Undergraduate degree  36 (10.9%)    13 (14.9%)    23 (9.5%)   







80 participants were excluded based upon a-priori exclusion criteria including participants who 
were over the age of 40 (n = 14), pregnant or breastfeeding (n = 5), had irregular menstrual 
cycles (under 25 days or over 35 days; n = 14), had one or both ovaries removed (n = 1), 
endorsed four or more infrequency scale items (n = 1), hormonal contraceptive users who were 
not currently experiencing menstrual periods and therefore could not be assigned a cycle phase 
(e.g., extended hormonal contraceptive users; n = 10), people who have current or chronic 
medical conditions that could affect hormone levels (e.g., depression, thyroid disorders, 
diabetes), or are currently using medication that may affect hormone levels (e.g., steroids, 
antidepressant medication; n = 32), and free-cycling women who used OCs within the past six 
months (n = 3). All participants scored within the normal limit (below 70T) for the social 
desirability scale, and therefore nobody was excluded on that basis. 
Of the 252 participants remaining, there were 75 men, 110 hormonal contraceptive (HC) 
users, and 67 free-cyclers (FCs). The majority of the women who completed the study (64.4%) 
were in the correct phases during participation in the two parts of the study (i.e., Follicular = 
days 3 to 10; Luteal = days -3 to -9); whereas 11.9% were outside the target testing days by 1 
day, 9.0% by two days, 6.2% by three days, 6.2% were four or more days off, and 2.3% only 
completed one phase of the study. Participants more than three days outside of the target testing 
days or those who did not complete both phases of the study were excluded from subsequent 
analyses (n = 15). Of the 237 participants remaining, participants with an anxiety disorder were 
also excluded (n = 6; 3 men and 3 HC users), as we intended to examine sub-clinical symptoms. 
A further eight participants were excluded based on having progesterone levels inconsistent with 
their reported cycle phases. Thus, the final sample size was 223 participants, including 72 men, 



























Figure 1. Flowchart of study participants. 
 
Participants who completed the online screening 
questionnaire (N = 509) 
   Exclusions (n = 109) 
* Age > 40 (n = 14) 
* Pregnant/ breastfeeding (n = 5) 
* Irregular menstrual cycle (n = 14) 
* One or both ovaries removed (n = 1) 
* Endorsed > 3 infrequency scale items (n = 1) 
* Not experiencing menstrual periods (n = 10) 
* Medical conditions/medications affecting hormone levels (n = 32) 
* Free-cyclers who used oral contraceptives in past 6 months (n = 3) 
* More than 3 days outside of target testing days (n = 15) 
* Participants with an anxiety disorder (n = 6) 





Sample after exclusions  
(n = 223; 178 laboratory, 45 online) 
 
 
Participants who went on to complete the two phase 
questionnaires (n = 332; 261 in laboratory, 71 online) 






age of participants was 20.83 (SD = 3.68), with the majority being of European descent (79.4%), 
single (92.8%), Christian (56.2%), exclusively heterosexual (82.4%), and having some university 
education (50.4%; see Table 2 and 3 for full demographic characteristics). 
Group equivalency between the three groups was examined using chi-squared tests and 
one-way ANOVAs, depending on whether the variable was dichotomous or continuous. There 
were no significant differences between the three groups in terms of ethnicity, religion, sexual 
orientation, or education (see Table 3). However, the groups did differ on age and marital/ 
relationship status. A one-way ANOVA revealed a significant difference between the groups in 
terms of age, F(2, 220) = 7.59, p = .001. A Tukey post-hoc test revealed that age was 
significantly younger in HC users (M = 19.79, SD = 2.37, n = 100) compared to men (M = 21.63, 
SD = 4.07, p = .003, n = 72) or FCs (M = 21.73, SD = 4.66, p = .005, n = 51). There was also a 
significant difference between groups in terms of marital and relationship status. Free-cycling 
women and women using hormonal contraceptives did not differ according to relationship status, 
χ2 (1) = 71.75, p = .19; phi = - 0.11, but men were significantly more likely to be single and less 
likely to be in a relationship compared to women, χ2 (1) = 10.20, p = .001; phi = .22. 
Based on the PSST, twenty-two percent of the sample met criteria for PMS, while 4.7% 
reported symptoms consistent with PMDD (see Table 4 for more detailed reproductive history). 
The majority of women taking hormonal contraceptives were taking OCs (88%; see Table 5). 
The most commonly used OCs were Alesse and Tri-Cyclen Lo (see Table 6). Oral contraceptives 
were also categorized according to their phasicity (e.g., monophasic, triphasic), progesterone 
dosage (low versus high), and level of androgenicity for later analyses (Black, Francoeur, & 
Rowe, 2004; Dickey, 2010; Ninger, 2000; see Table 6). Across all women, the mean testing day 






Demographic Characteristics of the Final Sample after Exclusions (N = 223) 
             
          
Variable       M (SD)       
                
Age         20.83 (3.68)    
   
Years of Education       13.96 (2.48)  
_____________________________________________________________________________________ 
        n (%)    
 
Marital status  Married/common law   12 (5.4%)    
Single     194 (87.0%)    
    Divorced/separated   3 (1.3%)      
       
Dating/Relationship Yes     125 (56.1%)      
   No/Single     89 (39.9%) 
        
Ethnicity  European Descent   195 (87.5%) 
African Canadian/Black    5 (2.2%)       
Middle Eastern    2 (0.9%)     
Native-Canadian/Aboriginal  8 (3.6%)     
East Indian    2 (0.9%)   
Asian     5 (2.2%)        
Other      6 (2.7%)      
   
Religion  Christian    123 (56.2%)   
   Agnostic    21 (9.6%)       
   Buddhist    3 (1.4%)        
   Muslim     2 (0.9%)        
   Atheist     45 (20.5%)     
Other     25 (11.4%)     
 
Sexual Orientation Asexual    0 (0%)    
   Exclusively heterosexual  183 (82.4%)    
Predominantly heterosexual  25 (11.3%) 
Equally hetero/homosexual   4 (1.8%)     
Predominantly homosexual  5 (2.3%)     
Exclusively homosexual  5 (2.3%)  
 
Education  High school diploma   64 (28.8%) 
Some college    0 (0%)   
College diploma   13 (5.9%)       
Some university   112 (50.4%)      
Undergraduate degree   27 (12.2%)      
 Master’s degree    6 (2.7%)     
 






Demographic Characteristics of the Final Sample after Exclusions (N = 223), Separated by Group 
             
          
Variable       Men     HC users    FCs    p-value 
     (n = 72)        (n = 100)           (n = 51)            
               
           
    M (SD)      
 
Agea     21.63 (4.07)    19.79 (2.37)    21.73 (4.66)  .001         
 
Years of Education    14.36 (2.47)    13.82 (1.74)    13.68 (3.51)  .25 
_____________________________________________________________________________________ 
        
           n (%) 
Marital statusb           .04 
Married/common law   3 (4.2%)    3 (3.0%)    6 (11.8%)  
Single    65 (90.3%)    90 (90.0%)    39 (76.5%)    
 Divorced/separated  1 (1.4%)    0 (0%)    2 (3.9%)     
          
Dating/Long-term Relationship         .003 
Yes    29 (40.3%)    68 (68%)    28 (54.9%)    
 No/Single   39 (54.2%)    30 (33%)    20 (39.2%)   
 
Ethnicity           .16 
European Descent  61 (84.7%)    93 (93%)    41 (80.3%) 
African Canadian/Black    3 (4.2%)    0 (0%)    2 (3.9%)     
Middle Eastern    0 (0%)        1 (1%)    1 (2.0%) 
Native-Canadian/Aboriginal 2 (2.8%)    2 (2%)    4 (7.8%)     
East Indian   2 (2.8%)    0 (0%)    0 (0%)   
Asian    2 (2.8%)    1 (1%)    2 (3.9%)     
Other       2 (2.8%)    3 (3%)    1 (2.0%)  
 
Religion           .46  
Christian   34 (47.2%)    55 (56.7)    34 (68.0%) 
 Agnostic   10 (13.9%)    9 (9.3%)    2 (4.0%)     
 Buddhist   1 (1.4%)    1 (1%)    1 (2.0%)     
 Muslim    1 (1.4%)    0 (0% )    1 (2.0%)     
 Atheist    18 (25%)    21 (21.6%)    6 (12.0%)  
Other    8 (11.1%)    11 (11.3%)    6 (12.0%)     
 
Sexual Orientation          .10 
Asexual   0 (0%)     0 (0%)    0 (0%) 
Exclusively heterosexual 54 (75%)    86 (86.9%)    43 (84.3%)    
Predominantly heterosexual 8 (11.1%)    11 (11.1%)    6 (11.8%)    
Equally hetero/homosexual  1 (1.4%)    2 (2%)    1 (2.0%)     
Predominantly homosexual 4 (5.6%)    0 (0%)    1 (2.0%)     





Table 3 - continued 
             
          
Variable       Men     HC users    FCs    p-value 
     (n = 72)        (n = 100)           (n = 51)            
               
           M (SD)  
Education           .30  
High school diploma  18 (25%)    32 (32%)    14 (28.0%)    
Some college   0 (0%)     0 (0%)     0 (0%)   
College diploma  5 (6.9%)    3 (3%)    5 (10.0%)     
Some university  36 (50%)    53 (53%)    23 (46.0%)     
Undergraduate degree  12 (16.7%)    10 (10%)    5 (10.0%)     
 Master’s degree   1 (1.4%)    2 (2%)    3 (6.0%)      
 
Note. This table includes missing data due to unanswered items.  HC = hormonal contraceptive; FCs = free-cyclers. a Hormonal 
contraceptive users were significantly younger than men or free-cycling women. b Men were significantly more likely to be 





















Women’s Reproductive History (n = 151) 
 
 
Variable       n  % M SD  
           
 
Age at first menstruation     148  12.75 1.77  
  
Length of menstrual cycle (days)    147  28.14 6.99  
  
Length of period (days)      150  5.02 1.23  
   
Regularity of cycle  Some months I get my period 
    and some months I don’t. 3 2.0%  
    I usually get my period every 
    month, but it is irregular . 13 8.8% 
    I usually get my period within 
    2 to 3 days of when I expect it. 88 59.5%  
    My period is like clockwork. 44 29.7% 
 
Current HC user  Yes    100 66.2% 
    No    51 33.8% 
 
Length of HC use (years)     95  3.80 2.80 
 
Former HC user  Yes    22 44.9% 
    No    27 55.1%  
 
PMS diagnosis   Yes    33 22.0% 
    No    117 78.0% 
 
PMDD diagnosis  Yes    7  4.7% 
    No    143 95.3%  
 
Times pregnant   0    136 91.9% 
1    7 4.7%     
    2    3 2.0%      
    3    2 1.4%   
  
Number of children  1    3 37.5% 
    2    4 50.0% 
    3    1 12.5%  
 
Note. Counts may not sum to 151 as a result of unanswered items. HC = hormonal contraceptive; PMS = premenstrual syndrome; 








Types of Hormonal Contraceptives used in Current Hormonal Contraceptive Users (n = 100) 
 
 
Hormonal Contraceptive Type     n (%)  
           
 
Oral Contraceptives      88 (88) 
Injection       1 (1) 
Contraceptive Patch      3 (3) 
Implant       0 (0) 
Vaginal Ring       5 (5) 
Barrier        0 (0) 




















Oral Contraceptive Brands along with their Phasicity, Progestin Dose, and Androgenic Activity  
in current Oral Contraceptive Users (n = 88) 
 
 
Brand   n (%)  Phasicity  Progestin Dose   Androgenic Act. 
           
 
Alesse   18 (20.5) Monophasic  Low   Intermediate 
   
Alysena  3 (3.4)  Monophasic  Low   Intermediate  
Apri   3 (3.4)  Monophasic  Low   Low   
Aviane   10 (11.4) Monophasic  Low   Intermediate 
Cyclessa  1 (1.1)  Monophasic  High   Low 
Cyclen   1 (1.1)  Triphasic  Low   Low 
Demulen 30  2 (2.3)  Monophasic  High   Intermediate 
Diane 35  3 (3.4)  Monophasic  High   Low   
Linessa   3 (3.4)  Triphasic  High   Low   
Loestrin  1 (1.1)  Monophasic  High   High   
Marvelon  5 (5.7)  Monophasic  Low   Low   
Min-Ovral  4 (4.5)  Monophasic  Low   Intermediate 
MinEstrin 1/20  1 (1.1)  Monophasic  High   Intermediate 
Portia   1 (1.1)  Monophasic  Low   Intermediate 
Seasonale  1 (1.1)  Monophasic  Low   Intermediate 
Tri-Cyclen  4 (4.5)  Triphasic  Low   Low 
Tri-Cyclen Lo  13 (14.8) Triphasic  Low   Low 
Yasmin   6 (6.8)  Monophasic  High   None 
Yaz   8 (9.1)  Monophasic  High   None 
 





luteal phase was 6 days prior to menstruation (M = -6.26, SD = 2.67, range: -12- 1, n = 151). 
Approximately 75% of women were tested first in the follicular phase and second in the luteal 
phase, while the remaining women were tested first in the luteal phase and second in the 
follicular phase. In addition, 67% of free-cycling women who completed the study in the 
laboratory provided confirmation of the start of their next period in order to verify their testing 
days. 
Materials 
Online Screening Questionnaire 
The screening questionnaire was presented online through SurveyMonkey and included 
background and reproductive history. The screening questionnaire was used to collect menstrual 
cycle information so women could be scheduled to complete the additional questionnaires during 
specific phases of their cycle, as well as screening for later exclusion criteria (e.g., age, irregular 
menstrual cycles, medical conditions, etc.). 
The Background Information Questionnaire consisted of questions pertaining to basic 
demographic information (e.g., age, sex, education), reproductive history (e.g., age at puberty, 
use of hormonal contraceptives), and psychological and medical history (e.g., current medication 
use, psychiatric or medical diagnoses). This questionnaire has been widely used in the Health,  
Hormones, and Behaviour Laboratory and was included in several published studies (e.g., 
Oinonen & Mazmanian, 2007). Women also completed the Premenstrual Symptoms Screening 
Tool (PSST; Steiner et al., 2003). The PSST was designed as a screening tool for both PMS and 
PMDD and is based on DSM-IV criteria for PMDD. A screening tool is ideal in research or in 
practice when daily prospective measures across two cycles are not practical or possible. Each 





sample of 508 women who completed the PSST, including hormonal contraceptive users and 
non-users (Steiner et al., 2003), rates of PMDD and moderate to severe PMS were very similar 
across hormonal contraceptive users (i.e., 5.9% and 26%, respectively) and non-users (i.e., 4.8% 
and 25.6%, respectively). 
Although published research has used the PSST (e.g., Steiner et al., 2011), the authors of 
the scale have yet to report the full psychometric properties of the instrument. However, two 
recent studies that translated the PSST into Korean and Persian found high internal consistency 
reliability (αs ≥ .90; Choi et al., 2011; Siahbazi, Hariri, Montazeri, Banaem, & Hajizadeh, 2011). 
Phase Questionnaires  
The Padua Inventory-Washington State University Revision (PI-WSUR; Burns, Keortge, 
Formea, & Sternberger, 1996) 
The PI-WSUR consists of 39 items, broken down into subscales that measure five 
different content dimensions relevant to OCD: contamination obsessions and washing 
compulsions (e.g., “I find it difficult to touch garbage or dirty things”), dressing/grooming 
compulsions (e.g., “I feel obliged to follow a particular order in dressing, undressing, and 
washing myself”), checking compulsions (e.g., “When I handle money, I count and recount it 
several times”), obsessional thoughts about harm to self/others (e.g., “When I hear about a 
disaster, I think it is somehow my fault”), and obsessional impulses to harm self/others (e.g., “I 
sometimes have an impulse to steal other people’s belongings, even if they are of no use to me”). 
Items are rated according to a 5-point Likert-type scale from 0 (not at all) to 4 (very much).  
Burns and colleagues (1996) found the scale had high internal consistency reliability (α = 
.92). Internal consistency reliability statistics for the 5 subscales were: .85 for contamination 





compulsions, .77 for obsessional thoughts about harming self/others, and .82 for obsessional 
impulses to harm self/others. The revised version reduced the amount of shared variance with 
worry, thus making the measure a more distinct measure of obsessionality. Based on the 
normative data for non-clinical and clinical samples reported by Burns and colleagues (1996), 
cut-off scores below 6 and above 14 have been used to identify individuals who are low and high 
in contamination fears (e.g., Deacon & Olatunji, 2007). 
Grabill and colleagues (2008) reviewed 16 measures of OCD and reported that the PI-
WSUR had good psychometric properties. Test-retest reliability over a 6-month period was 
adequate (r = .76; Grabill et al., 2008). In terms of convergent and discriminant validity, scores 
on the PI-WSUR correlated with the Maudsley Obsessive Compulsive Inventory (MOCI; r = 
.61) significantly more than the Penn State Worry Questionnaire (PSWQ; r = .37) in a large 
student sample (Jonsdottir & Smari, 2000). Consistent with previous findings, women scored 
significantly higher on the contamination obsessions and washing compulsions subscale, 
whereas men scored higher on the obsessional impulses to harm self/others subscale (Jonsdottir 
& Smari, 2000). 
Disgust Scale -Revised (DIS-R; Haidt et al., 1994, modified by Olatunji, Williams, et al., 2007) 
The original Disgust Scale consisted of 32 items that measured the following eight 
domains of disgust: food, body products, animal, sex, personal hygiene, envelope violations, 
death, and magical thinking. The internal consistency reliability for the entire scale was .84, but 
the authors cautioned that the internal consistency for the subscales was too low for the scales to 
be individually interpreted (αs < .63; Olatunji et al., 2008). 
Olatunji, Williams, and colleagues (2007) later revised the Disgust Scale after examining 





were removed due to unacceptable item-total correlations and the number of subscales was 
reduced from 8 to 3 based on factor analysis. The three subscales included core disgust (e.g., 
“Seeing a cockroach in someone else's house doesn't bother me”), animal reminder disgust (e.g., 
“It would bother me to be in a science class, and to see a human hand preserved in a jar”), and 
contamination-based disgust (e.g., “I never let any part of my body touch the toilet seat in public 
restrooms”). Although the internal consistency reliability increased for the core and animal 
reminder disgust subscales (.74 and .78, respectively), it remained low for contamination (.61). A 
recent study by van Overveld, de Jong, Peters, and Schouten (2011) supported the three-factor 
solution over a two-factor solution, suggesting that although the internal consistency for the 
contamination scale is lower than the other two scales, it still provides incremental validity. The 
response format of the scale was also revised from a dichotomous response (i.e., true/false) to a 
continuous Likert-type scale (i.e., 0 to 4 or strongly disagree to strongly agree). Finally, the scale 
includes two questions that act as infrequency items to identify individuals who are not paying 
attention to the task (e.g., “I would rather eat a piece of fruit than a piece of paper”).  
Three Domain Disgust Scale (TDDS; Tybur et al., 2009) 
This scale represents a multidimensional model of disgust consisting of pathogen (e.g., 
“Sitting next to someone who has red sores on their arm”), sexual (e.g., “Finding out that 
someone you don’t like has sexual fantasies about you”), and moral disgust (e.g., “Forging 
someone’s signature on a legal document"). The authors demonstrated discriminant validity 
across the three domains of disgust. For instance, primary psychopathy was negatively correlated 
with moral disgust and sexual disgust but unrelated to pathogen disgust. Perceived vulnerability 
to disease was related to pathogen and sexual disgust but not moral disgust. Different disgust 





sensitivity to pathogen disgust positively correlated with neuroticism, sexual disgust sensitivity 
positively correlated with conscientiousness, and moral disgust positively correlated with 
extraversion (Tybur et al., 2009). 
These three subscales have considerably higher internal consistency reliabilities 
compared to the Disgust Scale-Revised at .87, .84, and .87 for pathogen, sexual, and moral 
disgust, respectively. Due to the high internal consistency of the pathogen scale it was preferred 
in the current study over the contamination-based disgust subscale of the Disgust Scale-Revised 
when looking only at contamination-based disgust as opposed to general disgust sensitivity. 
Sexual and moral disgust are not a key focus of the present study and therefore were not 
included. The pathogen subscale includes 7 items that are rated on a 6-point Likert-type scale 
from 0 (not at all disgusting) to 6 (extremely disgusting). 
Responsibility Attitude Scale (RAS; Salkovskis et al., 2000) 
The RAS consists of 26 items that measure beliefs about responsibility, a key component 
in the cognitive model of OCD. Sample items include, “I often take responsibility for things 
which other people don’t think are my fault” and “Even if harm is a very unlikely possibility, I 
should always try to prevent it at any cost.” Items are rated using a 7-point Likert-type scale from 
1 (totally agree) to 7 (totally disagree). The total score for the RAS is the mean of all 26 items. 
For ease of comprehension, scores were reversed (totally agree = 7, totally disagree = 1) so that 
higher scores represent higher responsibility beliefs.  
Individuals with OCD have been found to score significantly higher on the RAS (M = 
4.69, SD = 1.01) compared to individuals with a DSM-IV anxiety disorder (M = 4.00, SD = 0.92), 
and control participants (M = 3.48, SD = 1.01; Salkovskis et al., 2000). The two week test-retest 





.92, whereas it was slightly lower in a study by Smári and Hόlmsteinsson (2001; α = .87). 
Concurrent validity was demonstrated by showing associations with additional measures of 
obsessive compulsive symptoms such as the Maudsley Obsessive Compulsive Inventory (MOCI; 
r = .57) and the Obsessive Compulsive Inventory (OCI; r = .54).  
Domain-Specific Risk-Taking scale (DOSPERT; Blais & Weber, 2006) 
The original DOSPERT scale (Weber, Blais, & Betz, 2002) contains 50 items assessing 
risk-taking across five domains: ethical, financial, health/safety, recreational, and social. All five 
domains of risk-taking were associated with concurrent ratings of sensation seeking. Women 
were found to be more risk aversive than men, with significant differences in every subscale 
except for social risk-taking. The scale was refined to 40 items to enhance the psychometric 
properties and then a shortened version (30-items) was created, which was used in the present 
study (Blais & Weber, 2006). 
The shortened DOSPERT scale measures risk-taking by asking participants to rate the 
likelihood that they would engage in risky activities if in a given situation. The scale measures 
risk-taking across five domains: social (e.g., “Admitting that your tastes are different from those 
of a friend”), recreational (e.g., “Taking a skydiving class”) financial (e.g., “Betting a day’s 
income at a high-stake poker game”), health/safety (e.g., “Driving a car without wearing a seat 
belt”), and ethical (e.g., “Passing off somebody else’s work as your own”). Items are rated on a 
7-point Likert-type scale from 1 (extremely unlikely) to 7 (extremely likely). The response scale 
was increased from a 5-point Likert-type scale to a 7-point Likert-type scale in the most recent 
version to increase the sensitivity of the measure. Higher scores represent greater risk-taking 






The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
The HADS is a widely used screening measure for anxiety (e.g., “I feel tense or wound 
up”) and depression (e.g., “I feel as if I am slowed down”). The scale contains a 7-item subscale 
measuring anxiety and a 7-item subscale measuring depression. Each item is scored on a 4-point 
Likert-type scale from 0 to 3, resulting in a maximum score of 21 per subscale. Subscale scores 
of 7 or under are considered in the normal range, scores between 8 and 10 are considered at risk 
of a mood disorder, and scores 11 and higher indicate a probable “case” of a mood disorder 
(Snaith, 2003; Zigmond & Snaith, 1983). However, Bjelland, Dahl, Haug, and Neckelmann 
(2002) found that a cut-off score of 8 to define a “case” was met with the best balance between 
specificity and sensitivity.  
Bjelland and colleagues (2002) examined the psychometric properties of the HADS 
across 747 studies. The authors found support for a two factor solution corresponding to the 
anxiety and depression subscales. The subscales were moderately correlated (mean r = .56). The 
mean internal consistency reliability for the anxiety and depression subscales were .83 and .82, 
respectively. Concurrent validity was established by showing medium to strong correlations with 
established questionnaires measuring anxiety and depression such as the Beck Depression 
Inventory (r = .62-.73 for HADS-D) and the State-Trait Anxiety Inventory (r = .64 -.81 for 
HADS-A). Furthermore, sensitivity and specificity were nearly identical between the HADS and 
the General Health Questionnaire. In a large sample of nearly 52,000 individuals, Mykletun, 
Stordal, and Dahl (2001) also supported the two-factor solution of the HADS and found 
appropriate internal consistency reliability and shared variance between the subscales.  
Personality Research Form (PRF) Infrequency and Social Desirability Scales (Jackson, 1984) 





scales, both containing 16 items each. The Infrequency Scale assesses careless or non-purposeful 
responding, confusion, language difficulties, or lying. These items were used in the current 
questionnaire as a validity check to insure that participants were attending appropriately to item 
content. Items are coded as true or false, for instance “I have never talked to anyone by 
telephone.” Answering true to this question would indicate an infrequent response. Infrequent 
responses are coded as “1”, while frequent responses are coded as “0”. Although one infrequent 
response alone may not be concerning, endorsing four or more items likely indicates non-
purposeful responding (Jackson, 1984). Therefore, participants who endorsed four or more items 
on the Infrequency Scale were excluded from data analysis. 
Social Desirability assesses the extent to which participants are responding to the actual 
content of the items or if they are consistently answering questions in a socially desirable way. 
Impression management could be present if an individual attempts to portray themselves in an 
overly favorable light or free from shortcomings. For instance, answering false to the question, “I 
would be willing to do something a little unfair to get something that was important to me” 
would be a socially desirable response.  
The Karolinska Directed Emotional Faces (KDEF; Lundqvist, Flykt, & Öhman, 1998) 
The KDEF is a set of human facial expressions depicting the six basic human emotions 
(i.e., fear, anger, disgust, happiness, sadness, surprise) in addition to a neutral expression. These 
stimuli were created in the Department of Clinical Neuroscience at the Karolinska Institutet in 
Sweden for use in psychological research and can be obtained free of charge. The stimuli set 
contains 35 women and 35 men (mean age = 25 years), each displaying all seven expressions 
from five different angles (straight on, half left profile, half right profile, full left profile, and full 





A validation study was recently undertaken to evaluate the hit rate, intensity, and arousal 
ratings for 490 stimuli from the KDEF (straight on profiles of the seven expressions; Goeleven, 
De Raedt, Leyman, & Verschuere, 2008). Close to 300 university students took part in the 
validation study. The average hit rate was 72%, with fear having the lowest hit rate (43%) and 
happiness being the most easily identifiable emotion (92%). As expected, neutral expressions 
were given lower arousal and intensity ratings compared to the six basic emotions. Disgust had 
the highest intensity rating, although happy and surprised were not significantly lower. Test-
retest reliability over the course of a week was very high (88% similarity in ratings), and 
intensity and arousal ratings were highly correlated across the two times (r = .75; r = .78, 
respectively). The authors conclude that the KDEF facial database is valid and is comparable to 
other databases.  Goeleven et al. (2008) provide tables with the best 20 pictures per emotion and 
unbiased hit rate accuracy scores for each emotion. One noted drawback when using this 
database is that the stimuli are limited to faces of European descent. 
Emotion Discrimination Task 
In the emotion discrimination task participants were asked to discriminate between 
disgust, fear, and neutral expressions. One-hundred and eighty colored photographs of facial 
expressions from the KDEF were used including 60 expressions of disgust, 60 expressions of 
fear, and 60 neutral expressions. Of the 70 total photographs for each emotion provided in the 
stimuli set, 10 were removed from each of the three types of expressions used (i.e., disgust, fear, 
and neutral). These photos were removed based upon reviewing the unbiased hit rate accuracy 
scores provided by Goeleven et al. (2008).  Unbiased hit rate accuracy scores were listed as a 
decimal number between 0 (never correctly identified) and 1 (always correctly identified). The 





emotions. Of the 180 photographs chosen, there were an equal number of women (n = 90) and 
men (n = 90). 
Stimuli were presented using a customized script developed with Python programming 
language (van Rossum & Drake, 2011). The script was loaded onto an Acer Aspire laptop with a 
17 inch/43.2 cm screen, with all participants seated an equal distance from the computer screen. 
A small cross was presented in the centre of the screen for 1000 ms for fixation, followed by a 60 
ms mask, and then a 100 ms or 60 ms presentation of facial expressions depending on condition. 
Facial expressions were presented in a randomized order, one at a time, followed by a forced 
choice discrimination response between two possible options. Three different forced-choice 
discriminations were made: fear versus disgust, fear versus neutral, and disgust versus neutral. 
During the fear versus disgust discriminations emotions were presented for 100ms, whereas 
neutral discriminations were presented for 60 ms to increase difficulty. Responses were made by 
pressing one of two keys indicated on the keyboard using the index fingers (e.g., f and j; 
counterbalanced across participants). Photographs were presented against a black background 
and instructions were presented in size 18 Gentium Basic Bold font. A text file was generated 
including participants’ responses and reaction times. 
Hand Measurements  
 Hands were scanned and saved onto a desktop computer in the Health, Hormones, and 
Behaviour Laboratory in order to examine 2D:4D. All jewelry was removed to ensure accurate 
measurement. Second and fourth digit length was measured from the tip of the finger down to 
the basal crease connecting to the palm of the hand using Photoshop. For each hand, the length 
of the second and fourth digits was each measured twice in Photoshop using the ruler tool. The 





right hand 2D:4D and left hand 2D:4D score. Hand measurements were only taken for 
participants who completed the study in the laboratory, not for participants who completed the 
study online. 
Salivary Progesterone Collection 
Free-cycling women were asked not to eat, drink, smoke, or brush their teeth one hour 
before coming into the laboratory (as this can negatively affect hormone analysis, Moffat & 
Hampson, 1996). Saliva samples were collected in the laboratory using the passive drool 
collection method recommended by Salimetrics. Participants allowed saliva to pool in their 
mouth and then passively drooled down a straw into a 2mL polypropylene cryovial. Cryovials 
were tightly sealed, labelled, and stored in a freezer in the Health, Hormones, and Behaviour 
Laboratory at -20°C, and later shipped to Salimetrics for analysis. Biosafety clearance was 
obtained through Human Resources at Lakehead University prior to data collection to ensure 
appropriate safety procedures were employed. 
Procedure  
Potential participants were recruited through posters across the Lakehead University 
campus and emails and presentations to students in Introductory Psychology and upper year 
psychology courses who were eligible for bonus points. Potential participants were told that the 
purpose of this study was to examine the effects of hormones on emotion and mood. Interested 
students were asked to email the researcher and were subsequently provided with a secure 
website link to SurveyMonkey to complete the Online Screening Questionnaire. Participants read 
the covering letter A (see Appendix A) and filled out consent form A (see Appendix B). The 
online questionnaire took approximately 5 minutes for men to complete and 10 minutes for 





to OC use and the menstrual cycle. Participants were thanked and given debriefing form A (see 
Appendix D). Separate consent and debriefing forms were used for the screening and 
experimental questionnaires due to differences in task completion.  
Using the contact information obtained in the online questionnaire, participants were 
contacted by phone or email within the week and an appointment was scheduled for the first of 
two laboratory sessions at the Health, Hormones, and Behaviour Laboratory at Lakehead 
University. Email addresses and phone numbers were stored separately, and used only to 
schedule appointments. All participants (i.e., free-cycling women, women taking hormonal 
contraceptives, and men) were scheduled for two sessions approximately 14 days apart. For 
women, testing appointments were scheduled according to their menstrual cycle phase (i.e., 
during either the luteal phase or follicular phase of the menstrual cycle). Testing order was 
assigned in a pseudo-random fashion. Preference was given to random assignment to follicular or 
luteal phase for the first testing session in order to ensure attrition rates were equal across 
menstrual cycle phases. However, due to the notable difficulty in menstrual cycle research of 
ensuring that women were in the correct phase of the cycle, women who were almost in a phase 
of interest were scheduled for that phase immediately. 
Menstrual cycle phase was determined through the help of answers to the online 
screening questions (e.g., by listing the first day of their last menstrual period and expected start 
of the next menstrual period). Participants who were scheduled to participate in the follicular 
phase first were tested on days 3-10 using the forward counting method (i.e., 3 to 10 days after 
the start of menstruation) and then again 14 days later. In contrast, participants scheduled to 
participate first in the luteal phase were tested on days -3 to -9 using the backwards counting 





To ensure all participants were treated equally, men were also tested 14 days apart. Free-cycling 
women were asked to email the experimenter when their next period began for confirmation to 
ensure proper cycle days. Although ideally all participants would have been tested during the 
same time each day (e.g., 9:00am-12:00pm) to reduce the variability in hormone levels 
throughout the day, this would significantly prolong data collection. Therefore, each participant 
was scheduled at the same time (or as close as possible) for their second session (e.g., 3:00pm for 
session one and 3:00pm for session two). Time of day was recorded and had no effect on 
progesterone levels (analyses presented below). 
Upon arrival to the laboratory for the first experimental session participants were given 
covering letter B (see Appendix E) and consent form B to read and sign (see Appendix F). 
Participants were informed that they would be completing an emotion discrimination task, 
followed by completion of several questionnaires (see Appendix G), having their hands scanned, 
and finish by providing a saliva sample for hormonal analysis (only free-cycling women or non-
OC users). The emotion discrimination task was presented first to ensure that the disgust 
questionnaire did not prime participants to perform better on the facial recognition task or 
influence their perception of the task. The completion time for the laboratory session ranged 
from 30 to 60 minutes.  
An identical procedure as listed above was used for the second experimental session. The 
phase two questionnaire was identical to the phase one questionnaire found in Appendix G. At 
the end of the second session, participants were debriefed (see Appendix H) and given details on 
how they could be provided with a summary of the results of the study if so desired. 
This study also included a fully online version for potential participants across Canada in 





information from this questionnaire was used to schedule women during the two menstrual cycle 
phases as described above (with men being tested 14 days apart, as before). The only difference 
between the two versions of the study was that participants in the online version were not able to 
complete the emotion discrimination task, provide hand scans, or give saliva samples. The fully 
online version contained different consent and debriefing forms due to the differences in task 
completion.  
Planned Data Analyses 
Primary Hypotheses. 
1.  Free-cycling women will show an increase in contamination-based OCD symptoms, disgust 
sensitivity, and responsibility beliefs and a decrease in risk-taking during the luteal phase of the 
menstrual cycle compared to the follicular phase, whereas women taking hormonal 
contraceptives will show significantly attenuated effects compared to free-cycling women in 
terms of these dependent variables. 
Potential moderating variables will also be explored to see if subgroups of women  
display different patterns of behavior change cross the cycle. 
A 2 × 2 (Group [Free-cyclers, hormonal contraceptive users] × Phase [follicular, luteal]) 
repeated measures multivariate analysis of covariance (MANCOVA) was conducted with age as 
a covariate to examine group differences across time on the four dependent variables: OCD 
symptoms (PI-WSUR scores), disgust sensitivity (DS-R scores), risk-taking (DOSPERT scores), 
and responsibility beliefs (RAS scores). A group × phase interaction was expected, with free-
cycling women scoring significantly higher than women taking hormonal contraceptives on the 





A MANOVA is superior to performing multiple ANOVAs because it protects against 
inflated Type I errors (Tabachnick & Fidell, 2007). Wilks’ lambda is the recommended statistic 
to test the significance of main effects and interactions with MANOVA.  
Potential moderators of behavior change across the menstrual cycle were entered as 
between-subjects factors into a repeated measures MANOVA and the interaction with phase was 
examined across the four main dependent variables. Univariate follow up tests were conducted if 
the interaction term was significant. 
2. Increasing salivary progesterone levels across the menstrual cycle will be associated with 
increased OCD symptomatology, disgust sensitivity, responsibility beliefs, and decreased risk-
taking across the cycle. 
This hypothesis was examined using Pearson product-moment correlations between 
square root transformed progesterone change scores and change scores (Luteal-Follicular) for the 
four main dependent variables.   
3. a) Women will show increased sensitivity for identifying facial expressions of disgust 
compared to men.   
A 2 × 2 (Testing time [time1/follicular, time2/luteal] × Sex [male, female]) repeated-
measures ANOVA was conducted, looking for a main effect of sex. 
3. b) Free-cycling women with a more liberal bias in terms of perceiving facial expressions of 
disgust will have increased levels of progesterone and pathogen disgust compared to women 
with a more conservative bias. 
 Independent samples t-tests were conducted using average bias scores across the two 
sessions as the grouping variable and average levels of progesterone and pathogen disgust across 





0 representing a liberal bias and scores above 0 representing a conservative bias when detecting 
facial expressions of disgust.  
Supplementary Hypotheses 
1. Sex differences will be found in disgust sensitivity and risk-taking, with women scoring higher 
than men in disgust sensitivity and lower in risk-taking.  
Sex differences in disgust sensitivity and risk-taking were examined using two t-tests  
with sex as the grouping variable and average disgust sensitivity (DS-R) and risk-taking 
(DOSPERT) scores across the two testing times as the outcome variables. 
2. Women who are more hormonally sensitive (i.e., meet criteria for PMS) will report greater 
average OCD symptoms across the menstrual cycle. 
A t-test was conducted to compare women who met criteria for PMS according to the 
PSST and women who did not meet PMS criteria on average square-root transformed OCD 
symptoms (PI-WSUR Scores). 
Exploratory Hypothesis 
Is there a relationship between 2D:4D and symptoms of obsessive-compulsive disorder? 
A Pearson product-moment correlation was used to examine the relationship between 
mean obsessive-compulsive symptoms (PI-WSUR scores) and 2D:4D (ratio of the second to 
fourth digit). 
Signal detection analysis 
Signal detection analysis was used to analyze the emotion discrimination data. Signal 
detection is typically used to determine the threshold where an individual can detect the signal 
amidst noise (e.g., in the context of a hearing test). The standard format is a “yes” or “no” 





and the stimulus (present/signal, absent/noise). If a participant responded yes and the stimulus 
was present, that would be classified as a hit (H). If the participant responded no when the 
stimulus was present, that would be classified as a miss (M). If the participant responded yes 
when the stimulus was not present, it would be classified as a false alarm (FA). Finally, if the 
stimulus was not present and the participant responded no, that would be a correct rejection 
(CR). In the present study the signal detection analysis was used with a forced-choice response 
format. For instance, when discriminating between disgust and fear, a hit would constitute 
correctly recognizing the emotion as disgust when it was disgust. A miss would consist of failing 
to recognize the correct emotion or saying fear when the emotion was disgust. A false alarm 
would consist of saying the emotion is disgust when it is not and a correct rejection would be 
classifying the emotion as fear when it is fear.  
Accuracy was examined using d’ (sensitivity index) and c (bias index). Sensitivity is a 
discrimination index that provides an estimate of high or low ability to discriminate (Macmillan, 
2002). Perfect sensitivity was present if a participant showed a 100% hit rate and a 0% false 
alarm rate, whereas poor sensitivity was present if a participant could not distinguish between 
stimuli and had similar hit and false alarm rates (Macmillan & Creelman, 2005). Theoretically, 
sensitivity is conceptualized as the difference between the means of the signal and noise 
distributions. Sensitivity will be estimated using the following equation: 𝑑′ = 𝑧(𝐻) − 𝑧(𝐹𝐴), 
where a score of zero represents performance levels at chance. Furthermore, positive scores 
show a greater ability to discriminate between stimuli and negative scores show a reduced ability 
to discriminate between stimuli. Sensitivity scores were calculated for each individual subject 






Response bias (c) refers to the amount of signal needed in order to say “yes” or “no”. For 
instance, some participants may be more liberal and make more yes judgments, while other 
participants may be more conservative and make more no judgments (Macmillan & Creelman, 
2005). Similarly, in the present study, some participants will require more “signal” to classify a 
facial expression as disgust while others require less “signal.” Response bias was calculated 
using the following equation: 𝑐 =  − 1
2
[𝑧(𝐻) + 𝑧(𝐹𝐴)]. Scores of 0 represent performance free 
from bias, whereas scores below 0 represent a liberal bias and scores above 0 represent a 
conservative bias. 
  Results 
Data Screening 
All variables were screened prior to analysis in order to check for missing data, errors in 
data coding, and extreme cases or outliers. For participants who were missing data on the main 
dependent measures (e.g., PI-WSUR, DS-R, DOSPERT, RAS, and HADS), if less than 20% of 
the data from a given scale were missing, the missing items were replaced with the participant’s 
averaged item score from the remaining items that were completed from the total scale or 
subscale (if relevant). None of the participants were missing more than 20% of items on any 
given scale. Imputing mean scores for missing items can help increase statistical power and 
provides a good estimate of reliability for the measure (Bono, Ried, Kimberlin, & Vogel, 2007). 
Univariate outliers were identified as z-scores greater than ± 3.29 (e.g., skewness value/ 
standard error for skewness = skewness z-score; Tabachnick & Fidell, 2007). According to these 
criteria, one participant (ID: 198) had a score on the time 2/Luteal DOSPERT scale that was 
identified as an outlier. The raw score appeared to be part of the distribution but was the largest 





next most extreme value (Tabachnick & Fidell, 2007, p. 77), restoring normality, Shapiro-Wilk’s 
(277) = .99, p = .26. 
Three univariate outliers (z-scores greater than 3.29) were found for fear versus disgust 
sensitivity (d’) time 1/follicular scores and for fear versus disgust sensitivity (d’) time 2/luteal 
scores. These six scores represented sensitivity scores between -1 and -2 and were removed. As 
mentioned above, scores of zero represent chance levels of discrimination and these scores 
would represent a very poor ability to discriminate between facial expressions.  
Multivariate outliers were examined using Mahalanobis distance (p < .001; Tabachnick & 
Fidell, 2007). When examining the main four dependent variables across both time points for 
multivariate outliers using Mahalanobis distance (chi-squared critical value = 26.12), four 
outliers were identified (2 men, 1 hormonal contraceptive user, 1 free-cycler). These participants 
were therefore excluded from the hypotheses involving OCD symptoms, disgust sensitivity, risk-
taking, and responsibility beliefs.  
Kurtosis and skewness were examined in order to check for normality in the data. Mean 
progesterone levels at both the follicular and luteal phase were found to be significantly 
positively skewed. A square-root transformation was applied to both mean follicular and mean 
luteal progesterone levels, restoring normality, Shapiro-Wilk’s (43) = .98, p > .05. 
Screening Survey 
Five-hundred and nine participants completed the initial screening questionnaire (394 
women, 115 men). In terms of family psychiatric history, the majority of participants (67%) 
responded that their parents or siblings had never been diagnosed or treated for a mental illness, 
compared to 24% who responded yes, and 9% of participants who were unsure. Only 3% of 





Participants with a positive family psychiatric history of a mood or anxiety disorder had 
significantly higher than expected rates of PMS according to the PSST, χ2 (1, N = 338) = 13.54, 
p < .001; phi = 0.2 (see Figure 2). Furthermore, participants with a positive family psychiatric 
history of a mood or anxiety disorder were more likely to report moderate to severe symptoms of 
anxiety pre-menstrually compared to women without such a family history, χ2 (1, N = 336) = 
24.25, p < .001; phi = 0.27. 
Progesterone Analysis 
Of the free-cycling women who participated in the lab-based version of the study, saliva 
samples from 56 women were sent to Salimetrics for progesterone analysis. Of the 56 samples 
(112 samples across both time points), each sample was tested in duplicate, with a correlation of 
.99 between Result 1 and Result 2 (p < .001). The mean concentration of the two progesterone 
samples from each session were used in all subsequent data analyses. Measurement reliability, or 
precision, was assessed using the coefficient of variation (CV). Intra-assay CV is the degree to 
which the two duplicate measurements of the sample differ (i.e., the standard deviation of the 
two duplicate results divided by the duplicate mean, multiplied by 100). The average % CV for 
this sample was 4.9, with less than 10% being considered good (Salimetrics, 2010; Schultheiss & 
Stanton, 2009).  
Salivary analyses from 44 participants remained after the exclusion criteria were applied, 
as reported above. Eight of these participants were found to have reversed progesterone levels, 
with significantly higher progesterone levels in the follicular phase (M = 83.13 pg/mL, SD = 
43.57, n = 8) compared to the luteal phase (M = 53.84 pg/mL, SD = 34.20, n = 8), t(7) = 4.84, p = 
.002, and were therefore excluded from subsequent analyses. For these eight participants, they 









Figure 2. The relationship between family psychiatric history and PMS diagnosis. Women with a 
positive family psychiatric history of a mood or anxiety disorder had significantly higher than 









before menstruation in the luteal phase (M = -9.0, SD = 3.34). However, only 5 of these 8 women 
were tested during the intended period in the luteal phase (i.e., days -3 to -9). Five women were 
tested in the luteal phase 10-12 days prior to menstruation, likely before the peak rise in 
progesterone that occurs in the luteal phase, which may help to explain the uncharacteristic 
progesterone levels. Consistent with this idea, difference scores in progesterone levels across the 
two phases were relatively small in these women (M = -29.29, SD = 18.50, n = 8) compared to 
the majority of free-cycling women (M = 122.29, SD = 85.78, n = 36). 
For the remaining participants with usable salivary progesterone samples, day eight was 
the average testing day for the follicular phase (M = 8.06, SD = 2.21, range: 3-12, n = 36) and six 
days prior to menstruation was the average testing day for the luteal phase (M = -6.14, SD = 
2.93, range: -12- 1, n = 36). As expected, progesterone levels were significantly higher in the 
luteal phase (M = 192.88 pg/mL, SD = 99.94, n = 36) compared to the follicular phase (M = 
70.60 pg/mL; SD = 39.09, n = 36), t(35) = - 8.55, p < .001. In a review of the measurement of 
salivary progesterone, Ellison (1993) reports average follicular progesterone levels of below 30 
pg/mL and average luteal progesterone levels of 100-200 pg/mL. Thus, the luteal phase 
progesterone levels in the current study were well within normal limits, but follicular levels were 
somewhat higher than normal by this estimation. However, Immuno-Biological Laboratories 
report normal values for progesterone in the follicular phase as 28-82 pg/mL and 127-446 pg/mL 
in the luteal phase (IBL Hamburg, 2006), which are consistent with levels found in the current 
study. 
Engaging in more than three hours of vigorous exercise a week and having gained or lost 
five pounds in the past month have both been linked to lower progesterone levels in the literature 





levels in the current sample. Although a change in weight in the past month did not affect 
follicular , t(34) = .04, p = .97, or luteal progesterone levels, t(34) = .99, p = .33, women who 
exercised vigorously for more than three hours a week did have significantly lower luteal 
progesterone levels (M = 123.69 pg/mL, SD = 35.53, n = 10) compared to women who exercised 
less than three hours a week (M = 219.50 pg/mL, SD = 104.30, n = 26), t(33.81) = 4.10, p < .001. 
Therefore, exercise was included as a covariate for further progesterone analyses. 
Data were collected between 11:00 am and 7:00 pm, with a median time of 3:00 pm. 
Time of day had no effect on progesterone levels, with no difference between mean follicular 
progesterone levels before 3:00 pm (M = 62.20 pg/mL, SD = 30.52, n = 16) and after 3:00 pm (M 
= 77.31 pg/mL, SD = 44.42, n = 20), t(34) = 1.16, p = .26, or between mean luteal progesterone 
levels before 3:00 pm (M = 183.88 pg/mL, SD = 80.83, n = 16) and after 3:00 pm (M = 200.08 
pg/mL, SD = 114.54, n = 20), t(34) = 0.48, p = .64. 
Details of Study Measures 
The scale means, standard deviations, and internal consistencies for the final sample are 
shown in Table 7, separated by time 1 and time 2. The data were recoded for all subsequent 
analyses, so that time 1 always refers to the follicular phase and time 2 always refers to the luteal 
phase for women. 
Women who met criteria for PMS had significantly higher HADS anxiety scores 
averaged across both sessions (M = 11.44, SD = 3.86, n = 33) compared to women without PMS 
(M = 7.95, SD = 3.29, n = 116), t(147) = -5.17, p < .001. Average HADS depression scores were 
also significantly higher in women with PMS (M = 5.82, SD = 2.87, n = 33) compared to women 
without PMS (M = 3.20, SD = 2.19, n = 116), t(147) = -5.64, p < .001. Finally, although average 






Scale Means, Standard Deviations, and Internal Consistencies for the Final Sample (N = 223) 
            
              Time 1                             Time 2____________________ 
       
Scale    N M (SD)  Internal  N M (SD)          Internal  
                         Consistency         Consistency  
               
       
PI-WSUR 
Total   223 23.73 (16.26) .91  219 21.92 (15.60) .92  
Contamination Obsessions 223 8.72 (6.58) .86  219 8.48 (6.65) .88  




Total    223 46.31 (16.33) .87  218 50.12 (16.59) .88 
Contamination-Based 223 5.55 (11.91) .51  218 5.43 (3.28) .50 
Disgust Subscale 
 
Three Domain Disgust Scale 




Total   223 92.61 (23.50) .86  218 92.17 (24.79) .88 
 
RAS 
Total   223 3.89 (.89) .92  218 3.62 (1.05) .94 
 
Social Desirability Scale 221 11.62 (2.76) .07  215 11.59 (2.84) .11 
 
HADS 
Anxiety   223 8.41 (3.92) .83  218 8.11 (3.76) .80 
Depression   223 3.67 (2.60) .65  218 3.77 (2.76) .72 
 
Infrequency 
Total   222 .19 (.45) .09  211 .24 (.53) .20 
               
Note. PI-WSUR = Padua Inventory-Washington State University Revision; DOSPERT = Domain-Specific Risk-Taking Scale; 







(M = 3.76, SD = 2.58, n = 150), t(216) = -0.22, p = .83, average HADS anxiety scores were 
significantly higher in women (M = 8.72, SD = 3.69, n = 150) compared to men (M = 7.39, SD = 
3.24, n = 68), t(216) = -2.56, p = .01. 
 The intercorrelations between the four main dependent variables are presented in Table 8. 
As expected, disgust sensitivity was positively correlated with OCD contamination symptoms 
and responsibility beliefs, OCD contamination symptoms were positively correlated with 
responsibility beliefs, and disgust sensitivity was negatively correlated with risk-taking. OCD 
contamination symptoms were not correlated with risk-taking, although this might have been 
expected. 
There were no significant differences in baseline scores between free-cycling women and 
women using hormonal contraceptives in terms of the main dependent variables: contamination 
OCD symptoms, t(147) = -0.10, p = .92, disgust scores, t(147) = 0.97, p = .33, risk-taking scores, 
t(147) = -0.62, p = .54, or responsibility beliefs, t(147) = -0.64, p = .52. 
Primary Hypotheses 
Hypothesis 1. Free-cycling women will show an increase in contamination-based OCD 
symptoms, disgust sensitivity, and responsibility beliefs and a decrease in risk-taking during the 
luteal phase of the menstrual cycle compared to the follicular phase, whereas women taking 
hormonal contraceptives will show significantly attenuated effects compared to free-cycling 
women in terms of these dependent variables. 
Potential moderating variables will also be explored to see if subgroups of women  
display different patterns of behavior change cross the cycle. 
A 2 × 2 (Group [Free-cyclers, hormonal contraceptive users] × Phase [follicular, luteal]) 







Intercorrelations between the Main Four Dependent Variables Averaged across the two Time  
 
Points for all Participants (N = 223) 
 
 
Dependent Variables   1  2  3  4    
 
 
                            
(1) OCD contamination symptoms  1  .42**  -.04  .29**  
   
 
(2) Disgust sensitivity     1  -.32**  .14* 
   
 
(3) Risk-taking        1  .08 
 
  
(4) Responsibility beliefs         1 
  
         
    
















OCD contamination symptoms (Square root transformed PI-WSUR Subscale 1 scores), disgust 
sensitivity (DS-R scores), risk-taking (DOSPERT scores), and responsibility beliefs (RAS 
scores), with age entered as a covariate. 
The MANOVA assumption of homogeneity of covariance was satisfied (Box’s M = 
46.87, F(36, 34634.48) = 1.21, p = .18). According to Wilk’s criterion, the combination of the 
four dependent variables did not show a significant multivariate effect in relation to group, 
Wilk’s = .98, F(4, 142) = .75, p = .56, partial 2 = .02, or phase, Wilk’s = .97, F(4, 142) = 1.11, p 
= .35, partial 2 = .03 (see Table 9 for group means). Contrary to predictions, the phase × group 
interaction was not significant, Wilk’s = .98, F(4, 142) = .87, p = .49, partial 2 = .02. There was 
also no effect of age, Wilk’s = .95, F(4, 142) = 1.88, p = .12, partial 2 = .05, nor was the phase 
× age interaction significant, Wilk’s = .95, F(4, 142) = 1.69, p = .15, partial 2 = .05. 
Change scores were also examined between HC users and FCs in terms of the four main 
dependent variables using a series of ANCOVAs, with age as a covariate. Contrary to the 
prediction that HC users would have lower change scores across the cycle compared to FCs, 
there were no differences between the two groups in terms of OCD contamination symptoms, 
F(1, 145) = .67, p = .41, disgust sensitivity, F(1, 145) = .39, p = .54, risk-taking, F(1, 145) = 
1.69, p = .20, or responsibility beliefs, F(1, 145) = .14, p = .71. 
Given that high progesterone and triphasic OCs more naturally mimic a women’s 
menstrual cycle, low dose and monophasic OC users were compared to FCs on the four main 
dependent variables to maximize any potential differences between FCs and OC users. A 2 × 2 
(Phase [follicular, luteal] × Group [low progesterone OC users, FCs]) repeated measures 
MANCOVA was conducted, with age as a covariate. There was no significant main effect of 






Group Means for the Four Main Dependent Variables, Separated by Time and Group 
             
          
Dependent Variable  Group  Mean  SD  N      
                
 
PI-WSUR Contamination  HC  8.78  5.82  98    
(Follicular)   FC  8.88  6.07  50  
  
PI-WSUR Contamination  HC  8.63  6.51  98 
(Luteal)   FC  9.28  7.04  50 
 
Disgust Scale-Revised  HC  52.24  15.15  98 
(Follicular)   FC  49.54  14.05  50 
 
Disgust Scale-Revised            HC 52.18  15.90  98 
(Luteal)   FC  47.98  14.55  50 
 
DOSPERT   HC  85.42  24.27  98 
(Follicular)   FC  88.00  23.91  50 
 
DOSPERT   HC  87.41  23.82  98 
(Luteal)   FC  87.00  22.30  50 
 
RAS    HC  3.75  0.94  98 
(Follicular)   FC  3.85  1.05  50 
 
RAS    HC  3.58  1.01  98  
(Luteal)   FC  3.60  0.97  50     
 
Note. HC = hormonal contraceptive users; FC = free-cycling women; PI-WSUR Contamination = Padua Inventory-
Washington State University Revision, contamination obsessions and washing compulsions subscale; DOSPERT = 










.64, p = .64, partial 2 = .02, or phase × group interaction, Wilk’s = .95, F(4, 104) = 1.41, p = 
.24, partial 2 = .05. 
In addition, a 2 × 2 (Phase [follicular, luteal] × Group [monophasic OC users, FCs]) 
repeated measures MANCOVA was conducted with age as a covariate. There was no effect of 
phase, Wilk’s = .94, F(4, 109) = 1.77, p = .14, partial 2 = .06,  group, Wilk’s = .95, F(4, 109) = 
1.58, p = .18, partial 2 = .06, or phase × group type interaction, Wilk’s = .97, F(4, 109) = .86, p 
= .49, partial 2 = .03.  
Moderators of behaviour change across the menstrual cycle 
Body mass index, relationship status, and sexual activity were examined as potential 
moderating variables in free-cycling women. Body mass index (BMI) was converted to a 
dichotomous variable using a median split, resulting in a group of women with low BMI (n = 25) 
and high BMI (n = 24). A 2 × 2 (BMI [low, high] × Phase [follicular, luteal]) repeated measures 
MANOVA was conducted, finding no significant main effect of BMI, Wilk’s = .89, F(4, 44) = 
1.37, p = .26, partial 2 = .11, or BMI × phase interaction, Wilk’s = .93, F(4, 44) = .84, p = .51, 
partial 2 = .07.  
 Relationship status (single, n = 19; in a dating or long-term relationship, n = 28) was next 
added as a between-subjects factor to the 2 × 2 (Relationship status [single, in a relationship] × 
Phase [follicular, luteal]) repeated measures MANOVA. There was no main effect found for 
relationship status, Wilk’s = .94, F(4, 42) = .63, p = .64, partial 2 = .06, nor was the relationship 
status × phase interaction significant, Wilk’s = .89, F(4, 42) = 1.34, p = .27, partial 2 = .11. 
Thus, neither BMI nor relationship status were significant moderators of behaviour change 





Sexual activity was added as a between-subjects factor in a 2 × 2 (Sexually active [yes, 
no] × Phase [follicular, luteal]) repeated measures MANOVA with the four dependent measures 
(OCD contamination symptoms, disgust sensitivity, risk-taking, and responsibility beliefs). 
There was a significant main effect of sexual activity, Wilk’s = .75, F(4, 45) = 3.72, p = .01, 
partial 2 = .25. Women who were sexually active in the past month had significantly higher 
risk-taking scores (M = 101.06, SD = 19.21, n = 17) than women who were not sexually active 
(M = 80.52, SD = 20.29, n = 33), t(48) = -3.45, p = .001. Women who were sexually active also 
had lower disgust sensitivity (M = 43.88, SD = 13.64, n = 17) compared to women who were not 
sexually active (M = 51.27, SD = 13.54, n = 33), although the difference was marginal, t(48) = 
1.82, p = .07. 
The phase × sexually active interaction was also significant, F(4, 45) = 2.89, p = .03, 
partial 2 = .20. Sexual activity was found to be a significant moderator of both OCD 
contamination symptoms and risk-taking in free-cycling women. Univariate ANOVAs showed 
significant phase × sexually active interactions for both OCD contamination symptoms, F(1, 48) 
= 5.41, p = .02, partial 2 = .10, and risk-taking, F(1, 48) = 7.04, p = .01, partial 2 = .13. 
Contamination OCD symptoms were found to increase from the follicular phase to the luteal 
phase of the cycle in non-sexually active participants (Mchangescore = 0.16, SD = 0.70, n = 33), 
whereas OCD contamination symptoms decreased across the cycle in sexually active participants 
(Mchangescore = -0.32, SD = 0.65, n = 17), t(48) = 2.33, p = .02 (see Figure 3). Risk-taking scores 
increased across the cycle in women who were not sexually active (Mchangescore = 2.55, SD = 
14.53, n = 33), whereas women who were sexually active showed a decrease in risk-taking 









Figure 3. Significant interaction between OCD contamination symptoms across the menstrual 
cycle and sexual activity (p = .02). OCD contamination symptoms increased across the cycle in 
non-sexually active participants (n = 33) and decreased across the cycle in sexually active 








4). Note that when the MANOVA was conducted only with HC users, there was no interaction 
between phase and sexual activity, F(4, 93) = .51, p = .73. 
Furthermore, in the current study, number of lifetime sexual partners was significantly 
related to OCD contamination symptoms in all women, r(141) = -.17, p = .04. However, there 
was no relationship between number of lifetime sexual partners and OCD contamination 
symptoms in men, r(61) = -.01, p = .96. Twenty-five percent of women scored a 13 or above on 
the contamination obsessions and washing compulsions subscale of the PI-WSUR, a cut-off 
score that indicates a level of symptomatology consistent with individuals diagnosed with OCD 
(Burns et al., 1996). These women reported a significantly lower number of lifetime sexual 
partners (M = 2.43, SD = 2.94, n = 35) compared to women with OCD contamination symptoms 
more similar to a non-clinical sample (i.e., a score below 13) (M = 4.50, SD = 6.31, n = 103), 
t(123.03) = 1.87, p = .01. In men, there was no significant difference between the number of 
lifetime sexual partners for men below (M = 8.69, SD = 15.26, n = 49) or above the cut-off score 
(M = 7.00, SD = 8.91, n = 13) for clinically meaningful OCD contamination symptoms, t(60) = 
0.38, p = .70. 
Additional exploratory analyses were conducted to determine whether there might be two 
distinct groups of women, one group who shows an increase in OCD contamination symptoms 
across the menstrual cycle and another that doesn’t, and if these groups could be further 
differentiated. Women with increasing OCD contamination symptoms across the cycle were 
found to differ from women with no change in OCD contamination symptoms or a decrease in 
symptoms across the cycle in terms of several theoretically relevant variables, such as sexual 









Figure 4. Significant interaction between risk-taking scores across the menstrual cycle and sexual activity 
(p = .01). Risk-taking scores increased across the cycle in women who were not sexually active (n = 33), 











Compared to women who showed no change or decreased OCD contamination symptoms 
across the cycle, women with increasing OCD contamination symptoms across the cycle were 
significantly more likely to not be sexually active in the past month, χ2 (1, N = 148) = 6.53, p = 
.01; phi = -0.21, and to be single rather than in a relationship, χ2 (1, N = 143) = 4.40, p = .04; phi 
= -0.18. In addition, women with increased OCD contamination symptoms across the cycle had a 
significantly fewer number of lifetime sexual partners (M = 2.71, SD = 3.28, n = 59) compared to 
women whose OCD contamination symptoms stayed the same or decreased over the cycle (M = 
4.95, SD = 6.76, n = 83), t(125.74) = 2.62, p = .01. Lower risk-taking in the health domain was 
also found in women whose OCD contamination symptoms increased across the cycle (M = 
15.18, SD = 6.59, n = 60), compared to women whose OCD contamination symptoms remained 
the same or decreased over the cycle (M = 17.35, SD = 6.09, n = 88), t(146) = 2.07, p = .04. 
Finally, religious affiliation also differed between women with different patterns of OCD 
contamination symptoms across the cycle. The most common religious affiliations were 
Christian (n = 88, 60.7%), atheist (n = 26, 17.9%), and agnostic (n = 11, 7.6%). Thus, a 
dichotomous variable was created for religious affiliation comparing women who identified as 
Christian with those who identified as agnostic or atheist. Women with increasing OCD 
contamination symptoms across the cycle were more likely to be Christian compared to those 
who showed no change or a decrease in OCD symptoms across the cycle, χ2 (1, N = 124) = 5.09, 
p = .02; phi = -.20.   
Given the small number of free-cycling women with PMS (n = 11), in the late luteal 
phase of the cycle (n = 14), or with high contamination OCD contamination fears (n = 12), 
whether women met criteria for PMS, stage of luteal phase testing, and level of OCD 





Whether or not women met criteria for PMS according to the PSST was added as a 
between-subjects factor in a 2 × 2 (PMS [yes, no] × Phase [follicular, luteal]) repeated measures 
MANCOVA with the four dependent measures (OCD contamination symptoms, disgust 
sensitivity, risk-taking, and responsibility beliefs) and age as a covariate. There was no 
significant phase × PMS interaction, Wilk’s = .10, F(4, 141) = .18, p = .95, partial 2 = .01, 
meaning PMS did not moderate behavior change across the menstrual cycle, but there was a 
significant multivariate between-subjects main effect of PMS, Wilk’s = .88, F(4, 141) = 5.02, p = 
.001, partial 2 = .13.   
Women meeting criteria for PMS had significantly higher average OCD contamination 
scores (M = 10.82, SD = 6.59, n = 33) compared to women without PMS (M = 8.29, SD = 5.73, n 
= 114), t(145) = -2.16, p = .03. Women with PMS also had significantly higher average disgust 
sensitivity (M = 56.12, SD = 14.28, n = 33) compared to women without PMS (M = 49.48, SD = 
14.59, n = 114), t(145) = -2.31, p = .02. Finally, women meeting PMS criteria also had 
significantly higher average responsibility beliefs (M = 4.20, SD = 0.89, n = 33) than women not 
meeting criteria for PMS (M = 3.53, SD = 0.90, n = 114), t(145) = -3.80, p < .001. There were no 
differences between average risk-taking scores in women with PMS (M = 89.76, SD = 24.03, n = 
33) or without PMS (M = 85.84, SD = 22.41, n = 114), t(145) = -0.87, p = .39. 
Stage of luteal phase testing was also examined as a moderator, as some women were 
tested in the early luteal phase (days -5 to -12, n = 107), while others were tested in the late luteal 
phase (days -2 to -4, n = 36). Thus, position in the luteal phase was added as a between-subjects 
factor in a 2 × 2 (Stage of luteal phase [early, late] × Phase [follicular, luteal]) repeated measures 
MANCOVA with the four dependent measures (OCD contamination symptoms, disgust 





effect of stage of luteal phase testing, Wilk’s = .99, F(4, 137) = .61, p = .66, partial 2 = .02. The 
interaction between phase and position in the luteal phase was marginally significant, Wilk’s = 
.94, F(4, 137) = 2.25, p = .07, partial 2 = .06. Follow-up univariate ANCOVAs showed a 
marginally significant phase × stage of luteal phase testing interaction for OCD contamination 
symptoms, F(1, 40) = 3.53, p = .06, partial 2 = .03. Whereas contamination OCD symptoms 
increased from the follicular phase to the late luteal phase of the menstrual cycle (Mchangescore = 
0.15, SD = 0.75, n = 36), OCD contamination symptoms decreased across the cycle for women 
tested in the early luteal phase (Mchangescore = -0.08, SD = 0.62, n = 107), t(141) = 1.79, p = .08 
(see Figure 5). 
Finally, based on the cut-off scores identified by Burns and colleagues (1996), all women 
were separated into a low contamination fears (PI-WSUR scores < 6; n = 60) or high 
contamination fears (PI-WSUR scores > 14; n = 32) group. A 2 × 2 (Phase [follicular, luteal] × 
Contamination fear groups [low, high]) repeated measures MANCOVA was conducted across 
the four dependent measures (OCD contamination symptoms, disgust sensitivity, risk-taking, and 
responsibility beliefs), including age as a covariate. According to Wilk’s criterion, the 
combination of the four dependent variables showed a significant multivariate, between-subjects 
group effect of contamination fears, Wilk’s = .16, F(4, 86) = 116.45, p < .001, partial 2 = .84, 
and a significant phase × contamination fears interaction, Wilk’s = .85, F(4, 86) = 3.79, p = .007, 
partial 2 = .15.  
The between-subjects group effect of contamination fears showed that women scoring 
high in contamination fears had significantly higher average levels of disgust sensitivity (M = 
58.13, SD = 14.92, n = 32) compared to women low in contamination fears (M = 45.14, SD = 










Figure 5. Interaction between OCD contamination symptoms across the menstrual cycle and 
stage of luteal phase testing (p = .06). Contamination OCD symptoms increased across the cycle 
for women tested in the late luteal phase (n = 36), and decreased across the cycle for women 







significantly higher average responsibility beliefs (M = 4.02, SD = 1.01, n = 32) than women 
with low contamination fears (M = 3.36, SD = 0.91, n = 60), t(90) = -3.19, p = .002. In addition, 
as expected, women with high contamination fears clearly had higher average contamination 
OCD symptoms (M = 4.19, SD = 0.45, n = 32) compared to women with low contamination fears 
(M = 1.77, SD = 0.52, n = 60), t(90)= -22.32, p < .001. 
Level of contamination fears was found to be a significant moderator of behavior change 
across the cycle. The univariate follow-up tests showed that the phase × contamination fears 
interaction was significant for both OCD symptoms, Wilk’s = .91, F(1, 89) = 8.78, p = .004, 
partial 2 = .09, and disgust sensitivity, Wilk’s = .92, F(1, 89) = 7.53, p = .007, partial 2 = .08. 
Whereas women scoring low in contamination symptoms showed a decrease in contamination 
OCD symptoms across the menstrual cycle (Mchangescore = -0.14, SD = 0.55, n = 60), women with 
high contamination fears showed an increase in symptoms from the follicular to the luteal phase 
of the cycle (Mchangescore = .26, SD = 0.70, n = 32), t(90) = -2.99, p = .004 (see Figure 6). With 
disgust sensitivity, women with low contamination fears showed a decrease in disgust sensitivity 
across the menstrual cycle (Mchangescore = -1.92, SD = 7.39, n = 60), whereas women with high 
contamination fears showed an increase in disgust sensitivity across the menstrual cycle 
(Mchangescore = 2.94, SD = 7.65, n = 32), t(90) = -2.96, p = .004 (see Figure 7).  
Hypothesis 2. Increasing salivary progesterone levels across the menstrual cycle will be 
associated with increased OCD symptomatology, disgust sensitivity, responsibility beliefs, and 
decreased risk-taking across the cycle. 
Square root transformed progesterone levels were examined in relation to the four main 
dependent measures using change scores (Luteal – Follicular), as we were interested in whether 










Figure 6. Significant interaction between OCD contamination symptoms across the 
menstrual cycle and level of contamination fears (p = .004). Contamination OCD symptoms 
decreased across the menstrual cycle in women with low contamination fears (n = 60), and 
increased across the menstrual cycle in women with high contamination fears (n = 32). Error bars 












Figure 7. Significant interaction between disgust sensitivity scores across the menstrual cycle 
and level of contamination fears (p = .007). Disgust sensitivity scores decreased across the 
menstrual cycle in women with low contamination fears (n = 60), and increased across the 






measures (see Table 10). As hypothesized progesterone change scores were negatively 
associated with risk-taking (DOSPERT total difference scores), r(33) = -.46, p = .006 (see Figure 
8). The individual DOSPERT subscales (social, recreational, financial, health, and ethical risk-
taking) were also examined in relation to progesterone change scores (see Table 11), with the 
strongest correlation emerging for health/safety risk-taking (see Figure 9). 
Although non-significant, progesterone change scores were also positively associated 
with disgust sensitivity (Disgust Scale-R total difference scores), r(33) = .15, p = .38. In contrast 
to the hypothesis, progesterone change scores were not significantly correlated with OCD 
symptoms (Square root transformed PI-WSUR difference scores), r(33) = -.17, p = .32, and were 
negatively correlated with responsibility beliefs (RAS mean change scores), r(33) = -.41, p = .02. 
Progesterone difference scores were significantly correlated with anxiety difference scores 
(HADS), r(33) = .41, p = .01, showing that an increase in anxiety across the cycle corresponded 
to an increase in progesterone levels. Controlling for vigorous exercise (more than three hours a 
week), age, and BMI did not significantly affect the majority of the correlations, but after 
controlling for exercise the correlation between progesterone change scores and responsibility 
beliefs was no longer significant (Table 10). Further analyses revealed that exercise was related 
to both progesterone change scores and responsibility belief change scores. Women who 
exercised vigorously three hours a week or more had significantly lower progesterone change 
scores across the cycle (M = 62.31 pg/mL, SD = 32.41, n = 10) compared to free-cycling women 
who exercised less than three hours a week (M = 145.35 pg/mL, SD = 89.06, n = 26), t(34) = 
4.10, p < .001. In addition, women who exercised regularly showed an increase in responsibility 
beliefs across the cycle (Mchangescore = 0.1, SD = 0.50, n = 10), whereas women who exercised less 







Correlations between Progesterone Change Scores and OCD Symptoms, Disgust Sensitivity,  
 
Risk-taking, Responsibility Beliefs, and Anxiety Change Scores in Free-Cycling Women,  
 
including Partial Correlations (n = 35) 
 
 
Progesterone Control.  Control.         Control.         Control.       
∆ scores for exercise for age           for BMI         for all 3  
 
 
                            
OCD symptoms  
(PI-WSUR ∆ scores)  -.17  -.17  -.13  -.16  -.12 
 
Disgust sensitivity  
(DS-R ∆ scores)  .15  .04  .18  .13  .02 
 
Risk-taking  
(DOSPERT ∆ scores)  -.46**  -.50**  -.47**  -.46**  -.52** 
 
Responsibility Beliefs  
(RAS ∆ scores)  -.41*  -.26  -.36*  -.41*  -.25 
 
Anxiety  
(HADS ∆ scores)  .41*  .41*  .47**  .43*  .47** 
         
    
Note. * p <.05. ** p < .01. Control. = Controlling. BMI = body mass index; PI-WSUR = Padua Inventory-
Washington State University Revision; DS-R = Disgust Scale-Revised; DOSPERT = Domain-Specific Risk-Taking 












Figure 8. Scatterplot depicting the association between changes in square-root transformed 
progesterone levels across the menstrual cycle and changes in risk-taking across the menstrual 
cycle in free-cycling women (n = 35). The scatterplot indicates that increases in progesterone 










Correlations between Change in Risk-taking Subscales across the Cycle and Changes in 
Progesterone Levels (n = 35) 
 
                                       
           Sqrt Progesterone Change Scores 
  
 
Social Risk-taking Change Score     -.35*     
 
Recreational Risk-taking Change Score     -.02     
 
Financial Risk-taking Change Score     -.17     
 
Health/Safety Risk-taking Change Score     -.53**     
 
Ethical Risk-taking Change Score     -.19    
  
Total Risk-taking Change Score      -.46**    
             
    




















Figure 9. Scatterplot depicting the association between changes in square-root transformed 
progesterone levels across the menstrual cycle and changes in risk-taking in the health domain 
across the menstrual cycle in free-cycling women (n = 35). The scatterplot indicates that 
increases in progesterone across the cycle were significantly associated with decreases in risk-








25), t(33) = -2.91, p = .006. 
Hypothesis 3 (a). Women will show increased sensitivity for identifying facial 
expressions of disgust compared to men. 
A 2 × 2 (Testing time [time1/follicular, time2/luteal] × Sex [male, female]) repeated-
measures ANOVA was conducted. There was a significant main effect of sex, F(1, 169) = 5.25, 
p = .023, with women showing significantly greater sensitivity for identifying facial expressions 
of disgust (M = 2.03, SD = 0.59, n = 114) compared to men (M = 1.79, SD = 0.77, n = 57; see 
Figure 10). The testing time by sex interaction was not significant, F(1, 169) = .71, p = .40, 
although visual inspection of Figure 10 suggests that whereas men tend not to differ across 
testing sessions, women seem to show an increase in sensitivity to detecting facial expressions of 
disgust in the luteal phase. 
Additional analyses were also conducted comparing disgust sensitivity in FCs and HC 
users and within subgroups of HC users. There was no significant difference found between 
average disgust sensitivity (d’) across the cycle in FCs (M = 2.07, SD = 0.63, n = 37) and HC 
users (M = 2.01, SD = 0.58, n = 77), t(112) = -0.43, p = .67, nor was the difference in change 
scores across the cycle significant, t(164) = -1.40, p = .16. Sensitivity in detecting facial 
expressions of disgust was also examined as a function of progesterone dose and level of 
androgenic activity within OCs (see Table 12 for the average sensitivity scores for each group). 
Women taking OCs with high doses of progesterone showed significantly higher average 
sensitivity (d’) (M = 2.23, SD = 0.47, n = 18) compared to women taking OCs with low doses of 
progesterone (M = 1.90, SD = 0.60, n = 49), t(65) = -2.12, p = .04. The newest generation of OCs 
(e.g., Yaz, Yasmin) contains a new progestin, drospirenone, which is the only anti-androgenic 











Figure 10. Mean sensitivity (d’) scores for detecting disgust in facial expressions in men (n = 61) 
and women (n = 114), separated by testing time/menstrual cycle phase. There was a significant 
main effect of sex, with women showing significantly greater sensitivity for identifying facial 









Sensitivity for Detecting Disgust in Facial Expressions Broken Down by Group (Men, Free- 
 





Sensitivity (d’)    M (SD) N M (SD) N 
           
 
      Time 1   Time 2 
 
Men      1.81 (0.90)   61 1.80 (0.79)   58 
______________________________________________________________________________
     
      Follicular  Luteal    
   
FCs      1.98 (0.70)   37 2.16 (0.69)   38 
 
HC users     1.98 (0.70)   77 2.05 (0.62)   77 
 
Low Progesterone OC  1.86 (0.74)   49 1.94 (0.65)   49 
 
High Progesterone OC  2.25 (0.49)   18 2.21 (0.57)   18 
 
Anti-androgenic OC   2.36 (0.27)  12 2.40 (0.57)   12 
 
Low androgenic OC   1.89 (0.73)   47 1.98 (0.63)   47  
    
Intermediate androgenic OC  1.92 (0.87) 7 1.65 (0.54) 7 
 
High androgenic OC   1.17  1 1.43  1 
 










significantly higher average disgust sensitivity (d’; M = 2.38, SD = 0.36, n = 12) compared to 
women taking OCs with low to high androgenic properties, (M = 1.90, SD = 0.59, n = 55), 
t(25.53) = -3.63, p = .001. 
Hypothesis 3 (b). Free-cycling women with a more liberal bias in terms of perceiving 
facial expressions of disgust will have increased levels of progesterone and pathogen disgust 
compared to women with a more conservative bias. 
Women with a liberal bias in detecting facial expressions of disgust had higher average  
pathogen disgust scores (M = 22.83, SD = 7.28, n = 32) compared to women with a conservative 
bias (M = 16.60, SD = 6.24, n = 5), although this difference was only marginal, t(35) = -1.81, p = 
.08. However, the majority of free-cycling women showed a liberal bias, thus limiting the 
possible range of the analysis. There were no differences in average progesterone levels across 
the cycle between women with a liberal bias (M = 136.89 pg/mL, SD = 61.91, n = 30) and those 
with a conservative bias (M = 114.50 pg/mL, SD = 61.58, n = 4) in detecting facial expressions 
of disgust, t(32) = -0.68, p = .50. Furthermore, changes in bias across the cycle were not 
correlated with changes in progesterone across the cycle, r(34) = .06, p = .71, or changes in 
pathogen disgust across the cycle, r(33) = .08, p = .65. Thus, this hypothesis was generally not 
supported. 
Supplementary hypotheses 
1. Sex differences will be found in disgust sensitivity and risk-taking, with women scoring higher 
than men in disgust sensitivity and lower in risk-taking. 
 As hypothesized, significant differences were found in terms of disgust sensitivity and 
risk-taking between men and women. Average disgust sensitivity (Disgust Scale-R total scores) 





36.73, SD = 13.15, n = 66), t(212) = -6.79, p < .001. Average pathogen disgust was also 
significantly higher in women (M = 4.75, SD = 0.91, n = 147) compared to men (M = 4.03, SD = 
0.96, n = 66), t(211) = -5.24, p < .001. Furthermore, women showed significantly lower risk-
taking (DOSPERT scores; M = 86.78, SD = 22.69, n = 148) compared to men (M = 104.91, SD = 
18.72, n = 66), t(212) = 5.68, p < .001. 
2. Women who are more hormonally sensitive (i.e., meet criteria for PMS) will report greater 
average OCD symptoms across the menstrual cycle. 
As expected, women meeting PSST criteria for PMS had significantly higher average 
square-root transformed OCD symptoms (M = 5.22, SD = 1.55, n = 33) compared to women who 
didn’t meet criteria for PMS (M = 4.22, SD = 1.45, n = 114), t(145) = -3.41, p = .001. Given the 
fact that there is some commonality amongst the two scales in terms of anxiety-related items, all 
the individual PSST items were examined in relation to average OCD symptoms. Several of the 
PSST items relatively unrelated to anxiety were significantly correlated with average OCD 
symptoms, such as anger/irritability, overeating, hypersomnia, and physical symptoms (e.g., 
breast tenderness, bloating, muscle pain; see Table 13). 
Exploratory Hypothesis 
The ratio of the length of the second digit (index finger) to the fourth digit (ring finger), 
or 2D:4D, is used as a proxy measure of prenatal androgen and estradiol exposure. Digit ratios 
were calculated for the 261 participants who participated in the laboratory version of the study. 
Right hand and left hand 2D:4D were highly correlated, r(259) = .73, p < .001. As expected, 
digit ratio was higher in women (right 2D:4D, M = 0.966, SD = 0.03, n = 185) compared to men 







Correlations between individual items on the Premenstrual Symptoms Screening Tool (PSST) 
and Average OCD Symptoms in all Women (n = 148) 
 
                                       
PSST Item     Average PI-WSUR Total Scores 
  
 
1. Anger/irritability     .29** 
 
2. Anxiety/tension     .25**  
 
3. Increased sensitivity to rejection/ 
    tearfulness      .11    
 
4. Depressed mood/hopelessness   .21* 
 
5. Decreased interest in work activities  -.03 
 
6. Decreased interest in home activities  -.03 
 
7. Decreased interest in social activities  .04 
 
8. Difficulty concentrating    .04 
 
9. Fatigue/lack of energy    .03 
 
10. Overeating/food cravings    .19* 
 
11. Insomnia      .08 
 
12. Hypersomnia     .18* 
 
13. Feeling overwhelmed/out of control  .13 
 
14. Physical symptoms    .16*      
        
    







The relationship between 2D:4D and obsessive-compulsive symptoms was examined as 
an exploratory hypothesis using Pearson product-moment correlations. Padua Inventory total 
scores across the two sessions were averaged and transformed as the data were positively 
skewed. There was no relationship between square-root transformed average PI-WSUR scores 
and right hand 2D:4D, r(246) = .03, p = .59, or left hand 2D:4D, r(246) = .01, p = .90. 
The remaining core dependent measures in the study were also examined in association 
with 2D:4D. Digit ratio was also not related to average disgust sensitivity scores (Disgust Scale-
R Total Scores across time 1 and time 2), RH: r(248) = .02, p = .71, LH: r(248) = .03, p = .66, 
average risk-taking scores, RH: r(248) = -.09, p = .18, LH: r(248) = -.09, p = .17, or average 
RAS scores across sessions, RH: r(248) = .01, p = .85, LH: r(248) = .02, p = .72.  
Digit ratio was also examined in relation to sensitivity scores in the emotion 
discrimination task. Sensitivity scores for the fear versus disgust discrimination were averaged 
across the sessions to examine average sensitivity (d’) scores. Higher, or more feminized 2D:4D 
was associated with greater sensitivity in detecting emotions of disgust; RH: r(239) = .22, p = 
.001, LH: r(239) = .20, p = .002 (See Figure 11). This likely reflects the finding that women are 
better at recognizing facial expressions of disgust than men. However, even when looking at 
women alone, higher or more feminized 2D:4D was significantly associated with greater average 
sensitivity in detecting facial expressions of disgust, RH: r(166) = .17, p = .03, LH: r(166) = .20, 
p = .009. When examining men, higher or more feminized 2D:4D was also associated with 
greater average sensitivity in detecting facial expressions of disgust, but the correlation was only 
marginally significant for the right hand, RH: r(71) = .23, p = .05, and not significant for the left 










Figure 11. A scatterplot depicting the association between right hand 2D:4D and average disgust  











Finally, the relationship between 2D:4D and hormonally relevant variables was assessed. 
Women who met criteria for PMS has significantly higher or more feminized 2D:4D (RH; M = 
0.977, SD = 0.03, n = 49) than women who didn’t meet criteria for PMS (RH; M = 0.963, SD = 
0.03, n = 130), t(177) = -2.65, p = .009. The same finding was true for left hand 2D:4D, t(177) =  
-3.03, p = .003. These findings suggest that lower prenatal androgen exposure may be related to 
the later development of PMS. In addition, average progesterone levels across the two phases 
were significantly correlated with left hand 2D:4D, r(50) = .31, p = .03, and marginally 
correlated with right hand 2D:4D, r(50) = .27, p = .05.  
Discussion 
Increased contamination fears, disgust proneness, heightened responsibility, and risk-
aversion are all thought to be adaptive strategies that from an evolutionary perspective would 
help protect a woman’s offspring from threats (e.g., pathogens, accidents). The compensatory 
prophylaxis hypothesis posits that because high levels of progesterone suppress the immune 
system, disgust sensitivity and contamination fears increase to compensate for greater 
vulnerability to infection. Given that each menstrual cycle represents the possibility of 
conception and involves a rise in progesterone, changes in disease avoidant behaviour are also 
expected to occur at this time in addition to during pregnancy. However, in the current study, one 
of the main hypotheses, that women would show an increase in disgust sensitivity, obsessive-
compulsive symptomatology, and responsibility beliefs, and a decrease in risk-taking across the 
menstrual cycle, was generally not supported. The fact that increases in precautionary behavior 
were generally not shown across the menstrual cycle in all women is in contrast to the idea that 
this represents a hard-wired evolutionary mechanism, although caution must be taken not to over 





Although obsessive-compulsive symptoms, disgust sensitivity, responsibility beliefs, and 
risk-taking did not change across the menstrual cycle commensurate with changes in 
progesterone as expected, increased salivary progesterone levels across the cycle were positively 
correlated with increased anxiety and negatively correlated with risk-taking in free-cycling 
women. Women with PMS showed increased OCD symptoms, disgust-sensitivity and 
responsibility beliefs at both phases of the menstrual cycle. In addition, the results of this study 
supported previous research suggesting that not all women show the same patterns of behaviour 
change across the cycle. Changes in behaviour across the menstrual cycle interacted with sexual 
activity and level of contamination fears, such that non-sexually active women and women with 
high contamination fears showed an increase in contamination OCD symptoms across the 
menstrual cycle, whereas sexually active women and women with low contamination fears 
showed a decrease in contamination OCD symptoms across the menstrual cycle. Women whose 
OCD contamination symptoms increased across the menstrual cycle may represent a distinct 
subgroup of women, as they were more likely to be single, not sexually active, have fewer 
lifetime sexual partners, have decreased risk-taking in the health/safety domain, and to identify 
as religious (Christian) compared to women who showed no change in contamination OCD 
symptoms or a decrease in symptoms across the menstrual cycle. In terms of emotion 
recognition, women were more sensitive to detecting facial expressions of disgust than men, a 
difference that appeared to be driven by increased sensitivity in the luteal phase for women 
compared to men. In addition, women who were taking anti-androgenic OCs and OCs with 
higher progesterone dosages had significantly higher sensitivity in detecting disgust. Finally, 
women with higher digit ratios (2D:4D) were more likely to meet criteria for PMS and had 





This was the first study to examine OCD symptoms across the menstrual cycle 
employing both a within-subjects design and measuring salivary hormone levels. The current 
findings were consistent with those reported by Fessler and Navarrete (2003), who failed to find 
a relationship between contamination-related disgust sensitivity and immunosuppression (based 
on self-reported position in the menstrual cycle). The current findings failed to replicate 
Avgoustinaki and colleagues (2012), who found a significant correlation between progesterone 
levels (on day 21) and OCD symptoms (MMPI Psychasthenia subscale). However, progesterone 
levels explained a small and non-significant percentage of variance in subscale scores (7%). The 
current findings are also inconsistent with those of Fleischman and Fessler (2011), who found a 
significant positive correlation between progesterone levels and OCD contamination symptoms. 
The authors employed the same assessment measure as used in the current study (Padua 
Inventory), but their study design was cross-sectional, with participants providing saliva samples 
and completing all measures in one sitting. Women in the present study, generally speaking, did 
not show an increase in OCD contamination symptoms as they progressed from a low to high 
progesterone phase. Thus, it cannot be ruled out that the inconsistency in findings between the 
two studies could be a result of differences in study design. 
Gonda et al. (2008) were the only authors to use a within-subjects design when 
examining OCD symptoms across the menstrual cycle. These authors found that anxiety and 
OCD symptoms (measured by the STAI and SCL-51) increased over the menstrual cycle, with 
higher scores in the late luteal phase compared to the late follicular phase. Although the current 
study did not find a menstrual cycle phase effect in relation to anxiety (HADS) scores, change 
scores did show that increases in progesterone were significantly positively correlated with 





time interval in the late luteal phase (2 to 3 days before the onset of menses). Consistent with 
their findings, the significant correlation in the present study between progesterone change 
scores and anxiety change scores was higher in the late luteal phase of the cycle (r = .64) 
compared to the early luteal phase (r = .39).  
Main Hypotheses: Hypothesis 1 
Free-cycling women will show an increase in contamination-based OCD symptoms, 
disgust sensitivity, and responsibility beliefs and a decrease in risk-taking during the luteal 
phase of the menstrual cycle compared to the follicular phase, whereas women taking hormonal 
contraceptives will show significantly attenuated effects compared to free-cycling women in 
terms of these dependent variables. 
Potential moderating variables will also be explored to see if subgroups of women  
display different patterns of behavior change cross the cycle. 
Contrary to the prediction, free-cycling women did not show increases in contamination 
OCD, disgust sensitivity, responsibility beliefs, or a decrease in risk-taking across the menstrual 
cycle. Given the fact that women taking hormonal contraceptive pills have lower levels of 
progesterone compared to free-cycling women (Fleischman et al., 2010), it was hypothesized 
that women taking hormonal contraceptives and free-cycling women would show different 
patterns in terms of contamination-based OCD symptoms, disgust sensitivity, responsibility 
beliefs, and risk-taking across the cycle. However, the phase by group interaction was not 
significant, nor were there any differences in change scores across the cycle on the four main 
dependent measures between FCs and HC users. Free-cycling women were also compared to 
women with low progesterone OCs and monophasic OCs, but no differences emerged between 





These findings are inconsistent with previous research, which has shown that OC users 
do not display the same patterns as free-cycling women across the menstrual cycle in a number 
of areas (e.g., facial preferences, Penton-Voak et al., 1999; mate preference, Alvergne & 
Lummaa, 2010, Little, Jones, & Burriss, 2007; relationship jealousy, Cobey, Pollet, Roberts, & 
Buunk, 2011; voice attractiveness, Pipitone & Gallup, 2008). However, differences did emerge 
between HC users and FCs in the present study when moderator analyses were conducted. 
Whereas there was a significant interaction between sexual activity and change in contamination 
OCD symptoms across the menstrual cycle in FCs, the interaction was not significant in HC 
users. 
Moderators of behaviour change across the menstrual cycle. 
PMS. The interaction was not significant between phase of the menstrual cycle and 
whether or not women met criteria for PMS according to the PSST for any of the main 
dependent variables. A significant interaction might have been expected given that women who 
experience affective and physical changes pre-menstrually might also show an increase in related 
symptoms (e.g., OCD) pre-menstrually. Furthermore, up to nearly 50% of women with OCD 
report premenstrual worsening of OCD symptoms, number of PMS symptoms has been found to 
predict worsening of OCD symptoms in the postpartum period, and a diagnosis of OCD is often 
comorbid with PMS and PMDD (Labad et al., 2005; Vulink et al., 2006). 
There was a significant main effect of PMS, which showed that women who met criteria 
for PMS had significantly higher average levels of disgust sensitivity, OCD symptoms, and 
responsibility beliefs compared to women not meeting criteria for PMS. These findings are 
consistent with Firoozi and colleagues (2012), who found that women with PMS had 





these symptoms were higher across both phases of the menstrual cycle compared to the control 
group.  
Level of contamination fears. Although sub-clinical contamination OCD symptoms did 
not increase across the cycle in all free-cycling women as hypothesized, women who scored 
above a cut-off score for contamination fears (similar to individuals diagnosed with OCD) on the 
PI-WSUR did actually show an increase in OCD contamination symptoms from the follicular to 
luteal phase of the cycle. This finding is in line with previous research that has shown up to 49% 
of women with OCD experience premenstrual worsening of OCD symptoms (Vulink et al., 
2006), suggesting that hormones such as progesterone affect OCD symptomatology. It’s possible 
that perhaps OCD symptoms have to rise to a certain level in order to be exacerbated by 
increased progesterone levels, or vice versa. 
Stage of luteal phase testing. Different patterns of change in contamination OCD 
symptoms across the cycle emerged depending on whether women were tested from the 
follicular phase to the early luteal phase or from the follicular phase to the late luteal phase. 
Women tested in the late luteal phase showed an increase in contamination OCD symptoms 
across the menstrual cycle, women tested in the early luteal phase showed a decrease in OCD 
symptoms across the menstrual cycle. This finding is consistent with Gonda and colleagues 
(2008), who found that anxiety and OCD symptoms were greater in the late luteal phase 
compared to the late follicular phase of the menstrual cycle. The compensatory prophylaxis 
hypothesis would likely predict that disgust sensitivity (and OCD contamination symptoms) 
would be highest during peak progesterone levels. However, peak progesterone levels should 
occur in the mid-luteal phase not the late luteal phase of the cycle. In the current study 





(although not significantly). Perhaps late luteal symptoms are reflective of a sensitivity to the 
drop in progesterone that occurs from the mid to late luteal phase of the cycle. 
Sexual activity. Sexual activity was also found to be an important moderator in the 
current study, affecting two of the four main dependent variables in free-cycling women (risk-
taking and OCD contamination symptoms). A significant interaction was found between OCD 
contamination symptoms and menstrual cycle phase as a function of women’s sexual activity. 
Free-cycling women who were not sexually active showed an increase in contamination OCD 
symptoms across the menstrual cycle, whereas women who were sexually active showed a 
decrease in contamination OCD symptoms from the follicular phase to the luteal phase. 
Furthermore, whereas risk-taking increased across the cycle in women who were not sexually 
active, sexually active women showed a significant decrease in risk-taking from the follicular to 
luteal phase of the cycle. 
A decrease in OCD symptoms across the menstrual cycle in sexually active women 
seems contrary to the compensatory prophylaxis hypothesis, as it would predict increased 
contamination fears during times of increased progesterone. Furthermore, women who are 
sexually active and are not using birth control are most likely to get pregnant and are perhaps the 
most in need of disease-avoidant behaviour.  
There is evidence to suggest that obsessive compulsive symptoms interfere with sexual 
functioning. Individuals with OCD have been found to have lower sexual satisfaction and sexual 
desire compared to individuals without OCD, with greater severity of OCD symptoms associated 
with lower levels of sexual satisfaction (Amini et al., 2014). Although women with other anxiety 
disorders also experience decreased sexual functioning (Van Minnen & Kampman, 2000), 





and Kampman (2000) found that patients with OCD were less satisfied with their sex lives and 
reported more sexual dysfunction compared to both patients with panic disorder and controls. 
Similarly, Aksaray, Yelken, Kaptanoğlu, Oflu, and Özaltin (2001) found that women with OCD 
were more sexually non-sensual, avoidant, and anorgasmic compared to women with GAD. 
Furthermore, patients who reported contamination obsessions were more sexually non-sensual 
and avoidant compared to patients with other types of obsessions (e.g., symmetry/exactness; 
Aksaray et al., 2001). 
Sexual stimuli (e.g., sweat, semen, saliva) are some of the strongest elicitors of disgust 
imaginable, although avoidance of these contaminants would be at odds with the goal of 
procreation (Al-Shawaf, Lewis, & Buss, 2015; Borg & de Jong, 2012). Therefore, it is 
hypothesized that sexual arousal may weaken the disgust response or make individuals less 
avoidant of disgust-provoking stimuli (Al-Shawaf et al., 2015). In fact, in a recent study by Borg 
and de Jong (2012) women watched either an erotic film to induce sexual arousal, a sports clip to 
induce positive arousal, or a neutral film and then engaged in a series of behavioural tasks that 
represented various domains of disgust (e.g., sticking your finger in a bowl of seemingly used 
condoms). The authors found that participants in the sexual arousal condition rated sexual stimuli 
as less disgusting compared to participants in the positive arousal or neutral condition. The 
sexual arousal group also conducted the greatest percentage of tasks in comparison to the other 
two groups. Given that disgust sensitivity and contamination OCD symptoms are positively 
correlated, these findings suggest that sexual arousal or sexual activity may decrease disgust and 
contamination OCD symptoms. In the current study average disgust sensitivity across the two 






The interaction between sexual activity and menstrual cycle phase for OCD 
contamination symptoms is consistent with the Periovulatory Sociosexuality Tactic Shift (PSTS), 
for which level of sociosexuality predicted two different patterns of mating strategies across the 
menstrual cycle. Oinonen et al. (2008) found that restricted women became more sexual when 
more fertile and unrestricted women became less sexual when more fertile. Thus, restricted 
women may become more sexual and less concerned with contamination when more fertile, or 
their risk of conception is higher. However, the finding of increased risk-taking across the cycle 
in women who are not sexually active doesn’t appear to fit with this theory, as you might expect 
increased risk-taking in the fertile phase of the cycle if women become more sexual and less 
concerned with contamination. 
Previous research has shown that women who differ in sociosexuality and related 
constructs show different patterns of behavior change across the menstrual cycle (e.g., Edelstein 
et al., 2011; Oinonen et al., 2008; Scarbrough & Johnston, 2005). Therefore, the different 
patterns of change in OCD contamination symptoms across the cycle depending on sexual 
activity may represent two distinct groups of women who display different patterns across the 
cycle. In fact, exploratory analyses suggested that there were differences between women who 
showed increases in OCD contamination symptoms across the cycle and those who showed no 
change or a decrease in OCD contamination symptoms across the cycle. Women with increasing 
OCD contamination symptoms across the cycle were more likely to be single, not sexually 
active, to have fewer lifetime sexual partners, to have decreased risk-taking in the health/safety 
domain, and to identify as religious (Christian). This combination of variables seems to suggest 
that women who show increased OCD contamination symptoms across the cycle may be more 





Women who showed an increase in OCD contamination symptoms across the menstrual 
cycle were found to converge on a number of factors related to restricted sociosexuality (e.g., 
lower number of lifetime sexual partners, not currently sexually active, and not currently in a 
relationship), in addition to identifying with a Christian religious orientation and decreased risk-
taking in the health domain. Restricted sociosexuality has been linked to both religion and 
disease prevalence. For instance, people who were intrinsically motivated toward religion were 
found to have more restricted sociosexuality (e.g., desiring less sexual partners over time; Rowatt 
& Schmitt, 2003). Sociosexuality and contamination fears may also be linked, as women have 
been found to be more restricted sexually in regions with higher parasite prevalence (Park & 
Schaller, 2009).  
Some researchers hypothesize that high levels of disgust and contamination fears resulted 
in more conservative beliefs and attitudes to promote group exclusion as a form of protection 
against potential threats from outgroups (e.g., disease; Terrizzi, Shook, & McDaniel, 2013). For 
instance, disgust (which is positively correlated with contamination OCD symptoms) has been 
found to positively correlate with more socially conservative values (Terrizzi, Shook, & Ventis, 
2010). In addition, religious conservatism was found to mediate the relationship between disgust 
and negative attitudes toward out-group members (Terrizzi, Shook, & Ventis, 2012). Future 
research is needed to replicate the finding that a subgroup of conservative women with more 
restricted sexuality are more likely to show increased contamination OCD symptoms across the 
menstrual cycle.  
Hypothesis 2 





with increased OCD symptomatology, disgust sensitivity, responsibility beliefs, and decreased 
risk-taking across the cycle. 
 It was hypothesized that changes in progesterone levels across the menstrual cycle would 
be positively correlated with changes in OCD contamination symptoms, disgust sensitivity, 
responsibility beliefs, and negatively correlated with changes in risk-taking across the cycle. 
There was a significant negative association between increased progesterone levels across the 
menstrual cycle and decreased risk-taking across the cycle, but none of the other main dependent 
variables were significantly correlated with changes in progesterone levels after controlling for 
potential confounds. It’s unclear why increased general anxiety scores (HADS) across the cycle 
were positively correlated with increases in progesterone but increased OCD symptoms were 
not.  
The correlation between changes in progesterone and changes in responsibility beliefs 
across the cycle was in the opposite direction of the predicted relationship. Perhaps responsibility 
beliefs do not generally increase in the luteal phase but would be more likely to be primed in 
times of high progesterone given a proper stimulus. For instance, it would be interesting to 
examine whether participants, when presented with a scenario of possible harm to an infant, 
would be more likely to intervene and prevent harm in times of increased progesterone (and 
perhaps level of baseline responsibility beliefs would interact with behavior change). Thus, this 
is an area where future research is warranted in order to make stronger claims about the 
relationship between progesterone and responsibility beliefs. 
As hypothesized, increases in salivary progesterone across the menstrual cycle were 
significantly associated with decreased risk-taking across the cycle. Previous findings have 





found that naturally cycling women reduced risky behaviours that would increase their risk of 
sexual assault around the time of ovulation (e.g., “walk through dimly lit area in the evening”) 
and increased non-risky behaviour (e.g., “visit friends”), whereas women taking hormonal 
contraceptives showed neither effect. Using a lottery task, Buser (2012) found that participants 
were twice as likely to choose a riskier payment scheme during periods of low progesterone 
compared to high progesterone. These findings are consistent with evolutionary theory, which 
posits that competitiveness is more desirable during the more fertile phase of the menstrual cycle 
and less desirable during high progesterone times such as the luteal phase of the menstrual cycle 
and pregnancy when the focus is on maintaining long-term commitment (Buser, 2012). 
Increasing progesterone levels across the menstrual cycle in free-cycling women were 
also found to be significantly correlated with decreased risk-taking in the social domain. 
Progesterone is thought to play an important role in terms of affiliative behaviors, such as 
creating and maintaining social relationships. Just as behavioural changes that occur in the 
follicular phase near ovulation (e.g., greater attraction to masculine faces) are important for 
mating purposes, behavioural changes in the luteal phase are thought to be related to social and 
affiliative functions (Maner & Miller, 2014). Each rise in progesterone across the luteal phase of 
the menstrual cycle represents an attempt to prepare the body for pregnancy. Therefore, it is 
hypothesized that high progesterone levels would be associated with behaviour considered 
adaptive during pregnancy, such as solidifying social bonds to ensure support during pregnancy 
and long-term resources to help raise a child (McLean & Anderson, 2009; Schultheiss, Dargel, & 
Rohde, 2003).  
Studies have in fact shown a link between progesterone and affiliation motives. 





implicit motives of affiliation, as measured by the Picture Story Exercise. Participants were 
tested at three time points, corresponding to the early follicular, periovulatory, and luteal phases 
of the cycle. During the periovulatory and luteal phases, salivary progesterone levels were 
significantly higher in the affiliation-arousal group than the control group for normally cycling 
women. Average levels of progesterone were moderately positively correlated with affiliation 
motive for normally cycling women, but there was no relationship between progesterone and 
affiliation motive in women taking hormonal contraceptives. Furthermore, viewing a movie clip 
meant to implicitly prime motives for affiliation lead to a significant elevation in progesterone 
levels compared to participants who viewed movie clips that implicitly primed power motives or 
were neutral (Schultheiss, Wirth, & Stanton, 2004). Recent research also suggests that high 
levels of progesterone may prime the need for close relationships. Brown et al. (2009) found that 
participants who engaged in a closeness induction with a partner had significantly greater 
salivary progesterone levels following the task compared to those who engaged in a neutral task. 
Furthermore, in a second session a week later, increases in progesterone were predictive of self-
reported willingness for participants to risk their life for their partner. 
Of all of the subscales of the DOSPERT, decreased risk-taking in the health/safety 
domain was the most associated with increases in progesterone across the menstrual cycle. This 
finding is consistent with the compensatory prophylaxis hypothesis, which posits that increases 
in progesterone are accompanied by increases in disease avoidant behavior. One the items on the 
health/safety subscale pertains to the likelihood of engaging in unprotected sex. Being less likely 
to engage in unprotected sex would limit exposure to possible sexually transmitted infections. 
This fits with previous findings showing disease prevalence negatively correlated with openness 





ourselves to risky or dangerous situations we can decrease the risk of disease transmission 
(Schaller & Murray, 2008). Becoming more cautious with health and safety and disease 
avoidance during times of high progesterone may be an adaptation for pregnancy, as exposure to 
viruses and toxins during pregnancy can result in serious deformation in the developing fetus 
(Lienard, 2011; Tybur & Gangestad, 2011). 
Hypothesis 3 
(a). Women will show increased sensitivity for identifying facial expressions of disgust 
compared to men. 
Consistent with previous research (e.g., Collignon et al., 2010), women were found to 
have significantly greater average sensitivity for identifying facial expressions of disgust 
compared to men. Although the testing time by sex interaction was not significant, inspection of 
Figure 10 suggests that women may show an increase in sensitivity to detecting facial 
expressions of disgust in the luteal phase of the menstrual cycle. This would be consistent with 
the compensatory prophylaxis hypothesis, as increased progesterone levels would be associated 
with greater sensitivity to cues of disgust. An alternative explanation is the possibility that men 
and women differed in practice effects, with women potentially benefitting more from prior 
experience with the task than men going into the second testing phase. 
(b). Free-cycling women with a more liberal bias in terms of perceiving facial 
expressions of disgust will have increased levels of progesterone and pathogen disgust compared 
to women with a more conservative bias. 
It was also predicted, based on the compensatory prophylaxis hypothesis, that during 
times of immunosuppression (or increased progesterone) it would be beneficial to have a more 





prediction, there was no significant relationship between bias in perceiving facial expressions of 
disgust and progesterone levels. Pathogen disgust was marginally higher in women with a liberal 
bias in detecting disgust compared to a conservative bias, as expected, but very few women had a 
conservative bias. There was also no difference in change scores between progesterone levels 
and pathogen disgust and bias across the cycle. However, bias scores did not change very much 
across the cycle and were generally quite liberal to begin with. For instance, in free-cycling 
women in the follicular phase 74% of participants had a negative or liberal bias, which increased 
slightly to 79% in the luteal phase. Perhaps if the faces were presented more quickly or the 
expressions were more ambiguous there might have been a stronger effect, given that individuals 
with OCD were more likely to perceive disgust in ambiguous facial expressions compared to 
controls (Jhung et al., 2010). 
These findings are not consistent with previous research examining the link between 
hormones and emotion recognition, although research findings in this area are not consistent. 
Guapo and colleagues (2009) did not find any differences in facial recognition accuracy for 
disgust across different phases of the menstrual cycle. In contrast, other researchers have found 
higher emotion recognition in the follicular phase compared to the luteal phase and a negative 
correlation between progesterone levels and emotion recognition accuracy (Derntl, Kryspin-
Exner, et al., 2008; Derntl, Windischberger, et al., 2008). However, women were more likely to 
misperceive other negative emotions as disgusted when in the luteal phase (Derntl, Kryspin-
Exner, et al., 2008). Therefore, it may not be that women are more accurate at identifying disgust 
in the luteal phase, but that during times of increased progesterone (similar to pregnancy) it is 
important not to miss signals of disgust, or misjudge them for other emotions. However, in the 





progesterone levels. The fact that studies in this area are so inconsistent is likely a reflection of 
the vast differences in methodology employed as well as the small sample sizes utilized. 
From an evolutionary perspective high levels of progesterone are thought to increase 
attention and vigilance to social stimuli and potential threats as a mechanism to protect fetal 
development. In a recent study, Wolohan, Bennett, and Crawford (2013) found sex and 
menstrual cycle differences between participants in an eye-gaze cueing task. Participants were 
instructed to respond to a target that was presented next to a face with a fearful expression, with 
eye gaze either consistent with the target or inconsistent. Women responded significantly faster 
to the target in the congruent condition compared to men, and women in the luteal phase showed 
a significantly quicker reaction time compared to women in the follicular phase of the menstrual 
cycle. These findings are consistent with the current study in which women had greater 
sensitivity in detecting disgust compared to men, especially during the luteal phase of the 
menstrual cycle, and past literature showing that women were more accurate at identifying 
emotions that signal a threat (i.e., fear, anger, and disgust) in late pregnancy when progesterone 
levels were higher compared to early pregnancy (Pearson et al., 2009). 
Emotion recognition was also compared between free-cycling women and women using 
hormonal contraceptives. Given the difference in progesterone levels between free-cycling 
women and hormonal contraceptive users, one might expect that hormonal contraceptive users 
would experience reduced emotion recognition. In fact, a recent study found that women taking 
OCs detected significantly fewer facial expressions of disgust compared to non-users (Hamstra, 
De Rover, De Rijk, & Van der Does, 2014). However, in the current study free-cycling women 
and women using hormonal contraceptives did not differ in mean sensitivity for detecting facial 





within OC users, depending on the progesterone dosage and androgenic activity of the OCs. 
High dose progesterone and anti-androgenic OCs were associated with significantly higher 
sensitivity for detecting facial expressions of disgust.  
 Increased androgenic activity hindering emotion recognition is consistent with the 
finding of lower sensitivity in detecting disgust in males versus females in the current study and 
fits with previous literature. A recent study conducted by Pletzer, Kronbichler, and Kerschbaum 
(2015) found that women taking OCs with anti-androgenic progestins had significantly better 
facial recognition performance compared to users of OCs with androgenic progestins or free-
cycling women. Furthermore, enhanced facial recognition in anti-androgenic OC users was 
related to greater grey matter volume in brain structures associated with facial recognition (e.g., 
fusiform face area; Pletzer et al., 2015). Similarly, Van Honk and colleagues (2011) found that a 
single dose of testosterone administered to female participants significantly reduced their ability 
to infer emotions in the Reading the Mind in the Eyes Task (RMET). Furthermore, 2D:4D was 
found to interact with cognitive empathy, such that testosterone administration had more of an 
effect on women with low, or more masculinized 2D:4D ratios, suggesting that activational 
effects may be dependent on fetal testosterone priming (Van Honk et al., 2011). In the current 
study, higher, or more feminized 2D:4D was significantly associated with greater sensitivity in 
detecting emotions of disgust, which supports the notion that hormones modulate emotion 
recognition.  
 The reverse is also true, with women taking more androgenic OCs becoming more 
“malelike” in their behavior. For instance, in terms of visuospatial abilities there are large sex 
differences in mental rotation, with men outperforming women (see Voyer, Voyer, & Bryden, 





differences in OC androgenicity mediated performance on a mental rotation task. Whereas 
women taking the most androgenic OCs had the best performance on a mental rotation task, 
women taking Yasmin (an anti-androgenic OC) had the worst task performance. These findings 
speak to both the organizational (e.g., 2D:4D) and activational (e.g., current OC progestin dosage 
or androgenicitiy) effects of hormones on human behavior. 
Neural Correlates of Negative Mood Symptoms across the Menstrual Cycle 
The amygdala, located within the limbic system of the brain, is involved in the processing 
of emotions. Although the amygdala is often associated with fear processing, it appears to have a 
much broader, more integrative function (Schienle, Schäfer, Stark, Walter, & Vaitl, 2005). 
Hyperactivity of the amygdala appears to be a commonality across anxiety disorders (Etkin & 
Wager, 2007). Even in individuals without anxiety disorders, personality traits such as 
neuroticism and anxiety sensitivity increased amygdala responsiveness in an emotion-processing 
task with young adults (Stein, Simmons, Feinstein, & Paulus, 2007). In an fMRI study involving 
63 healthy women who were presented with either neutral or disgusting pictures, both trait 
anxiety and disgust sensitivity were found to positively correlate with the activation of the right 
amygdala (Schienle et al., 2005). 
Sex differences have been found in relation to amygdala activation. Hormones are 
thought to play a role in these sex differences given that the amygdala is densely populated with 
steroid hormone receptors (Stevens & Hamann, 2012). A recent meta-analysis of nearly 100 
neuroimaging studies examined sex differences in brain activation to emotional stimuli (Stevens 
& Hamann, 2012). Key differences were found in the amygdala, with women showing greater 
activation than men in the left amygdala for negative emotions, and men showing greater 





increased reactivity to negative emotional stimuli in women that may help to explain the 
increased prevalence of mood and anxiety disorders in women (Stevens & Hamann, 2012). 
Women with PMDD have also been found to show significantly increased amygdala activity in 
response to negative stimuli in the premenstrual phase of the cycle relative to control participants 
(Protopopescu et al., 2008).  
Progesterone also affects amygdala activation. Women using OCs have been shown to 
have decreased amygdala reactivity compared to free-cycling women when presented with 
negative emotional stimuli (Petersen & Cahill, 2015). In a neuroimaging study, Van Wingen and 
colleagues (2008) found that a single dose of progesterone administered to women in their 
follicular phase (which increased progesterone concentrations to levels similar to the luteal 
phase) resulted in increased amygdala reactivity. Van Wingen and colleagues hypothesize that 
women with PMS/PMDD might experience a greater activation of the amygdala in response to 
progesterone or its main metabolite, allopregnanolone. Perhaps increased amygdala activation in 
response to increases in progesterone is an evolutionary adaptation for pregnancy that allows for 
increased vigilance to potential threats of harm to the offspring. Oxytocin, another hormone that 
is important during pregnancy, also affects amygdala reactivity. Lischke and colleagues (2012) 
found that following intranasal administration of oxytocin, amygdala reactivity increased in 
response to viewing threatening scenes. 
The worsening of OCD symptoms observed in many women across the menstrual cycle 
might also involve the amygdala. Atmaca and colleagues (2008) found that patients with 
refractory OCD showed a reduction in amygdalar volume by 23% compared to healthy control 
subjects. Furthermore, a positron emission tomography (PET) study showed that OCD patients 





contamination-related pictures compared to a control group (van den Heuvel et al., 2004). 
However, a more recent study found that greater severity of aggression, checking, sexual, and 
religious symptom dimensions predicted greater activation of the right amygdala during an 
emotional face-matching task in patients with OCD compared to controls, whereas this 
association was not found in other symptom dimensions (e.g., contamination, symmetry/ 
exactness, hoarding; Via et al., 2014). Not all studies have shown increased activity in the 
amygdala in OCD patients compared to controls (e.g., Cannistraro et al., 2004), although 
responsivity to fearful versus neutral faces tends to be a common paradigm that may not show 
the same effects as more individualized stimuli. 
Progesterone and its metabolites also alter the function of neurotransmitters, including 
gamma aminobutyric acid A (GABA), the main inhibitory neurotransmitter system in the brain. 
Negative mood symptoms in response to changes in progesterone levels may be caused by the 
effect of progesterone metabolites on GABA (Bäckström et al., 2011). The main metabolites of 
progesterone (pregnanolone and allopregnanolone) have been shown to directly influence the 
GABAA receptor complex (Andréen et al., 2009). As progesterone concentrations rise across the 
menstrual cycle and peak in the luteal phase, progesterone’s metabolites also show the same 
increases across the cycle. Allopregnanolone has been shown to induce negative mood 
symptoms when in the range of concentrations similar to the luteal phase (Andréen et al., 2009). 
In women with PMDD associations have been found between the severity of symptoms and 
changes in GABA concentrations or GABAA receptor sensitivity (Andréen et al., 2009; 
Bäckström et al., 2011). Therefore, it appears as though a subset of women may be more 





Although the hormonal sensitivity hypothesis seems to focus more exclusively on 
changes in estrogen across reproductive events and vulnerability for depression, these findings 
suggest that sensitivity to changes in progesterone should not be overlooked. In fact, a failure to 
adapt to changes in progesterone and its metabolites may play an important role in terms of 
biological support for the hormonal sensitivity hypothesis. Gordon and colleagues (2015) 
recently proposed a novel model which hypothesizes that vulnerability to depression for some 
women during the menopause transition may result from a HPA axis dysregulation as a result of 
a failure of the GABAA receptor to adapt to fluctuations in allopregnanolone as estrogen and 
progesterone levels become more erratic. It is important to continue this line of research to help 
better understand the etiology of the increased vulnerability to depression in some women as a 
result of fluctuations in both estrogen and progesterone across key reproductive events. 
Limitations and Future Directions 
Given the number of exclusion criteria utilized, menstrual cycle research results in a  
subsample of women that may not be entirely representative of the whole population of free-
cycling women. Although the use of these exclusion criteria increases the internal validity of the 
study, it may limit the external validity, or generalizability of the findings. In the current study, 
56 free-cycling women were excluded for reasons such as age over 40, pregnant or 
breastfeeding, irregular menstrual cycles, ovaries removed, using medications or having medical 
conditions affecting hormone levels, recent use of hormonal contraceptives, being outside of 
specified testing days, and reversed progesterone levels; thus the remaining women represented 
healthy women with normal menstrual cycles. The exclusion criteria also limited the number of 
saliva samples ultimately included in data analysis (i.e., 36 of 56), which may have reduced the 





necessary from a practical standpoint given that they affect hormone levels (e.g., pregnancy, age 
consistent with perimenopause, removal of ovaries). Furthermore, it would be difficult to 
schedule women with irregular and longer than average menstrual cycles within the proper 
testing windows. Therefore, a lack of exclusion criteria would result in an overly heterogeneous 
sample that would cloud interpretation of the data. 
Although certain exclusion criteria are employed consistently across studies in this field 
(e.g., menstrual cycle length), many studies differ considerably in the specific testing days and 
phases of the cycle that are examined. Considerable differences are likely to be found across 
studies that use different testing days across the menstrual cycle, such as one particular day in the 
menstrual cycle (e.g., Avgoustinaki et al., 2012), a 2-3 day window (Gonda et al., 2008), or up to 
a 10-day window. With a larger sample size it would be possible to more closely examine 
changes in the main dependent variables according to more specific phases (e.g., early vs. late 
luteal).  
It is also possible that excluding women with a mood or anxiety disorder diagnosis when 
looking at fluctuations in mood across the menstrual cycle is actually limiting the value of the 
study. By omitting women with the most severe symptoms who might also be the most likely to 
experience fluctuations in affect across the menstrual cycle, we might be increasing the risk of a 
Type II error and reducing the sensitivity of the study. For instance, Moreira and colleagues 
(2013) examined specific risk factors that predicted the exacerbation of OCD symptoms across 
the menstrual cycle. Higher levels of anxiety and depression, suicidality, and sexual/religious 
obsessions were found to be more common in women with pre-menstrual worsening of OCD 
symptoms (Moreira et al., 2013). It is common practice to exclude women with a mood or 





interfere with hormone levels. However, it would be interesting for future studies to examine 
how changes in behavior across the menstrual cycle differ in these women. 
The young age of the sample may also be a potential limiting factor in relation to the 
hormonal analyses. Progesterone levels have been found to be lowest in 18-19 year olds and 
highest in 25-34 year olds (Lipson & Ellison, 1992). Thus, younger women experience a lower 
peak in progesterone levels during the luteal phase of the menstrual cycle. Furthermore, before 
women reach their mid-twenties they tend to have a relatively high proportion of anovulatory 
cycles (Hampson & Young, 2008). In the current study however, there was no association 
between age and salivary progesterone concentrations in the luteal phase. An additional concern 
regarding the progesterone analyses is that if progesterone levels are measured too early within 
the luteal phase there will not be a significant increase in progesterone concentrations relative to 
the follicular phase and if progesterone levels are measured too late in the luteal phase then 
progesterone concentrations will already be falling. This was likely an issue in the current study 
given that the testing days ranged over approximately a 12 day span. However, this problem is 
likely common in menstrual cycle research as a very large sample size is needed in order to be 
left with a large enough pool of participants after all of the exclusionary criteria are applied. It 
was also difficult to have a large enough sample size to look at moderator variables within the 
free-cycling subset of women. 
In the current study, women were tested during days 2-13 for the follicular phase and 
twelve days prior to menstruation up to day 1 of menstruation for the luteal phase. These testing 
windows were slightly longer than initially planned, as we aimed for follicular testing during 
days 3 to 10 and luteal testing during days -3 to -9. A smaller testing window for each phase 





mid-luteal phase would have allowed for the highest progesterone levels, although in the present 
study we were able to compare women who were tested in the early luteal phase to women who 
were tested in the late luteal phase. However, a within-subjects design allowed for each woman 
to be tested during a time of relatively low and high progesterone. Finally, the two different 
testing orders (e.g., follicular then luteal; luteal then follicular) were not evenly counterbalanced 
as 75% of women were tested first in the follicular phase and second in the luteal phase. Ideally, 
50% of women should have been tested across both conditions, so this represents a limitation of 
the study. 
There are reasons to suggest that combining all women taking oral contraceptives into a 
single group may be problematic (Hampson & Young, 2008). There are numerous types of OCs 
differing in hormone dosage and delivery across the cycle (e.g., monophasic versus triphasic 
formulations). Women have also been found to differ considerably in their metabolism rate for 
the same dose of an OC (Hampson & Young, 2008). Furthermore, menstrual cycle research 
typically compares women using OCs and free-cycling women in between-subjects designs, 
which often doesn’t account for individual variability and differences between the groups (e.g., 
in sexual behaviour, Little, 2013). However, in the current study every effort was made to further 
distinguish between the different types of OCS by progestin dosage, phasicity, and even 
androgenic activity. Furthermore, a within-subjects design allowed for measurement of 
individual changes in behavior across the cycle in both groups. 
In the present study PMS was measured using the Premenstrual Symptoms Screening 
Tool (PSST; Steiner et al., 2003). The American College of Obstetricians and Gynecologists 
propose that PMS symptoms be confirmed prospectively across two menstrual cycles (Halbreich 





measurements, a screening tool is more practical in research settings. Furthermore, the PSST is 
based on DSM-IV criteria for PMDD and assesses functional impairment across a number of 
areas.  The PSST did not overinflate the number of women meeting criteria for PMDD, the more 
serious form of PMS, as the number of women meeting PMDD criteria in the current study 
(4.7%) was comparable to estimates given in the literature (e.g., Steiner et al., 2003). 
In hindsight, an additional limitation of the study was including only the pathogen 
subscale of the Three Domain Disgust scale and not the entire scale (i.e., excluding the sexual 
and moral disgust subscales). It would have been interesting to examine sexual disgust, 
especially in the context of the interaction between OCD symptoms and sexual activity. Given 
that sexual arousal has been found to decrease the disgust response, it would have been 
interesting to examine whether low levels of sexual disgust were related to decreased 
contamination-based OCD symptoms. Furthermore, it would have been interesting to examine 
whether moral disgust was positively correlated with responsibility beliefs and negatively 
correlated with social risk-taking.  
The hormonal milieu is substantially different across reproductive events such as the 
luteal phase of the menstrual cycle, the postpartum period, and perimenopause (Altemus et al., 
2014). Although the luteal phase of the menstrual cycle is often compared to pregnancy due to 
the rise in progesterone, progesterone levels differ significantly across these time points. For 
instance, in the current study progesterone levels increased an average of 280% across the 
menstrual cycle (SD = 385.39), representing a 2-3 fold increase. In comparison, during 
pregnancy progesterone levels increase 10-fold over maximum menstrual cycle levels (Bloch et 
al., 2003). Furthermore, the postpartum period, which is accompanied by a significant drop in 





(Russell et al., 2013). Furthermore, although the present study focused primarily on 
progesterone, changes are seen across multiple hormones and hormone metabolites during these 
major reproductive events (Altemus et al, 2014). Arguably, for some women it may not be the 
absolute levels of hormones but the fluctuations in hormones or their sensitivity to hormonal 
change that is important. 
The current study was primarily focused on the role of progesterone in attempting to 
explain the association between reproductive events and OCD and related symptoms. However, 
reproductive events are also associated with fluctuating estrogen levels. As previously discussed, 
estrogen’s effects on mood are very well documented. Estrogen has been found to modulate 
several neurotransmitter systems and has been examined as a treatment for postnatal and 
perimenopausal depression. Therefore, the fact that estrogen levels were not measured in the 
current study represents a potential limitation. Estrogen levels would have differed considerably 
between women tested in the early follicular phase compared to the late follicular phase, which 
would have introduced further noise in hormonal profiles across women, potentially reducing the 
power to detect changes related to the effects of progesterone. Further research should examine 
how estrogen and progesterone might interact to affect OCD symptoms across reproductive 
events. The exclusive focus on progesterone in the current study was mainly based upon specific 
predictions from the compensatory prophylaxis hypothesis. Given the fact that progesterone and 
estrogen have different effects on the immune system, it would be interesting to see what type of 
predictions might be made about the effects of estrogen on symptoms of OCD according to the 
compensatory prophylaxis hypothesis. For instance, deficiencies in estrogen in male mice have 





future work will be to attempt to disentangle the interaction between changes in estrogen and 
progesterone on mood and anxiety across reproductive events. 
The theory of hormonal sensitivity, or the idea that major reproductive events represent 
periods of particular vulnerability for some women is an important area for future research (e.g., 
Pope, Oinonen, Mazmanian, & Stone, 2015). Women who experience mood fluctuations over 
the menstrual cycle seem to be at risk for experiencing mood fluctuations during pregnancy and 
the postpartum period, and other major reproductive events. For instance, Forray, Focseneanu, 
Pittman, McDougle, and Epperson (2010) found that women whose OCD symptoms either began 
during pregnancy or were exacerbated during this time were more likely to have experienced a 
premenstrual exacerbation of their OCD symptoms compared to women whose OCD symptoms 
were unaffected by pregnancy or did not begin during this time. Future research is needed to 
determine which women are likely to experience fluctuations in mood or anxiety across the 
menstrual cycle, and which factors predict whether or not women will go on to experience an 
exacerbation of symptoms in pregnancy or the postpartum period. Long-term prospective studies 
are needed to follow a large sample of women throughout multiple reproductive events. Further 
studies are also needed to examine the effect of prenatal hormone exposure in relation to the 
hormonal sensitivity hypothesis. In the current study, meeting criteria for PMS was associated 
with higher 2D:4D, an indicator of lower prenatal androgen exposure. This is consistent with 
findings from Oinonen, Jarva, and Mazmanian (2008), who found that previous oral-
contraceptive users had higher 2D:4D than current users or non-users, suggesting that there may 
be a link between higher 2D:4D and discontinuation of oral-contraceptives due to 





Critics of the compensatory prophylaxis hypothesis suggest that it may be too narrow in 
focus as other factors unrelated to progesterone fluctuations can also predict greater disgust 
sensitivity (Al-Shawaf & Lewis, 2013). For instance, it would be adaptive for disgust sensitivity 
to increase in response to high levels of stress, as stress suppresses the immune system. In a 
study with over 500 participants, stress (single item measure) was a significant predictor of 
disgust sensitivity (DS-R; Al-Shawaf & Lewis, 2013). However, this finding is not that 
surprising given the interrelatedness of stress, anxiety, and disgust sensitivity. Anxiety scores 
have reliably been found to be positively associated with disgust sensitivity (e.g., Thorpe, Patel, 
& Simonds, 2003). Although anxiety and stress have been found to represent different 
constructs, they are highly correlated (e.g., r = .74, Crawford & Henry, 2003). Therefore, the 
relationship between stress and increased disgust sensitivity would be expected. In the present 
study anxiety scores as measured by the HADS were significantly positively correlated with 
disgust sensitivity as well. However, Al-Shawaf and Lewis (2013) do raise an important point- 
many factors can lead to increased disgust sensitivity. For instance, in the current study women 
with PMS had greater levels of anxiety, disgust sensitivity, OCD symptoms, and responsibility 
beliefs. 
Future neuroimaging work may help to tie together currently divergent lines of research. 
Trait anxiety, disgust sensitivity, and progesterone are all associated with increased activation of 
the amygdala; women with PMDD show increased amygdala reactivity to negative stimuli; and 
individuals with OCD show heightened amygdala activation in response to symptom-
provocation. Future studies could combine measurement of amygdala reactivity with measures of 
GABAA receptor sensitivity to try and predict which women might be most likely to experience 






In this broad area of literature there are a number of potentially important clinical 
implications that are worth discussion. First, it is important that clinicians are aware of the fact 
that reproductive events including menarche, the premenstrual phase of the menstrual cycle, 
pregnancy, postpartum, and perimenopause can be associated with either the onset or 
exacerbation of mood and anxiety disorders. For practitioners who provide longer-term 
counselling, it is important to be cognizant of changes in mood or anxiety disorders across 
reproductive events. Symptoms of OCD may be exacerbated during situations where the safety 
of close relationships are threatened, such as illness, death of a relative, or martial problems 
(Feygin, Swain, & Leckman, 2006), or during periods of increased responsibility (e.g., leaving 
home, starting a new job, or pregnancy). In terms of clinical assessment, mood fluctuations could 
be linked to symptoms of PMS or negative mood side effects in response to HC use. For 
clinicians who are looking for a comprehensive assessment tool to explore menstrual, 
contraceptive, perinatal, and perimenopausal history, Martini, Wittchen, Soares, Rieder, and 
Steiner (2009) created a new women specific platform that can be added into the World Health 
Organization-Composite International Diagnostic Interview (WHO-CIDI).  
 It is important for clinicians to be aware of the fact that intrusive thoughts are very 
common in pregnancy and the postpartum period, and to be able to distinguish between “normal” 
or adaptive anxiety versus clinically significant symptoms. Furthermore, women who present 
with OCD in the postpartum period may be reluctant to report intrusive thoughts about harming 
their child as they are afraid of the consequences. Clinicians can be reassured that there has never 
been a case of “pure OCD” where a woman has intentionally harmed her child. Women with 





lengths to avoid acting on them. In contrast, infanticide is extremely rare and generally occurs in 
cases of postpartum psychosis. In such cases there is typically a lack of insight, no fear or 
anxiety associated with the thoughts, and other symptoms are present that necessitate emergency 
psychiatric hospitalization (Abramowitz et al., 2003; Ross & McLean, 2006). 
Conclusions 
Although several previous studies have suggested that sub-clinical OCD symptoms 
increase across the menstrual cycle in relation to changes in progesterone in free-cycling women, 
the current study failed to show such a relationship, although increases in progesterone were 
found to be related to increased anxiety more generally. This was the first study to combine both 
a within-subjects design and direct measurement of hormones. Thus, it is currently unclear 
whether or not all free-cycling women experience an increase in subclinical OCD symptoms 
across their menstrual cycles, as there are substantial methodological differences across the 
studies completed to date. The current findings suggest that perhaps not all women experience an 
increase in precautionary behaviour across the menstrual cycle, but that distinct subgroups of 
women may exist who show different patterns of behaviour change across the cycle. This is an 
important area for further research given that women who do experience menstrual cycle 
changes in precautionary behaviour appear to be at risk for the onset or exacerbation of anxiety-
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Appendix A: Emotions and Mood Covering Letter A 
Dear Potential Participant, 
  
 You are invited to participate in the Emotions and Mood Study at Lakehead University. 
This study is being conducted by Emily Fawcett (Psychology Doctoral student) under the 
supervision of Dr. Dwight Mazmanian (Associate Professor) at Lakehead University. The 
purpose of the study is to examine the impact of reproductive hormones on emotion and mood.  
 
 Participation in this phase of the study involves completing an online questionnaire that 
will take approximately 5 to 10 minutes to complete. The questionnaire will include questions 
such as demographic information (e.g., age, sex, education), health information, and reproductive 
history. If you provide your phone number or email address, you will be contacted to participate 
in the next phase of this study which involves coming into the Health, Hormones, and Behaviour 
(HHAB) Lab at Lakehead University on two occasions over the course of a month for 
approximately one hour each. Your contact information (e.g., phone number or email address) 
will only be used to schedule appointments, will be stored separately from your questionnaire 
responses, and will be destroyed after the study is completed so that your data will be 
anonymous. Your data will be kept in a secure manner by Dr. Dwight Mazmanian at Lakehead 
University for at least five years, as per university requirements. Only the researchers will be 
able to access your information. If the research findings are published, there will be no 
information which could identify you. At the end of storage, all paper files will be shredded and 
all computer files will be deleted. 
 
Participation in this study is completely voluntary and you may withdraw from the study 
at any time without penalty. There are no known physical or psychological risks associated with 
this study. However, answering questions about oneself can sometimes lead to slight discomfort 
or interesting insights. You can choose not to answer any questions that make you feel 
uncomfortable. To thank you for your participation in the laboratory component of this study, 
you will be given a $5 Tim Horton’s gift certificate for each session (for a maximum of $10). 
Individuals enrolled in Introductory Psychology can choose between receiving a bonus point per 
laboratory session (i.e., a maximum of 2 bonus points), or the Tim Horton’s gift certificates. 
 
If you have any questions or concerns about this study please contact Ms. Fawcett at 
emotionsandmood@lakeheadu.ca, or Dr. Mazmanian by phone at (807) 343-8257. Other 
collaborators involved in this study include Dr. Kirsten Oinonen (Associate Professor of 
Psychology at Lakehead University). If you have any questions about your rights as a research 
subject or concerns about this study please contact Susan Wright (Research Ethics and 
Administration Officer) at the Lakehead University Research Ethics Board at (807) 343-8283. 
 
Sincerely, 
Emily Fawcett, M.A. (Doctoral Candidate)  Dwight Mazmanian, Ph.D., C.Psych. 
Department of Psychology    Department of Psychology 
  Lakehead University, 955 Oliver Rd.   Lakehead University, 955 Oliver Rd. 
 Thunder Bay, ON, P7B 5E1    Thunder Bay, ON, P7B 5E1 
 emotionsandmood@lakeheadu.ca   dwight.mazmanian@lakeheadu.ca 





Appendix B: Consent Form A 
 
The purpose of the study is to examine the impact of reproductive hormones on emotion 
and mood. This study is being conducted by Emily Fawcett (Psychology Doctoral student) under 
the supervision of Dr. Dwight Mazmanian (Associate Professor) at Lakehead University. 
 
 Your participation in this study will involve completing an online questionnaire that will 
take approximately 5 to 10 minutes to complete. The questionnaire will include topics 
such as demographic information (e.g., age, sex, education), health information, and 
reproductive history. 
 If you provide your phone number or email address, you will be contacted to participate 
in the next phase of this study which involves coming into the Health, Hormones, and 
Behaviour (HHAB) Lab at Lakehead University on two separate occasions over the 
course of a month for approximately one hour each. 
 There are no known physical or psychological risks associated with this study. 
 You may decline to answer any question you wish. 
 Your participation is voluntary, you may refuse to participate in any part of the study, and 
you may withdraw from the study at any time without penalty. 
 Potential benefits of participating in this research include advancing research on men’s 
and women’s health and learning a greater understanding of the research process. 
 All of the data collected in this study will be kept completely confidential. 
 Your information will be kept in a secure manner at Lakehead University for at least five 
years as stated by university rules. Only the researchers will have access to your 
information.   
 If the research findings are published, there will be no information which could identify 
you.  
 You may contact the researchers if you would like a summary of the results of the study 
when it is completed.  
 
I have read and understood the cover letter and consent form, and agree to participate in this 
study under these conditions. I also confirm that I am 17 years of age or older. 
 
Name:  _______________________________________ 
 
Date:  _______________________________________ 
 
Email address (if preferred method of contact):_______________________________________ 
  
Phone Number (if preferred method of contact):_______________________________________ 
 
 If you have any questions or concerns regarding this study please contact Emily Fawcett 
(emotionsandmood@lakeheadu.ca) or the supervisor of this study, Dr. Dwight Mazmanian (phone: (807) 
343-8257, email: dwight.mazmanian@lakeheadu.ca ). Other collaborators in this study include Dr. Kirsten 
Oinonen (Associate Professor of Psychology at Lakehead University). If you have any questions about your 



































Background Information Questionnaire 
 ____________________________________________________________________________________                                                                                                                                                             
1) Today’s date: _________________     _______________          _______________ 
                   Day of Week                Day of Month                  Month:  




3) Sex : Male  Female     
 
4) Height:  _____________ (feet & inches) or _________ (cm) 
 
5) Weight: _______ (pounds) or _______ (kg)   
 
6) Marital status: 
Married/common law    
Divorced/separated     
Widowed      
Single       
 
If you are NOT married, are you: 
In a dating relationship? Yes  No    
In a long-term relationship? Yes  No    
Other (please specify): _________________ 
 
7) What is your ethnic background? 
Caucasian/White    European   
African Canadian/Black   Middle Eastern  
Native-Canadian/Aboriginal   East Indian   
Hispanic/Latino    Asian    
Other (please specify): _________________ 
 
 
8) What is your religious affiliation? 
Christian    
Denomination? (Catholic, Baptist, Anglican, Latter Day Saints, etc.):________________ 
Agnostic   
Jewish      





Muslim      
Atheist    
Other (please specify): _________________ 
 
9) Strength of Religious Beliefs (please circle): 
1      2       3      4    5   6               7 
Not strong               Very strong  
 
10) Sexual Orientation (Circle the letter or number that best describes you): 
X Asexual (i.e., lack of interest in either sex) 
0 Exclusively heterosexual 
1 Predominantly heterosexual, only incidentally homosexual 
2 Predominantly heterosexual, but more than incidentally homosexual 
3 Equally heterosexual and homosexual 
4 Predominantly homosexual, but more than incidentally heterosexual 
5 Predominantly homosexual, only incidentally heterosexual 
6 Exclusively homosexual 
11) What is the highest level of education that you have achieved? (please check) 
 
Some elementary school _____ College diploma/ 
certificate 
_____ 
Elementary school _____ Some university _____ 
Some high school _____ Undergraduate degree _____ 
High school diploma _____ Master’s degree _____ 
Some college _____ Doctorate degree _____ 
 
12) Total years of education (grade 1-12 + any university or college years): _______ years 
 
13. a) Are you currently taking any medications? YES      NO  




14) Please list any medical or psychological conditions which you have been diagnosed with 








15) Have your parents or siblings ever been diagnosed or treated for a mental illness? 
Yes  No   Unsure  
 
16) If YES, please check any that apply to your parents or siblings: 
Depression      Bipolar disorder    
Schizophrenia      Panic disorder    
Obsessive-compulsive disorder   Social Phobia    
Posttraumatic Stress Disorder    Phobia (e.g., blood, needles)    
Generalized Anxiety Disorder         Other (please specify):____________________ 
 
 
THE FOLLOWING QUESTIONS ARE FOR MALES ONLY:  
1. How old were you when you: 
a) first shaved?                              ________years and ________months old 
 
b) began growing pubic hair?     ________years and ________months old 
 
c) voice changed?                           ________years and ________months old 
d) had your growth spurt?           ________years and ________months old 
 
e) first experienced nocturnal emission (i.e., “wet dream”)? _____years and _____months old 
 
 
2. How confident are you of the estimations above (please circle your answer): 
1      2       3      4    5   6               7 
Very unsure                Very sure  
 
3. Have you been sexually active (i.e., had sexual intercourse) in the past 6 months? 
Yes             No     
 
4. With how many different partners have you had sex (sexual intercourse) in your entire 
lifetime?_______ 
 
THE REST OF THE QUESTIONS ARE FOR FEMALES ONLY: 
 
1) How old were you when you first started menstruating (i.e., got your period)? 
________years and ________months old 
 
2)  How old were you when your breasts started developing? 





3)  How old were you when you first noticed pubic hair growth? 
________years and ________months old 
 
4) Are you currently pregnant? YES       NO  MAYBE  
 
5) Have you ever been pregnant?  Yes      No      If YES, how many times? _________ 
 
6) How many children have you given birth to in your lifetime? (as opposed to adopted or 
foster children)? _______________ 
  
7) If you have children, how old are they? ____________________ 
 
8)  Have you had surgery to have one or both of your ovaries removed?  
No       
I don’t know      
Yes, unknown number were taken out   
Yes, part of an ovary was taken out   
Yes, one was removed     
 Yes, both were removed    
 
9) In the past month, has your weight changed (i.e., increased or decreased) by 5 or more 
pounds?  Yes     No   
 
10) Do you exercise vigorously (e.g., running) for more than 3 hours a week? 
Yes       No   
 
11) Have you been sexually active (i.e., had sexual intercourse) in the past 6 months? 
Yes             No      
 
12) With how many different partners have you had sex (sexual intercourse) in your entire 
lifetime?_______ 
 
13) Are you currently taking hormonal contraceptives (i.e., birth control, patch, injection)?  
 
YES  NO     
 
14) IF YOU ARE CURRENTLY TAKING HORMONAL CONTRACEPTIVES, please 
put an X beside the type of hormonal contraceptive you are currently taking. 
Oral contraceptives: 
Alesse   ____         Min-Ovral  ____        
Apri   ____   MinEstrin 1/20 ____        
Aviane   ____   Norinyl  ____        





Brevicon 1/35  ____         Ortho 0.5/35         ____   
Celesta  ____       Ortho 1/35                   ____  
Cerazette (progesterone only) ____     Ortho 7/7/7  ____  
Cyclen   ____          Ortho 10/11  ____ 
Cyestra 35  ____         Ortho-Cept  ____       
Demulen 30  ____      Ortho-Novum 1/50      ____ 
Demulen 50  ____      Ovral   ____ 
Diane 35  ____       Portia   ____ 
Gianvi   ____      Synphasic  ____ 
Linessa  ____      Tri-Cyclen  ____    
Loestrin   ____         Tri-Cyclen Lo  ____     
Marvelon  ____   Triphasil  ____ 
Microgynon  ____     Triquilar  ____  
Microlite  ____      Yasmin  ____ 
Micronor (progesterone only) ____   Yaz   ____ 
Other  _____ Name: ___________ 
 
Injected contraceptives:    
Depo-Provera         ____   Lunelle     ____ 
Other  _____ Name: __________ 
 
Contraceptive patch: 
Ortho-Evra ____    Other  _____   Name: ___________ 
 
Implant (in the upper arm):    




NuvaRing  ____   Other  _____ Name: ___________ 
 
Extended use Oral Contraceptives (3 or 4 periods per year): 
Seasonique  ____   Seasonale  ____ 
 
Barrier Methods: 





Cervical cap ____            Other: ____ Name: _________ 
 
If you use any other type of birth control not listed above, please list it here: 
____________________________________________________________________________ 
OR, I am taking hormonal contraceptives, but I’m not sure of which type    
 
15) IF YOU ARE CURRENTLY TAKING HORMONAL CONTRACEPTIVES, how long 
have you been taking hormonal contraceptives?  ______ years ______ months 
 
16) IF YOU ARE CURRENTLY TAKING ORAL CONTRACEPTIVES, what phase of 
your oral contraceptives are you currently in?  
 Week 1 of  active pills 
 Week 2 of active pills 
 Week 3 of active pills 
 Pill-free/Inactive/Sugar pill week (when most women have their period) 
 I take my pills continuously so I don’t get my period 
 
17) IF YOU ARE CURRENTLY TAKING HORMONAL CONTRACEPTIVES, do you 
have any intentions of discontinuing the use of oral contraceptives within the next few 
weeks?  YES   NO   MAYBE  
 
18) If you are NOT currently taking oral contraceptives, have you ever taken oral 
contraceptives before?  YES   NO   
 
19) If you have previously taken oral contraceptives but are not taking them right now, 
how many years and months has it been since you last took oral contraceptives?  
 _______ years and  ______  months  
 
20) If you are not currently taking oral contraceptives, would you say that you are 
currently practicing some form of contraception (i.e., are you using some physical or 
chemical method to prevent pregnancy)? YES   NO  
 
21) Which statement best describes your menstrual cycle? 
 I do not experience a menstrual period 
 I have not had my period in the past three months. 
 Some months I get my period and some months I don’t.  
 I usually get my period every month, but it is irregular and I cannot predict when it will  
start. 
 I usually get my period within two to three days of when I expect it. 







22) On average, what is the typical length (in days) of your menstrual cycle (i.e., how many 
days are there from the first day of one period to the first day of your next period)? Most 
people range between 25 and 35 days. Women on standard birth control pills 
have a 28-day cycle.  
______days 
 
23) On average, how many days does your period last for? (Most people’s periods last 
between 1 and 10 days). 
______ days 
 
24) Are you menstruating (i.e., on your period) today? Yes        No   
IF YES, for how many days (including today) have you been menstruating (i.e., on your 
period)? _____ days 
 
25) Using the calendars below as a reference, please indicate the FIRST day of your LAST 
menstrual period (i.e., the day your last period started). Please also indicate the day that you 
believe your next menstrual period will start (i.e., the day when you expect your next period). If 




























26) How confident are you that the above circled day was the first day of your last period? 
(Circle the best response) 
 
0 1 2 3 4 5 6 7 8  
0%  25%           50%            75%          100% 
 
27) How confident are you that the above day with an X is the day that you will next get 
your period?  (Circle the best response) 
0 1 2 3 4 5 6 7 8  




Do you experience some or any of the following premenstrual symptoms which start the week 
before your period and stop within a few days of bleeding? (please mark an “X” in the 
appropriate box) 
Symptom Not at all Mild Moderate Severe 
1. Anger/irritability     
2. Anxiety/tension     
3. Tearful/increased sensitivity to rejection     
4. Depressed mood/hopelessness     
5. Decreased interest in work activities     
6. Decreased interest in home activities     
7. Decreased interest in social activities     
8. Difficulty concentrating     
9. Fatigue/lack of energy     
10. Overeating/food cravings     
11. Insomnia     
12. Hypersomnia (needing more sleep)     
13. Feeling overwhelmed or out of control     
14. Physical symptoms: breast tenderness, 
headaches, joint/muscle pain, bloating, weight 
gain 
    
 
Have your symptoms, as listed above, interfered with: 
 Not at all Mild Moderate Severe 
A. Your work efficiency or productivity     
B. Your relationships with coworkers     
C. Your relationships with your family     
D. Your social life activities     







Appendix D: Debriefing Form A 
 Thank you for participating in the Emotions and Mood Study. This study is examining 
the effects of reproductive hormones on emotion and mood. This research is a part of Emily 
Fawcett’s doctoral dissertation and is being supervised by Dr. Mazmanian of the Department of 
Psychology at Lakehead University. You will be contacted shortly by the phone number or email 
address you provided in order to participate in the laboratory component of this study. Please be 
assured that your all of your responses will be coded to conceal your identity and your data will 
remain completely anonymous. Furthermore, your contact information (e.g., phone number or 
email address) will only be used to schedule appointments, will be stored separately from your 
questionnaire responses, and will be destroyed after the study is completed. 
Participation in this study involves attending two laboratory sessions at the Health, 
Hormones, and Behaviour Lab at Lakehead University. The two sessions will be scheduled over 
the course of a month and will take approximately one hour each. To thank you for your 
participation in the laboratory component of this study, you will be given a $5 Tim Horton’s gift 
certificate after each session (for a maximum of $10). Individuals enrolled in Introductory 
Psychology will be able to choose between receiving a bonus point per laboratory session (i.e., a 




Emily Fawcett, M.A. (Doctoral Candidate)  Dwight Mazmanian, Ph.D., C.Psych. 
Department of Psychology    Department of Psychology 
  Lakehead University     Lakehead University 
 955 Oliver Road     955 Oliver Road 
 Thunder Bay, ON, P7B 5E1    Thunder Bay, ON, P7B 5E1 
 emotionsandmood@lakeheadu.ca   dwight.mazmanian@lakeheadu.ca 






Appendix E: Emotions and Mood Covering Letter B 
Dear Potential Participant, 
  
You are invited to participate in the Emotions and Mood Study at Lakehead University. 
This study is being conducted by Emily Fawcett (Psychology Doctoral student) under the 
supervision of Dr. Dwight Mazmanian (Associate Professor) at Lakehead University. The 
purpose of the study is to examine the effects of reproductive hormones on emotion and mood.  
 
 Participation in this phase of the study involves partaking in two laboratory sessions at 
the Health, Hormones, and Behaviour Lab at Lakehead University. The two sessions will be 
scheduled over the course of a month and will take approximately one hour each. Each session 
will involve completing a computerized emotion identification task, completing several 
questionnaires, and having your hands scanned. Questionnaires will ask about your mood, 
experiences of unwanted and repetitive thoughts and behaviour, risk-taking, the degree of disgust 
you feel in various situations, and your beliefs surrounding responsibility for causing or 
preventing harm. Finally, females will be asked to give a saliva sample for measurement of 
reproductive hormone levels. Your contact information (e.g., phone number or email address) 
will only be used to schedule appointments, will be stored separately from your questionnaire 
responses, and will be destroyed after the study is completed. Your data will be kept in a secure 
manner by Dr. Dwight Mazmanian at Lakehead University for at least five years, as per 
university requirements. Only the researchers will be able to access your information. If the 
research findings are published, there will be no information which could identify you. At the 
end of storage, all paper files will be shredded and all computer files will be deleted. 
 
Participation in this study is completely voluntary and you may withdraw from the study 
at any time without penalty. There are no known physical or psychological risks associated with 
taking part in this study. However, you can choose not to answer any questions that make you 
feel uncomfortable. To thank you for your participation in this study, you will be given a $5 Tim 
Horton’s gift certificate for each laboratory session you attend (for a maximum of $10). 
Individuals enrolled in Introductory Psychology can choose between receiving a bonus point per 
laboratory session (i.e., a maximum of 2 bonus points), or the Tim Horton’s gift certificates. 
 
If you have any questions or concerns about this study please contact Ms. Fawcett at 
emotionsandmood@lakeheadu.ca, or Dr. Mazmanian by phone at (807) 343-8257. Other 
collaborators involved in this study include Dr. Kirsten Oinonen (Associate Professor of 
Psychology at Lakehead University). If you have any questions about your rights as a research 
subject or concerns about this study please contact Susan Wright (Research Ethics and 
Administration Officer) at the Lakehead University Research Ethics Board at (807) 343-8283. 
 
Sincerely, 
Emily Fawcett, M.A. (Doctoral Candidate)  Dwight Mazmanian, Ph.D., C.Psych. 
Department of Psychology    Department of Psychology 
  Lakehead University, 955 Oliver Rd.   Lakehead University, 955 Oliver Rd. 
 Thunder Bay, ON, P7B 5E1    Thunder Bay, ON, P7B 5E1 
 emotionsandmood@lakeheadu.ca   dwight.mazmanian@lakeheadu.ca 





Appendix F: Consent Form B 
 
The purpose of the study is to examine the effects of reproductive hormones on emotion 
and mood. This study is being conducted by Emily Fawcett (Psychology Doctoral student) under 
the supervision of Dr. Dwight Mazmanian (Associate Professor) at Lakehead University. 
 
Please read the following points about this study: 
 Your participation in this study will involve coming into the Health, Hormones, and 
Behaviour Lab on two separate occasions, for approximately one hour each. 
 You will complete a computerized task involving facial expression recognition, answer 
several questionnaires, have your hands scanned, and a number of eligible women will be 
asked to provide a saliva sample for measurement of reproductive hormone levels. 
 Questionnaires will ask about your mood, experiences of unwanted and repetitive 
thoughts and behaviour, risk-taking, the degree of disgust you feel in various situations, 
and your beliefs responsibility for causing or preventing harm. 
 There are no known physical or psychological risks associated with taking part in this 
study. However, some people may find that certain questions lead to feelings of disgust 
or discomfort. You may decline to answer any question you wish. 
 Your participation is voluntary, you may refuse to participate in any part of the study, and 
you may withdraw from the study at any time without penalty. 
 Potential benefits of participating in this research include advancing research on men’s 
and women’s health and learning a greater understanding of the research process. 
 All of the data collected in this study will be kept completely confidential. 
 Your information will be kept in a secure manner at Lakehead University for at least five 
years as stated by university rules. Only the researchers will have access to your 
information. If the research findings are published, there will be no information which 
could identify you.  
 You may contact the researchers if you would like a summary of the results of the study 
when it is completed.  
 
I have read and understood the cover letter and consent form, and agree to participate in this 
study under these conditions. I also confirm that I am at least 17 years of age. 
 
Name:  _______________________________________ 
 
Date:  _______________________________________ 
 
Email address (if preferred method of contact):_______________________________________ 
 
Phone Number (if preferred method of contact):_______________________________________ 
 If you have any questions or concerns regarding this study please contact Emily Fawcett 
(emotionsandmood@lakeheadu.ca) or the supervisor of this study, Dr. Dwight Mazmanian (phone: (807) 
343-8257, email: dwight.mazmanian@lakeheadu.ca ). Other collaborators in this study include Dr. Kirsten 
Oinonen (Associate Professor of Psychology at Lakehead University). If you have any questions about your 




































Participant #: _______ 
_____________________________________________________________________________________ 
Phase 1 Questionnaire 
 ____________________________________________________________________________________                                                                                                                                                             
 
1) Today’s date: _________________     _______________          _______________ 
                   Day of week              Day of Month                          Month:  
                        (e.g., Monday)              (e.g., 5th)           (e.g., May) 
 
2) Sex: Male   Female   
 
3) Age: ______ 
 
PI-WSUR 
The following statements refer to thoughts and behaviours which may occur to everyone in 
everyday life.  For each statement, choose the reply which best seems to fit you within the past 
48 hours and the degree of disturbance which such thoughts or behaviours may create. 












2 I think even slight contact with bodily 
secretions (perspiration, saliva urine, etc.) 












3 I find it difficult to touch an object when I 
























5 I avoid using public toilets because I am 











6 I avoid using public telephones because I 























8 I sometimes have to wash or clean myself 












9 If I touch something I think is 
“contaminated”, I immediately have to 











10 If an animal touches me, I feel dirty and 
















11 I feel obliged to follow a particular order in 











12 Before going to sleep, I have to do certain 











13 Before going to bed, I have to hang up or 











14 I have to do things several times before I 











15 I tend to keep on checking things more 











16 I check and recheck gas and water taps and 











17 I return home to check doors, windows, 












18 I keep on checking forms, documents, 
checks, etc., in detail to make sure I have 











19 I keep on going back to see that matches, 











20 When I handle money, I count and recount 























22 Sometimes I am not sure I have done things 











23 When I read, I have the impression I have 
missed something important and must go 












24 I imagine catastrophic consequences as a 
result of absent-mindedness or minor errors 











25 I think or worry at length about having hurt 











26 When I hear about a disaster, I think it is 











27 I sometimes worry at length for no reason 












28 I get upset and worried at the sight of 














When I hear about a suicide or a crime, I 
am upset for a long time and find it difficult 
































31 When I look down from a bridge or a very 
high window, I feel an impulse to throw 











32 When I see a train approaching, I 












33 At certain moments, I am tempted to tear 











34 While driving, I sometimes feel an impulse 











35 Seeing weapons excites me and makes me 











36 I sometimes feel the need to break or 











37 I sometimes have an impulse to steal other 
people’s belongings, even if they are of no 











38 I am sometimes almost irresistibly tempted 











39 I sometimes have an impulse to hurt 














1) I try to get at least some sleep every night 
True  False  
 
2) I have attended school at some time during my life 
True  False  
 
3) I have never had any hair on my head 
True  False  
 
4) I have never ridden in an automobile 




Please indicate how much you agree with each of the following statements, or how true it is 
about you within the past 48 hours. Please write a number (0-4) to indicate your answer: 
     0 = Strongly disagree (very untrue about me) 
             1 = Mildly disagree (somewhat untrue about me) 





                             3 = Mildly agree (somewhat true about me) 
                                     4 = Strongly agree (very true about me) 
____1. I might be willing to try eating monkey meat, under some circumstances.  
____2. It would bother me to be in a science class, and to see a human hand preserved in a jar.  
____3. It bothers me to hear someone clear a throat full of mucous.  
____4. I never let any part of my body touch the toilet seat in public restrooms.  
____5. I would go out of my way to avoid walking through a graveyard.  
____6. Seeing a cockroach in someone else's house doesn't bother me.  
____7. It would bother me tremendously to touch a dead body.  
____8. If I see someone vomit, it makes me sick to my stomach.  
____9. I probably would not go to my favorite restaurant if I found out that the cook had a cold.  
____10. It would not upset me at all to watch a person with a glass eye take the eye  
out of the socket.   
____11. It would bother me to see a rat run across my path in a park.  
____12. I would rather eat a piece of fruit than a piece of paper  
____13. Even if I was hungry, I would not drink a bowl of my favorite soup if it had been 
stirred by a used but thoroughly washed flyswatter.  
____14. It would bother me to sleep in a nice hotel room if I knew that a man had died of a 
heart attack in that room the night before.  
 
In the past 48 hours, how disgusting would you find each of the following experiences? 
Please write a number (0-4) to indicate your answer: 
     0 = Not disgusting at all 
             1 = Slightly disgusting      
                     2 = Moderately disgusting    
                             3 = Very disgusting 
             4 = Extremely disgusting      
____15. You see maggots on a piece of meat in an outdoor garbage pail.  
____16. You see a person eating an apple with a knife and fork 
____17. While you are walking through a tunnel under a railroad track, you smell urine.  
____18. You take a sip of soda, and then realize that you drank from the glass that an 
   acquaintance of yours had been drinking from.  
____19. Your friend's pet cat dies, and you have to pick up the dead body with your bare hands.   
____20. You see someone put ketchup on vanilla ice cream, and eat it.  
____21. You see a man with his intestines exposed after an accident.  
____22. You discover that a friend of yours changes underwear only once a week.  
____23. A friend offers you a piece of chocolate shaped like dog-doo.  
____24. You accidentally touch the ashes of a person who has been cremated.  
____25. You are about to drink a glass of milk when you smell that it is spoiled.  





  condom, using your mouth.  






The following items describe a variety of concepts. Please rate how disgusting you find the 
concepts described in the items(within the past 48 hours), where 0 means that you do not 
find the concept disgusting at all and 6 means that you find the concept extremely 
disgusting. 
Not at all         Extremely 
disgusting         disgusting 
1. Stepping on dog poop      0       1       2       3      4       5       6 
2. Sitting next to someone who has red sores on their arm   0       1       2       3      4       5       6 
3. Shaking hands with a stranger who has sweaty palms  0       1       2       3      4       5       6 
4. Seeing some mold on old leftovers in your refrigerator   0       1       2       3       4      5       6 
5. Standing close to a person who has body odor   0        1       2       3       4      5       6 
6. Seeing a cockroach run across the floor    0        1       2       3       4      5       6 
7. Accidentally touching a person’s bloody cut   0       1       2       3       4      5       6 
 
Please rate the extent to which you agree to the following statement: 
When completing the disgust-related questions on the past two pages, I experienced a physical 
reaction to the questions (e.g., grimacing/contorting of the face, furrowing of the eyebrows, 
wrinkling of the nose, etc.). 
1                 2                 3                 4                 5                 6                 7   
Not at all         Extremely 
IN2 Scale 
1) I could easily count from one to twenty-five 
True  False  
 
2) I have never talked to anyone by telephone 
True  False  
 
3) I make all my own clothes and shoes 
True  False  
 
4) Things with sugar in them usually taste sweet to me 










For each of the following statements, please indicate the likelihood that you would engage in the 
described activity or behaviour if you were to find yourself in that situation in the next 48 hours. 
Provide a rating from Extremely Unlikely to Extremely Likely by circling the corresponding 
number. 
1. Admitting that your tastes are different from those of a friend.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
2. Going camping in the wilderness. (assuming it is summer) 
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
3. Betting a day’s income at the horse races.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
4. Investing 10% of your annual income in a moderate growth mutual fund.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
5. Drinking heavily at a social function.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
6. Taking some questionable deductions on your income tax return.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
7. Disagreeing with an authority figure on a major issue.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 








8. Betting a day’s income at a high-stake poker game.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
9. Having an affair with a married man/woman.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
10. Passing off somebody else’s work as your own.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
11. Going down a ski run that is beyond your ability.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
12. Investing 5% of your annual income in a very speculative stock.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
13. Going whitewater rafting at high water in the spring. (assume it is spring now). 
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
14. Betting a day’s income on the outcome of a sporting event. 
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
15. Engaging in unprotected sex with a stranger.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
16. Revealing a friend’s secret to someone else.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 





17. Driving a car without wearing a seat belt.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
18. Investing 10% of your annual income in a new business venture.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
19. Taking a skydiving class.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
20. Riding a motorcycle without a helmet.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
21. Choosing a career that you truly enjoy over a more secure one. 
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
22. Speaking your mind about an unpopular issue in a meeting at work.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
23. Sunbathing without sunscreen.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
24. Bungee jumping off a tall bridge.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
25. Piloting a small plane. 
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 





26. Walking home alone at night in an unsafe area of town.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
27. Moving to a city far away from your extended family.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
28. Starting a new career in your mid-thirties.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
29. Leaving your young children alone at home while running an errand.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
30. Not returning a wallet you found that contains $200.  
1      2       3      4    5   6               7 
Extremely       Moderately     Somewhat       Not sure      Somewhat      Moderately      Extremely 
 Unlikely            Unlikely        Unlikely             Likely            Likely             Likely 
 
31. Have you been sexually active (i.e., had sexual intercourse) in the past 7 days? 
Yes             No     
IN3 Scale: 
 
1) I usually wear something warm when I go outside on a very cold day 
True  False  
 
2) Sometimes I see cars near my home 
True  False  
  
3) I have never bought anything from a store 
True  False  
 
4) I can run a mile in less than four minutes 










This questionnaire lists different attitudes or beliefs which people sometimes hold. Read each 
statement carefully and decide how much you agree or disagree with it. For each of the attitudes, 
show your answer by putting a circle round the words which BEST DESCRIBE HOW YOU 
THINK. Be sure to choose only one answer for each attitude. Because people are different, there 
is no right answer or wrong answer to these statements. 
To decide whether a given attitude is typical of your way of looking at things, simply keep in 
mind what you have been like MOST OF THE TIME over the past 48 hours. 
 
1. I often feel responsible for the things which go wrong. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
2. If I don’t act when I can foresee danger, then I am to blame for any consequences if 
it happens. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
3. I am too sensitive to feeling responsible for things going wrong. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
4. If I think bad things, this is as bad as doing bad things. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
5. I worry a great deal about the effects of things which I do or don’t do. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
6. To me, not acting to prevent disaster is as bad as making disaster happen. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
7. If I know that harm is possible, I should always try to prevent it, however unlikely it 
seems. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
8. I must always think through the consequences of even the smallest actions. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
9. I often take responsibility for things which other people don’t think are my fault. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
10. Everything I do can cause serious problems. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 







11.  I am often close to causing harm. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
12. I must protect others from harm. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
13. I should never cause even the slightest harm to others. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
14. I will be condemned for my actions. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
15. If I can have even a slight influence on things going wrong, then I must act to 
prevent it. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
16. To me, not acting when disaster is a slight possibility is as bad as making that 
disaster happen. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
17. For me, even slight carelessness is inexcusable when it might affect other people. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
18. In all kinds of daily situations, my inactivity can cause as much harm as deliberate 
bad intentions. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
19. Even if harm is a very unlikely possibility, I should always try to prevent it at any 
cost. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
20. Once I think it is possible that I have caused harm, I can’t forgive myself. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
21. Many of my past actions have been intended to prevent harm to others. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
22. I have to make sure other people are protected from all of the consequences of 
things I do. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
23. Other people should not rely on my judgment. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 





24. If I cannot be certain I am blameless, I feel that I am to blame. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
25. If I take sufficient care then I can prevent any harmful accidents. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
26. I often think that bad things will happen if I am not careful enough. 
Totally         Agree very        Agree         Neutral       Disagree          Disagree        Totally 
Agree          much   Slightly        Slightly       very much        disagree 
 
SD Scale: 
1) I am never able to do things as well as I should. 
True  False  
2) I believe people tell lies any time it is to their advantage. 
True  False  
3) I would be willing to do something a little unfair to get something that was important to 
me. 
True  False  
4) I did many very bad things as a child. 
True  False  
5) I often question whether life is worthwhile. 
True  False  
6) My daily life includes many activities I dislike. 
True  False  
7) Many things make me feel uneasy. 
True  False  
8) I find it very difficult to concentrate. 
True  False  
9) I am quite able to make correct decisions on difficult questions. 
True  False  
10) My life is full of interesting activities. 
True  False  
11) If someone gave me too much change I would tell him. 
True  False  
12) I get along with people at parties quite well. 
True  False  
13) I am glad I grew up the way I did. 
True  False  
14) I am always prepared to do what is expected of me. 






15) I am one of the lucky people who could talk with my parents about my problems. 
True  False  
16) I am careful to plan for my distant goals. 





Read each statement and mark the box that comes closest to how you have been feeling in the 
past 48 hours. Your immediate reaction will probably be more accurate than a long, thought-out 
response. 
 
 1. I feel tense or ‘wound up’: 
 Most of the time     
 A lot of the time   
 Time to time. Occasionally.   
 
 Not at all 
 
2. I still enjoy the things I used to enjoy: 
 Definitely as much     
 Not quite so much  
 Only a little      
 Hardly at all 
3. I get a sort of frightened feeling as if something awful is about to happen: 
 Very definitely and quite badly   
 Yes, but not too badly  
 A little, but it doesn’t worry me   
 Not at all 
4. I can laugh and see the funny side of things: 
 As much as I always could    
 Not quite so much now  
 Definitely not so much now   





5. Worrying thoughts go through my mind: 
 A great deal of the time    
 A lot of the time  
 From time to time but not too often  
 Only occasionally 
6. I feel cheerful: 
 Not at all      
 Not often  
 Sometimes      
 Most of the time 
7. I can sit at ease and feel relaxed: 
 Definitely      
 Usually  
 Not often      
 Not at all 
8.  I feel as if I am slowed down:  
 Nearly all the time     
 Very often  
 Sometimes      
 Not at all 
9. I get a sort of frightened feeling like “butterflies” in the stomach: 
 Not at all      
 Occasionally  
 Quite often      
 Very often 
10.I have lost interest in my appearance: 
 Definitely     





 I may not take quite as much care  
 I take just as much care 
11.I feel restless as if I have to be on the move: 
 Very much indeed     
 Quite a lot  
 Not very much     
 Not at all 
12.I look forward with enjoyment to things: 
 As much as I ever did    
 Rather less than I used to  
 Definitely less than I used to   
 Hardly at all 
13.I get sudden feelings of panic: 
 Very often indeed     
 Quite often  
 Not very often     
 Not at all 
14.I can enjoy a good book or radio or TV programme: 
 Often       
 Sometimes  
 Not often      
 Very seldom 
IN4 Scale  
 
1) I have never brushed or cleaned my teeth 
True  False  
 
2) I have travelled away from my home town 






3) I have never felt sad 
True  False  
 
4) Sometimes I feel thirsty or hungry 
True  False  
 
THE FINAL QUESTIONS ARE FOR FEMALES ONLY: 
1) Are you menstruating (i.e., on your period) today? Yes        No   
IF YES, for how many days (including today) have you been menstruating (i.e., on your 
period)? _____ days 
 
2) Using the calendars below, please circle the first day of your last menstrual period.  If you are 
not completely sure, please estimate the day that you believe you started menstruating on.  Also, 























3) How confident are you that the above circled day was the first day of your last period? 
(Circle the best response) 
 
0 1 2 3 4 5 6 7 8  






4) How confident are you that the above day with an X is the day that you will next get 
your period?  (Circle the best response) 
0 1 2 3 4 5 6 7 8  















































Appendix H: Debriefing Form B 
 Thank you for participating in the Emotions and Mood Study at Lakehead University. 
The purpose of this study was to examine the impact of reproductive hormones on anxiety 
symptoms and disgust sensitivity across the menstrual cycle in women. Men were also included 
in this study for comparison purposes. However, there may be unique findings related to men as 
well.  Research has shown that women are at greater risk for developing anxiety disorders across 
major reproductive events such as puberty, across the menstrual cycle, the postpartum period, 
and menopause. Coincidentally, these times also correspond to fluctuations in reproductive 
hormone levels. Past research has also shown that females have higher disgust sensitivity 
compared to males and that hormones may be a factor in this sex difference. 
The questionnaires that were completed in the laboratory during this study measured 
mood, obsessive thinking and compulsive behaviour, disgust sensitivity, risk-taking, and beliefs 
surrounding responsibility for causing or preventing harm. Furthermore, your hands were 
scanned in order to measure the ratio of the length of your 2nd digit to your 4th digit (i.e., 2D:4D) 
and saliva samples were obtained from eligible participants in order to measure reproductive 
hormone levels. For females, the dates that you participated in this study corresponded to two 
phases of the menstrual cycle: the follicular phase and the luteal phase.  
Please be assured that all of your responses will be coded to conceal your identity and 
your data will remain completely anonymous. If you would like a summary of the results of this 
study, please email emotionsandmood@lakeheadu.ca and we will send you a summary of the 
study when it is completed. If you have become in any way distressed from completing this 
study, or have any mental health concerns, please do not hesitate to contact the following 
services: 
 Thunder Bay Crisis Response (available 24 hours) at (807) 346-8282 
 Lakehead University’s Student Health and Counselling Centre at (807) 343-8361 
 Thunder Bay Regional Health Sciences Centre Walk in Clinic at (807) 768-1333 
Below we have listed two articles if you are interested in learning more about the 
influence of reproductive hormones on emotions and mood. Thank you for taking part in this 
study. 
Recommended Readings: 
Fleischman, D. S., & Fessler, D. M. (2011). Progesterone's effects on the psychology of disease  
avoidance: Support for the compensatory behavioural prophylaxis hypothesis. Hormones 
and Behaviour, 59, 271-275.  
Sigmon, S. T., & Schartel, J. G. (2008). Anxiety, anxiety disorders, and the menstrual cycle. In  
M. J. Zvolensky & J. A. Smits (Eds.), Anxiety in health behaviours and physical illness 
(pp. 181-205). New York, NY: Springer.  
 If you have any questions or concerns regarding this study please contact Emily Fawcett 
(emotionsandmood@lakeheadu.ca) or the supervisor of this study, Dr. Dwight Mazmanian (phone: (807) 
343-8257, email: dwight.mazmanian@lakeheadu.ca ). Other collaborators in this study include Dr. Kirsten 
Oinonen (Associate Professor of Psychology at Lakehead University). If you have any questions about your 
rights as a research subject, please contact the Lakehead University Research Ethics Board at (807) 343-
8283. 
